[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_ea63fd5d-2e37-4fe7-b45b-faad8edb4146":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:ea63fd5d-2e37-4fe7-b45b-faad8edb4146,\"}":63},{"code":4,"data":5,"meta":19},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":21,"manageAffiliations":30,"indexDatabases":42,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},"ea63fd5d-2e37-4fe7-b45b-faad8edb4146","2023-05-29T10:46:20.635+00:00","2025-11-21T10:02:21.701+00:00",[],"Oncotarget",{"country":12,"issn":14,"title":16},{"VOID":13},"US",{"VOID":15},"19492553",{"EN":10},"PUBLISHER","PENDING",null,0,[22],{"id":23,"createTime":24,"updateTime":25,"relativeEntities":26,"label":27,"description":29,"parentId":19,"standard":19,"scholarHubFieldId":19},"d9687dc3-fd83-46ff-aef4-1925044c24eb","2023-05-29T10:24:05.052+00:00","2023-11-21T05:08:37.643+00:00",[],{"EN":28},"Oncology",{},[31],{"id":32,"createTime":33,"updateTime":34,"relativeEntities":35,"slug":36,"properties":37,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"url":19,"parentIds":41,"statistic":19},"d224ed36-f0b0-4540-bace-bd6676fce85a","2023-05-29T10:46:20.576+00:00","2023-12-26T02:46:51.264+00:00",[],"Impact-Journals-LLC",{"title":38},{"EN":39},"Impact Journals LLC","AFFILIATION",[],[43],{"id":44,"indexDatabase":45,"url":57,"indexYears":58,"academicFieldIds":59,"indexDatabaseRanking":61},"bc6746ac-bbe4-4026-80d5-f3e58d888400",{"id":46,"createTime":47,"updateTime":48,"relativeEntities":49,"label":50,"description":52,"key":54,"publicationTags":55,"standard":19},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":51,"VI":51},"Scopus - Elsevier",{"EN":51,"VI":53},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[56],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F19900191708","2010-2025",[60],"462e3fe4-4fc0-4c02-80d6-8d2af4fc74ea","SCOPUS__Q2","",{"meta":64,"data":66},{"total":65},"335",[67,586,1004,2645,3158,3707,4069,4464,4827,5285],{"id":68,"createTime":69,"updateTime":69,"relativeEntities":70,"slug":71,"properties":72,"entityType":87,"verifyStatus":88,"verifyTime":69,"verifyNote":89,"syncStatus":18,"languages":90,"translateLanguages":19,"viewCount":20,"primaryUrl":92,"fullTextUrl":19,"authors":93,"publicationType":442,"publisherRelationship":443,"citationCount":467,"citationInfo":468,"publishDate":471,"publishYear":472,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":473,"isForceReanalyzing":585},"5fecdc03-4eae-491c-9351-190ef78b36bb","2024-09-11T23:58:31.912+00:00",[],"Apigenin-inhibits-NF-%CE%BAB-and-Snail-signaling-EMT-and-metastasis-in-human-hepatocellular-carcinoma",{"mag":73,"keywords":75,"pmc":76,"openalex":78,"abstract":80,"title":81,"pm":83,"doi":85},{"VOID":74},"2405025605",{},{"VOID":77},"5173069",{"VOID":79},"W2405025605",{},{"EN":82},"Apigenin inhibits NF-κB and Snail signaling, EMT and metastasis in human hepatocellular carcinoma",{"VOID":84},"27203387",{"VOID":86},"10.18632\u002Foncotarget.9404","PUBLICATION","VERIFIED","Auto Verify",[91],"EN","https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.9404",[94,128,152,175,199,223,247,265,283,301,324,348,372,396,420],{"id":95,"sortIndex":96,"researcher":19,"roles":97,"affiliations":98,"properties":121},"02b794d8-5960-4e95-94f6-76b025a888e2",6,[],[99,110],{"id":100,"sortIndex":20,"affiliation":101,"properties":19},"0d1c1b17-4d2d-49b5-84e3-fcc266728753",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":105,"slug":106,"properties":107,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"96f54f6c-1782-447c-a691-089ed101d39d","2023-12-12T13:49:04.115+00:00","2024-09-11T23:58:31.928+00:00",[],"State-Key-Laboratory-of-Medicinal-Chemical-Biology-and-College-of-Pharmacy-Nankai-University-Tianjin-China",{"title":108},{"VI":109},"State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China",{"id":111,"sortIndex":112,"affiliation":113,"properties":19},"f9f094d0-8700-483e-bc1d-328127618bef",1,{"id":114,"createTime":115,"updateTime":115,"relativeEntities":116,"slug":117,"properties":118,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"8138ff39-28ee-44ce-b855-8d61ed65b8b3","2024-09-11T23:58:31.932+00:00",[],"Tianjin-Key-Laboratory-of-Molecular-Drug-Research-Nankai-University-and-Tianjin-International-Joint-Academy-of-Biomedicine-Tianjin-China",{"title":119},{"EN":120},"Tianjin Key Laboratory of Molecular Drug Research, Nankai University and Tianjin International Joint Academy of Biomedicine, Tianjin, China",{"openalex":122,"orcid":124,"title":126},{"VOID":123},"A5027138510",{"VOID":125},"https:\u002F\u002Forcid.org\u002F0000-0002-4465-4458",{"EN":127},"Wenguang Gu",{"id":129,"sortIndex":130,"researcher":19,"roles":131,"affiliations":132,"properties":145},"c61130c2-a19e-43cc-82ca-c1d8f32012b8",12,[],[133,139],{"id":134,"sortIndex":112,"affiliation":135,"properties":19},"63d2c0ec-a785-443a-90da-ad1fa27457d1",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":136,"slug":117,"properties":137,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":138},{"EN":120},{"id":140,"sortIndex":20,"affiliation":141,"properties":19},"d3bc634f-6e1f-4a61-8584-88e4600de69f",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":142,"slug":106,"properties":143,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":144},{"VI":109},{"openalex":146,"orcid":148,"title":150},{"VOID":147},"A5091169010",{"VOID":149},"https:\u002F\u002Forcid.org\u002F0000-0003-1542-1329",{"EN":151},"Yuan Guo",{"id":153,"sortIndex":20,"researcher":19,"roles":154,"affiliations":155,"properties":168},"749b1eea-4e2c-4f50-8fef-12984a050db8",[],[156,162],{"id":157,"sortIndex":20,"affiliation":158,"properties":19},"fd4f19e9-c90b-4e9d-bba4-2b0fe02d1b53",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":159,"slug":106,"properties":160,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":161},{"VI":109},{"id":163,"sortIndex":112,"affiliation":164,"properties":19},"3a93e106-1999-47c1-a271-3336d323ef68",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":165,"slug":117,"properties":166,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":167},{"EN":120},{"openalex":169,"orcid":171,"title":173},{"VOID":170},"A5065748896",{"VOID":172},"https:\u002F\u002Forcid.org\u002F0000-0002-5651-8293",{"EN":174},"Yuan Qin",{"id":176,"sortIndex":177,"researcher":19,"roles":178,"affiliations":179,"properties":192},"5f02ed4e-5143-4394-8e72-aab6cd5486d0",11,[],[180,186],{"id":181,"sortIndex":112,"affiliation":182,"properties":19},"ed053bfd-a74e-453e-aba0-f5d65d413a30",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":183,"slug":117,"properties":184,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":185},{"EN":120},{"id":187,"sortIndex":20,"affiliation":188,"properties":19},"864fc564-eb83-4c92-9713-c76df6ed7a5b",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":189,"slug":106,"properties":190,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":191},{"VI":109},{"openalex":193,"orcid":195,"title":197},{"VOID":194},"A5100381911",{"VOID":196},"https:\u002F\u002Forcid.org\u002F0000-0002-3929-1541",{"EN":198},"Qiang Zhang",{"id":200,"sortIndex":201,"researcher":19,"roles":202,"affiliations":203,"properties":216},"acb1137a-1414-4d73-9574-d55561032023",8,[],[204,210],{"id":205,"sortIndex":20,"affiliation":206,"properties":19},"1e6f9b8b-ff76-4e36-8b2c-40c723635193",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":207,"slug":106,"properties":208,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":209},{"VI":109},{"id":211,"sortIndex":112,"affiliation":212,"properties":19},"b9cff0b3-a713-43e3-aa4f-1e0badb53036",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":213,"slug":117,"properties":214,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":215},{"EN":120},{"openalex":217,"orcid":219,"title":221},{"VOID":218},"A5100633257",{"VOID":220},"https:\u002F\u002Forcid.org\u002F0000-0002-1210-622X",{"EN":222},"Chunhong Zhang",{"id":224,"sortIndex":225,"researcher":19,"roles":226,"affiliations":227,"properties":240},"18a31298-3ab6-4c34-a3c4-96f3a4179f6c",2,[],[228,234],{"id":229,"sortIndex":112,"affiliation":230,"properties":19},"8b3c831a-8a5d-41cd-84a5-1a1320063d28",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":231,"slug":117,"properties":232,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":233},{"EN":120},{"id":235,"sortIndex":20,"affiliation":236,"properties":19},"0d115c7e-8769-436f-85bf-042d882fb2e2",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":237,"slug":106,"properties":238,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":239},{"VI":109},{"openalex":241,"orcid":243,"title":245},{"VOID":242},"A5085610505",{"VOID":244},"https:\u002F\u002Forcid.org\u002F0000-0003-2987-3422",{"EN":246},"Honggang Zhou",{"id":248,"sortIndex":249,"researcher":19,"roles":250,"affiliations":251,"properties":258},"01fabca5-ed91-4930-a81f-e1c672675e69",5,[],[252],{"id":253,"sortIndex":20,"affiliation":254,"properties":19},"9bb7cc32-c19f-481f-921b-29a4e8d5860c",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":255,"slug":117,"properties":256,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":257},{"EN":120},{"openalex":259,"orcid":261,"title":263},{"VOID":260},"A5100443487",{"VOID":262},"https:\u002F\u002Forcid.org\u002F0000-0001-5254-6353",{"EN":264},"Shuang Chen",{"id":266,"sortIndex":267,"researcher":19,"roles":268,"affiliations":269,"properties":276},"43d41d54-429e-41dd-95e1-3caa6cd99c16",10,[],[270],{"id":271,"sortIndex":20,"affiliation":272,"properties":19},"7c2d4e6e-9684-4d73-9671-36534a05c46d",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":273,"slug":117,"properties":274,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":275},{"EN":120},{"openalex":277,"orcid":279,"title":281},{"VOID":278},"A5100784680",{"VOID":280},"https:\u002F\u002Forcid.org\u002F0000-0002-8096-7005",{"EN":282},"Huijuan Liu",{"id":284,"sortIndex":285,"researcher":19,"roles":286,"affiliations":287,"properties":294},"cb5c5444-30b4-4557-9f3b-e2fa3e547eb6",9,[],[288],{"id":289,"sortIndex":20,"affiliation":290,"properties":19},"94fb25e7-0782-40ef-8368-586cde83d8a6",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":291,"slug":117,"properties":292,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":293},{"EN":120},{"openalex":295,"orcid":297,"title":299},{"VOID":296},"A5101682999",{"VOID":298},"https:\u002F\u002Forcid.org\u002F0000-0003-1394-7925",{"EN":300},"Yanrong Liu",{"id":302,"sortIndex":112,"researcher":19,"roles":303,"affiliations":304,"properties":317},"fb8a1b22-6e52-4b6d-b86c-99ab19346a34",[],[305,311],{"id":306,"sortIndex":20,"affiliation":307,"properties":19},"168e333d-4476-40e1-8bbf-6f6ee43533f1",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":308,"slug":106,"properties":309,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":310},{"VI":109},{"id":312,"sortIndex":112,"affiliation":313,"properties":19},"69e741b8-050c-4cc9-b532-b80f9b304867",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":314,"slug":117,"properties":315,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":316},{"EN":120},{"openalex":318,"orcid":320,"title":322},{"VOID":319},"A5066699252",{"VOID":321},"https:\u002F\u002Forcid.org\u002F0000-0002-9847-5439",{"EN":323},"Dong Zhao",{"id":325,"sortIndex":326,"researcher":19,"roles":327,"affiliations":328,"properties":341},"3a124702-cf2c-47da-a79c-cdcae54801d6",7,[],[329,335],{"id":330,"sortIndex":112,"affiliation":331,"properties":19},"fef7aa25-e919-4daa-9193-10836858f7b4",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":332,"slug":117,"properties":333,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":334},{"EN":120},{"id":336,"sortIndex":20,"affiliation":337,"properties":19},"14150f5f-c764-4c68-8b37-fdd44910e2f7",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":338,"slug":106,"properties":339,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":340},{"VI":109},{"openalex":342,"orcid":344,"title":346},{"VOID":343},"A5100392002",{"VOID":345},"https:\u002F\u002Forcid.org\u002F0000-0002-5386-9530",{"EN":347},"Wei Wang",{"id":349,"sortIndex":350,"researcher":19,"roles":351,"affiliations":352,"properties":365},"5fc97345-ce14-4899-ae7f-bfb3cbfd1e61",4,[],[353,359],{"id":354,"sortIndex":112,"affiliation":355,"properties":19},"47989b13-9b6d-4dce-9c34-dfcec72dbb11",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":356,"slug":117,"properties":357,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":358},{"EN":120},{"id":360,"sortIndex":20,"affiliation":361,"properties":19},"080465b5-ea54-4f94-bba3-748611ce6e92",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":362,"slug":106,"properties":363,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":364},{"VI":109},{"openalex":366,"orcid":368,"title":370},{"VOID":367},"A5037377007",{"VOID":369},"https:\u002F\u002Forcid.org\u002F0000-0002-7139-169X",{"EN":371},"Weilong Zhong",{"id":373,"sortIndex":374,"researcher":19,"roles":375,"affiliations":376,"properties":389},"59acf2ff-a1ec-4fc1-af5f-82f2bf9af67f",13,[],[377,383],{"id":378,"sortIndex":112,"affiliation":379,"properties":19},"bae78a66-2de2-49b8-b8b7-1052ab56df47",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":380,"slug":117,"properties":381,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":382},{"EN":120},{"id":384,"sortIndex":20,"affiliation":385,"properties":19},"080b2c82-f8fc-4af1-8869-678dda32478d",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":386,"slug":106,"properties":387,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":388},{"VI":109},{"openalex":390,"orcid":392,"title":394},{"VOID":391},"A5017379979",{"VOID":393},"https:\u002F\u002Forcid.org\u002F0000-0002-8962-2193",{"EN":395},"Tao Sun",{"id":397,"sortIndex":398,"researcher":19,"roles":399,"affiliations":400,"properties":413},"d83b62ff-a6d3-441a-addd-367d42819e1e",14,[],[401,407],{"id":402,"sortIndex":20,"affiliation":403,"properties":19},"4cda3b9b-059c-4abb-b16c-5eeedcf75d6f",{"id":102,"createTime":103,"updateTime":104,"relativeEntities":404,"slug":106,"properties":405,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":406},{"VI":109},{"id":408,"sortIndex":112,"affiliation":409,"properties":19},"ec7c93bc-849c-48b6-92f6-52e692fe1eb7",{"id":114,"createTime":115,"updateTime":115,"relativeEntities":410,"slug":117,"properties":411,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":412},{"EN":120},{"openalex":414,"orcid":416,"title":418},{"VOID":415},"A5013811376",{"VOID":417},"https:\u002F\u002Forcid.org\u002F0000-0001-9431-290X",{"EN":419},"Cheng Yang",{"id":421,"sortIndex":422,"researcher":19,"roles":423,"affiliations":424,"properties":435},"f04168ff-de54-4017-8fc3-77626970a77f",3,[],[425],{"id":426,"sortIndex":20,"affiliation":427,"properties":19},"2bedbe33-051b-4e62-8101-df04faf97e87",{"id":428,"createTime":429,"updateTime":429,"relativeEntities":430,"slug":431,"properties":432,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"45fa38dd-5ffd-4e19-95fd-c580afa14336","2024-09-11T23:58:31.970+00:00",[],"Department-of-Pathology-The-People-s-Hospital-of-Shouguang-City-Shouguang-Shandong-Province-China",{"title":433},{"EN":434},"Department of Pathology, The People's Hospital of Shouguang City, Shouguang, Shandong Province, China",{"openalex":436,"orcid":438,"title":440},{"VOID":437},"A5068254443",{"VOID":439},"https:\u002F\u002Forcid.org\u002F0000-0002-5384-0666",{"EN":441},"Xinghui Wang","ARTICLE",{"url":19,"publisher":444,"properties":460},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":445,"slug":10,"properties":446,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":450,"manageAffiliations":451,"indexDatabases":452,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":447,"issn":448,"title":449},{"VOID":13},{"VOID":15},{"EN":10},[],[],[453],{"id":44,"indexDatabase":454,"url":57,"indexYears":58,"academicFieldIds":459,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":455,"label":456,"description":457,"key":54,"publicationTags":458,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":461,"pages":463,"issue":465},{"VOID":462},"7",{"VOID":464},"41421-41431",{"VOID":466},"27",89,{"total":467,"publishYear":19,"statisticByYear":469},{"2016":225,"2017":267,"2018":470,"2019":326,"2020":201,"2021":374,"2022":130,"2023":374,"2024":201},15,"2106-07-05",2106,[474,478,482,486,490,494,498,502,506,510,514,518,522,526,530,534,538,542,546,550,553,557,561,565,569,573,577,581],{"id":19,"text":475,"url":19,"identifiers":476},"Blay, 2013, Apigenin and its impact on gastrointestinal cancers, Mol Nutr Food Res, 57, 126, 10.1002\u002Fmnfr.201200424",{"doi":477},"10.1002\u002Fmnfr.201200424",{"id":19,"text":479,"url":19,"identifiers":480},"Seth, 2015, Ethnomedicinal review of Usnakantaka (Echinops echinatus Roxb.), Pharmacogn Rev, 9, 149, 10.4103\u002F0973-7847.162138",{"doi":481},"10.4103\u002F0973-7847.162138",{"id":19,"text":483,"url":19,"identifiers":484},"Katan, 1998, Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from anand a dietary supplement study, Am J Clin Nutr, 67, 255, 10.1093\u002Fajcn\u002F67.2.255",{"doi":485},"10.1093\u002Fajcn\u002F67.2.255",{"id":19,"text":487,"url":19,"identifiers":488},"Xie, 2015, Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer, Mol Med Rep, 11, 1004, 10.3892\u002Fmmr.2014.2801",{"doi":489},"10.3892\u002Fmmr.2014.2801",{"id":19,"text":491,"url":19,"identifiers":492},"Xie, 2015, Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt\u002Fbeta-catenin signaling pathway, Oncol Rep, 34, 1035, 10.3892\u002For.2015.4022",{"doi":493},"10.3892\u002For.2015.4022",{"id":19,"text":495,"url":19,"identifiers":496},"Xuegang, 2013, Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT, J Nutr Biochem, 24, 1766, 10.1016\u002Fj.jnutbio.2013.03.006",{"doi":497},"10.1016\u002Fj.jnutbio.2013.03.006",{"id":19,"text":499,"url":19,"identifiers":500},"Xie, 2013, Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells, Cancer Cell Int, 13, 54, 10.1186\u002F1475-2867-13-54",{"doi":501},"10.1186\u002F1475-2867-13-54",{"id":19,"text":503,"url":19,"identifiers":504},"Zhang, 2011, Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns, Phytomedicine, 18, 366, 10.1016\u002Fj.phymed.2010.08.006",{"doi":505},"10.1016\u002Fj.phymed.2010.08.006",{"id":19,"text":507,"url":19,"identifiers":508},"Mukhtar, 2015, Dietary agents for prevention and treatment of lung cancer, Cancer Lett, 359, 155, 10.1016\u002Fj.canlet.2015.01.038",{"doi":509},"10.1016\u002Fj.canlet.2015.01.038",{"id":19,"text":511,"url":19,"identifiers":512},"Andreeva, 2015, Apigenin Inhibits Growth of Breast Cancer Cells: The Role of ERalpha and HER2\u002Fneu, Acta Naturae, 7, 133, 10.32607\u002F20758251-2015-7-3-133-139",{"doi":513},"10.32607\u002F20758251-2015-7-3-133-139",{"id":19,"text":515,"url":19,"identifiers":516},"Liu, 2015, Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3derived sphere-forming cells, Mol Med Rep, 11, 2221, 10.3892\u002Fmmr.2014.2974",{"doi":517},"10.3892\u002Fmmr.2014.2974",{"id":19,"text":519,"url":19,"identifiers":520},"Lim, 2016, Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress, Int J Oncol, 48, 399, 10.3892\u002Fijo.2015.3243",{"doi":521},"10.3892\u002Fijo.2015.3243",{"id":19,"text":523,"url":19,"identifiers":524},"Mikulits, 2011, A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression, Mol Cancer Ther, 10, 850, 10.1158\u002F1535-7163.MCT-10-0917",{"doi":525},"10.1158\u002F1535-7163.MCT-10-0917",{"id":19,"text":527,"url":19,"identifiers":528},"Christofori, 2012, EMT as the ultimate survival mechanism of cancer cells, Semin Cancer Biol, 22, 194, 10.1016\u002Fj.semcancer.2012.02.013",{"doi":529},"10.1016\u002Fj.semcancer.2012.02.013",{"id":19,"text":531,"url":19,"identifiers":532},"Sen, 2014, Extracellular matrix density promotes EMT by weakening cell-cell adhesions, Mol Biosyst, 10, 838, 10.1039\u002FC3MB70431A",{"doi":533},"10.1039\u002FC3MB70431A",{"id":19,"text":535,"url":19,"identifiers":536},"Liu, 2011, Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma, Hepatology, 54, 1690, 10.1002\u002Fhep.24543",{"doi":537},"10.1002\u002Fhep.24543",{"id":19,"text":539,"url":19,"identifiers":540},"Jia, 2014, MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X, BMC Cancer, 14, 393, 10.1186\u002F1471-2407-14-393",{"doi":541},"10.1186\u002F1471-2407-14-393",{"id":19,"text":543,"url":19,"identifiers":544},"Albert, 2014, Network modeling of TGFbeta signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation, Cancer Res, 74, 5963, 10.1158\u002F0008-5472.CAN-14-0225",{"doi":545},"10.1158\u002F0008-5472.CAN-14-0225",{"id":19,"text":547,"url":19,"identifiers":548},"Sun, 2015, Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells, Oncotarget, 6, 40667, 10.18632\u002Foncotarget.5842",{"doi":549},"10.18632\u002Foncotarget.5842",{"id":19,"text":551,"url":19,"identifiers":552},"Giaccone, 2015, EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer, Mol Oncol",{},{"id":19,"text":554,"url":19,"identifiers":555},"Alahari, 2009, Molecular mechanisms controlling E-cadherin expression in breast cancer, Biochem Biophys Res Commun, 384, 6, 10.1016\u002Fj.bbrc.2009.04.051",{"doi":556},"10.1016\u002Fj.bbrc.2009.04.051",{"id":19,"text":558,"url":19,"identifiers":559},"Sun, 2010, Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry, Hepatology, 51, 545, 10.1002\u002Fhep.23311",{"doi":560},"10.1002\u002Fhep.23311",{"id":19,"text":562,"url":19,"identifiers":563},"Peng, 2016, N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells, Int J Oncol, 48, 595, 10.3892\u002Fijo.2015.3270",{"doi":564},"10.3892\u002Fijo.2015.3270",{"id":19,"text":566,"url":19,"identifiers":567},"Zhou, 2010, Snail: More than EMT, Cell Adh Migr, 4, 199, 10.4161\u002Fcam.4.2.10943",{"doi":568},"10.4161\u002Fcam.4.2.10943",{"id":19,"text":570,"url":19,"identifiers":571},"Kitahara, 2016, Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells, Oncol Rep, 35, 261, 10.3892\u002For.2015.4348",{"doi":572},"10.3892\u002For.2015.4348",{"id":19,"text":574,"url":19,"identifiers":575},"Nieto, 2002, The snail superfamily of zinc-finger transcription factors, Nat Rev Mol Cell Biol, 3, 155, 10.1038\u002Fnrm757",{"doi":576},"10.1038\u002Fnrm757",{"id":19,"text":578,"url":19,"identifiers":579},"Fang, 2013, Curcumin inhibits LPS-induced EMT through downregulation of NF-kappaB-Snail signaling in breast cancer cells, Oncol Rep, 29, 117, 10.3892\u002For.2012.2080",{"doi":580},"10.3892\u002For.2012.2080",{"id":19,"text":582,"url":19,"identifiers":583},"Garcia de Herreros, 2004, Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells, Oncogene, 23, 7345, 10.1038\u002Fsj.onc.1207990",{"doi":584},"10.1038\u002Fsj.onc.1207990",false,{"id":587,"createTime":588,"updateTime":588,"relativeEntities":589,"slug":590,"properties":591,"entityType":87,"verifyStatus":88,"verifyTime":606,"verifyNote":89,"syncStatus":18,"languages":607,"translateLanguages":19,"viewCount":20,"primaryUrl":608,"fullTextUrl":19,"authors":609,"publicationType":442,"publisherRelationship":829,"citationCount":852,"citationInfo":853,"publishDate":855,"publishYear":856,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":857,"isForceReanalyzing":585},"c29779b7-9fbd-4abe-af96-e5bb2ebde7b0","2024-09-11T23:58:07.232+00:00",[],"Prp19-facilitates-invasion-of-hepatocellular-carcinoma-via-p38-mitogen-activated-protein-kinase-Twist1-pathway",{"mag":592,"keywords":594,"pmc":595,"openalex":597,"abstract":599,"title":600,"pm":602,"doi":604},{"VOID":593},"2302060882",{},{"VOID":596},"5008335",{"VOID":598},"W2302060882",{},{"EN":601},"Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase\u002FTwist1 pathway",{"VOID":603},"26959880",{"VOID":605},"10.18632\u002Foncotarget.7877","2024-09-11T23:58:07.231+00:00",[91],"https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.7877",[610,632,649,666,683,722,739,761,778,795,812],{"id":611,"sortIndex":285,"researcher":19,"roles":612,"affiliations":613,"properties":625},"065bfff2-3f1c-4b09-afbd-4e814135533b",[],[614],{"id":615,"sortIndex":20,"affiliation":616,"properties":19},"eb5e5a11-61a3-4677-9df1-b869b4df685b",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":620,"slug":621,"properties":622,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"c779618f-50b1-45fb-b98b-1a783bd5bb2e","2023-12-24T16:19:26.017+00:00","2024-09-11T23:58:07.244+00:00",[],"Department-of-Gastroenterology-Zhongshan-Hospital-of-Fudan-University-Shanghai-China",{"title":623},{"VI":624},"Department of Gastroenterology, Zhongshan Hospital of Fudan University, Shanghai, China",{"openalex":626,"orcid":628,"title":630},{"VOID":627},"A5101568453",{"VOID":629},"https:\u002F\u002Forcid.org\u002F0000-0001-5995-7673",{"EN":631},"Ling Dong",{"id":633,"sortIndex":20,"researcher":19,"roles":634,"affiliations":635,"properties":642},"05d486b3-7573-4420-9c60-51e9298437b6",[],[636],{"id":637,"sortIndex":20,"affiliation":638,"properties":19},"0559eb52-abe1-4a7c-9c95-277d8bd194de",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":639,"slug":621,"properties":640,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":641},{"VI":624},{"openalex":643,"orcid":645,"title":647},{"VOID":644},"A5077934665",{"VOID":646},"https:\u002F\u002Forcid.org\u002F0000-0002-5419-6315",{"EN":648},"Jie Yin",{"id":650,"sortIndex":326,"researcher":19,"roles":651,"affiliations":652,"properties":659},"db14c92d-d6b0-4d39-9f5d-f31b2f1b41c5",[],[653],{"id":654,"sortIndex":20,"affiliation":655,"properties":19},"26f83944-8995-430b-bcfa-b6e0f558630b",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":656,"slug":621,"properties":657,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":658},{"VI":624},{"openalex":660,"orcid":662,"title":664},{"VOID":661},"A5100353673",{"VOID":663},"https:\u002F\u002Forcid.org\u002F0009-0001-6480-7976",{"EN":665},"Hao Chen",{"id":667,"sortIndex":201,"researcher":19,"roles":668,"affiliations":669,"properties":676},"81416f85-0c00-45b6-bfca-77d94db5697e",[],[670],{"id":671,"sortIndex":20,"affiliation":672,"properties":19},"ec5aecef-841d-49ed-bd8e-3b872e39d5d6",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":673,"slug":621,"properties":674,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":675},{"VI":624},{"openalex":677,"orcid":679,"title":681},{"VOID":678},"A5100725999",{"VOID":680},"https:\u002F\u002Forcid.org\u002F0000-0002-4623-9012",{"EN":682},"Taotao Liu",{"id":684,"sortIndex":267,"researcher":19,"roles":685,"affiliations":686,"properties":715},"97bae8e1-ae91-4396-a1d3-5117425ee69f",[],[687,698,704],{"id":688,"sortIndex":112,"affiliation":689,"properties":19},"499c58d9-6008-4592-8434-4ecd3b565991",{"id":690,"createTime":691,"updateTime":692,"relativeEntities":693,"slug":694,"properties":695,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"f29fbef6-8a2c-432e-a208-50c5ea7a3a80","2023-12-29T10:20:06.733+00:00","2024-09-11T23:58:07.343+00:00",[],"Key-Laboratory-of-Medical-Molecular-Virology-Shanghai-Medical-College-of-Fudan-University-Shanghai-China",{"title":696},{"VI":697},"Key Laboratory of Medical Molecular Virology, Shanghai Medical College of Fudan University, Shanghai, China",{"id":699,"sortIndex":20,"affiliation":700,"properties":19},"e11fc24d-b0c1-4472-afb7-014319262703",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":701,"slug":621,"properties":702,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":703},{"VI":624},{"id":705,"sortIndex":225,"affiliation":706,"properties":19},"3b563774-8eed-41b5-b870-492b2f438f5b",{"id":707,"createTime":708,"updateTime":709,"relativeEntities":710,"slug":711,"properties":712,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"0c257180-2259-46e5-980f-296bd0042128","2023-12-29T10:20:06.728+00:00","2025-06-12T00:58:54.979+00:00",[],"Shanghai-Institute-of-Liver-Diseases-Zhongshan-Hospital-of-Fudan-University-Shanghai-China",{"title":713},{"VI":714},"Shanghai Institute of Liver Diseases, Zhongshan Hospital of Fudan University, Shanghai, China",{"openalex":716,"orcid":718,"title":720},{"VOID":717},"A5100613309",{"VOID":719},"https:\u002F\u002Forcid.org\u002F0000-0003-3748-0709",{"EN":721},"Xizhong Shen",{"id":723,"sortIndex":422,"researcher":19,"roles":724,"affiliations":725,"properties":732},"dcc4eece-24e5-461a-a6b8-10bff3f90819",[],[726],{"id":727,"sortIndex":20,"affiliation":728,"properties":19},"5f6391d9-dbb5-4441-8978-e127060dead3",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":729,"slug":621,"properties":730,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":731},{"VI":624},{"openalex":733,"orcid":735,"title":737},{"VOID":734},"A5101636847",{"VOID":736},"https:\u002F\u002Forcid.org\u002F0000-0001-9975-3229",{"EN":738},"Qian Yu",{"id":740,"sortIndex":112,"researcher":19,"roles":741,"affiliations":742,"properties":754},"6bc4f63a-eccc-49de-8859-1298a28ff94e",[],[743],{"id":744,"sortIndex":20,"affiliation":745,"properties":19},"8deb9dfd-607f-4fb6-8d85-4a498f1d2a86",{"id":746,"createTime":747,"updateTime":748,"relativeEntities":749,"slug":750,"properties":751,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"e4051763-0e67-49e5-a22b-39858c543955","2024-01-12T11:56:07.631+00:00","2024-09-11T23:58:07.273+00:00",[],"Department-of-Biochemistry-and-Molecular-Biology-Shanghai-Medical-College-of-Fudan-University-Shanghai-China",{"title":752},{"VI":753},"Department of Biochemistry and Molecular Biology, Shanghai Medical College of Fudan University, Shanghai, China",{"openalex":755,"orcid":757,"title":759},{"VOID":756},"A5008244632",{"VOID":758},"https:\u002F\u002Forcid.org\u002F0000-0001-7701-2219",{"EN":760},"Lan Wang",{"id":762,"sortIndex":249,"researcher":19,"roles":763,"affiliations":764,"properties":771},"89107831-cf6d-4aff-a37a-796ada3a6269",[],[765],{"id":766,"sortIndex":20,"affiliation":767,"properties":19},"29bf3fbb-15df-4199-99aa-5171bb0f8e8d",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":768,"slug":621,"properties":769,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":770},{"VI":624},{"openalex":772,"orcid":774,"title":776},{"VOID":773},"A5019466916",{"VOID":775},"https:\u002F\u002Forcid.org\u002F0000-0003-2485-8688",{"EN":777},"Ying Fang",{"id":779,"sortIndex":96,"researcher":19,"roles":780,"affiliations":781,"properties":788},"2bb16c11-9807-4208-bfc8-0dcbdee7fc50",[],[782],{"id":783,"sortIndex":20,"affiliation":784,"properties":19},"73116083-5e87-4281-9189-d4e9dd9bb94d",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":785,"slug":621,"properties":786,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":787},{"VI":624},{"openalex":789,"orcid":791,"title":793},{"VOID":790},"A5001146558",{"VOID":792},"https:\u002F\u002Forcid.org\u002F0000-0002-4033-211X",{"EN":794},"Yian Zhang",{"id":796,"sortIndex":350,"researcher":19,"roles":797,"affiliations":798,"properties":805},"7bd5370b-6c60-4a0f-b68e-8c9d6248715b",[],[799],{"id":800,"sortIndex":20,"affiliation":801,"properties":19},"ab223b69-94be-4a62-9403-26aecb450f72",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":802,"slug":621,"properties":803,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":804},{"VI":624},{"openalex":806,"orcid":808,"title":810},{"VOID":807},"A5087478985",{"VOID":809},"https:\u002F\u002Forcid.org\u002F0009-0008-7815-0638",{"EN":811},"Ruidan Xue",{"id":813,"sortIndex":225,"researcher":19,"roles":814,"affiliations":815,"properties":822},"dd4f98a2-877c-4b95-a8cf-26325bd2ec99",[],[816],{"id":817,"sortIndex":20,"affiliation":818,"properties":19},"ee1e68a4-1ee4-4266-9442-72cc013fdd61",{"id":617,"createTime":618,"updateTime":619,"relativeEntities":819,"slug":621,"properties":820,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":821},{"VI":624},{"openalex":823,"orcid":825,"title":827},{"VOID":824},"A5083140041",{"VOID":826},"https:\u002F\u002Forcid.org\u002F0000-0002-2150-473X",{"EN":828},"Ji‐Min Zhu",{"url":19,"publisher":830,"properties":846},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":831,"slug":10,"properties":832,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":836,"manageAffiliations":837,"indexDatabases":838,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":833,"issn":834,"title":835},{"VOID":13},{"VOID":15},{"EN":10},[],[],[839],{"id":44,"indexDatabase":840,"url":57,"indexYears":58,"academicFieldIds":845,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":841,"label":842,"description":843,"key":54,"publicationTags":844,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":847,"pages":848,"issue":850},{"VOID":462},{"VOID":849},"21939-21951",{"VOID":851},"16",22,{"total":852,"publishYear":19,"statisticByYear":854},{"2017":422,"2019":225,"2020":422,"2021":350,"2022":350,"2023":350,"2024":112},"2016-04-19",2016,[858,862,866,870,874,878,882,886,890,894,898,901,905,908,912,916,920,924,928,932,936,940,944,948,952,956,960,964,968,972,976,980,984,988,992,996,1000],{"id":19,"text":859,"url":19,"identifiers":860},"Forman, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322\u002Fcaac.20107",{"doi":861},"10.3322\u002Fcaac.20107",{"id":19,"text":863,"url":19,"identifiers":864},"El-Serag, 2011, Hepatocellular carcinoma, N Engl J Med, 365, 1118, 10.1056\u002FNEJMra1001683",{"doi":865},"10.1056\u002FNEJMra1001683",{"id":19,"text":867,"url":19,"identifiers":868},"Huang, 2011, Neuregulin\u002Ferythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma, Hepatology, 53, 504, 10.1002\u002Fhep.24083",{"doi":869},"10.1002\u002Fhep.24083",{"id":19,"text":871,"url":19,"identifiers":872},"Mikulits, 2009, Epithelial-mesenchymal transition in hepatocellular carcinoma, Future Oncol, 5, 1169, 10.2217\u002Ffon.09.91",{"doi":873},"10.2217\u002Ffon.09.91",{"id":19,"text":875,"url":19,"identifiers":876},"Sleeman, 2006, Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol, 7, 131, 10.1038\u002Fnrm1835",{"doi":877},"10.1038\u002Fnrm1835",{"id":19,"text":879,"url":19,"identifiers":880},"Cano, 2007, Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?, Nat Rev Cancer, 7, 415, 10.1038\u002Fnrc2131",{"doi":881},"10.1038\u002Fnrc2131",{"id":19,"text":883,"url":19,"identifiers":884},"Fan, 2006, Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition, Clin Cancer Res, 12, 5369, 10.1158\u002F1078-0432.CCR-05-2722",{"doi":885},"10.1158\u002F1078-0432.CCR-05-2722",{"id":19,"text":887,"url":19,"identifiers":888},"Nouso, 2009, Twist expression promotes migration and invasion in hepatocellular carcinoma, BMC Cancer, 9, 240, 10.1186\u002F1471-2407-9-240",{"doi":889},"10.1186\u002F1471-2407-9-240",{"id":19,"text":891,"url":19,"identifiers":892},"Wu, 2009, Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma, Hepatology, 50, 1464, 10.1002\u002Fhep.23221",{"doi":893},"10.1002\u002Fhep.23221",{"id":19,"text":895,"url":19,"identifiers":896},"Voutsadakis, 2012, Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer, Tumour Biol, 33, 897, 10.1007\u002Fs13277-012-0355-x",{"doi":897},"10.1007\u002Fs13277-012-0355-x",{"id":19,"text":899,"url":19,"identifiers":900},"Shen, 2010, The potential role of ubiquitin c-terminal hydrolases in oncogenesis, Biochim Biophys Acta, 1806, 1",{},{"id":19,"text":902,"url":19,"identifiers":903},"Weissman, 2011, RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis, Nat Rev Cancer, 11, 629, 10.1038\u002Fnrc3120",{"doi":904},"10.1038\u002Fnrc3120",{"id":19,"text":906,"url":19,"identifiers":907},"Shen, 2012, Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19, Biochim Biophys Acta",{},{"id":19,"text":909,"url":19,"identifiers":910},"Shen, 2012, New insights into pre-mRNA processing factor 19: A multi-faceted protein in humans, Biol Cell, 104, 695, 10.1111\u002Fboc.201200011",{"doi":911},"10.1111\u002Fboc.201200011",{"id":19,"text":913,"url":19,"identifiers":914},"Gu, 2012, Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma, J Clin Invest, 122, 2554, 10.1172\u002FJCI58488",{"doi":915},"10.1172\u002FJCI58488",{"id":19,"text":917,"url":19,"identifiers":918},"Feng, 2012, Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase\u002FAkt signaling facilitates liver cancer progression, Hepatology, 55, 1787, 10.1002\u002Fhep.25596",{"doi":919},"10.1002\u002Fhep.25596",{"id":19,"text":921,"url":19,"identifiers":922},"Legerski, 2005, The Pso4 mRNA splicing and DNA repair complex interacts with WRN for processing of DNA interstrand cross-links, J Biol Chem, 280, 40559, 10.1074\u002Fjbc.M508453200",{"doi":923},"10.1074\u002Fjbc.M508453200",{"id":19,"text":925,"url":19,"identifiers":926},"Selmi, 2008, Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence, Cancer Cell, 14, 79, 10.1016\u002Fj.ccr.2008.06.005",{"doi":927},"10.1016\u002Fj.ccr.2008.06.005",{"id":19,"text":929,"url":19,"identifiers":930},"Maestro, 2006, Twist is substrate for caspase cleavage and proteasome-mediated degradation, Cell Death Differ, 13, 335, 10.1038\u002Fsj.cdd.4401744",{"doi":931},"10.1038\u002Fsj.cdd.4401744",{"id":19,"text":933,"url":19,"identifiers":934},"Kaneda, 2007, Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling, J Cell Sci, 120, 1350, 10.1242\u002Fjcs.000067",{"doi":935},"10.1242\u002Fjcs.000067",{"id":19,"text":937,"url":19,"identifiers":938},"Xu, 2011, Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness, Cancer Res, 71, 3980, 10.1158\u002F0008-5472.CAN-10-2914",{"doi":939},"10.1158\u002F0008-5472.CAN-10-2914",{"id":19,"text":941,"url":19,"identifiers":942},"Cohen, 1992, MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase, EMBO J, 11, 3985, 10.1002\u002Fj.1460-2075.1992.tb05492.x",{"doi":943},"10.1002\u002Fj.1460-2075.1992.tb05492.x",{"id":19,"text":945,"url":19,"identifiers":946},"Chen, 2001, TAK1 is a ubiquitin-dependent kinase of MKK and IKK, Nature, 412, 346, 10.1038\u002F35085597",{"doi":947},"10.1038\u002F35085597",{"id":19,"text":949,"url":19,"identifiers":950},"Yin, 2008, Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence, Hepatology, 48, 497, 10.1002\u002Fhep.22393",{"doi":951},"10.1002\u002Fhep.22393",{"id":19,"text":953,"url":19,"identifiers":954},"Terada, 2000, Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma, Liver, 20, 209, 10.1034\u002Fj.1600-0676.2000.020003209.x",{"doi":955},"10.1034\u002Fj.1600-0676.2000.020003209.x",{"id":19,"text":957,"url":19,"identifiers":958},"Di Fiore, 2009, Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor, Oncogene, 28, 2959, 10.1038\u002Fonc.2009.156",{"doi":959},"10.1038\u002Fonc.2009.156",{"id":19,"text":961,"url":19,"identifiers":962},"Mikulits, 2009, Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge, Oncogene, 28, 4022, 10.1038\u002Fonc.2009.253",{"doi":963},"10.1038\u002Fonc.2009.253",{"id":19,"text":965,"url":19,"identifiers":966},"Becker, 2010, Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients, Virchows Arch, 457, 705, 10.1007\u002Fs00428-010-0986-5",{"doi":967},"10.1007\u002Fs00428-010-0986-5",{"id":19,"text":969,"url":19,"identifiers":970},"Derynck, 2014, Molecular mechanisms of epithelial-mesenchymal transition, Nat Rev Mol Cell Biol, 15, 178, 10.1038\u002Fnrm3758",{"doi":971},"10.1038\u002Fnrm3758",{"id":19,"text":973,"url":19,"identifiers":974},"Chantry, 2011, Early phase TGFbeta receptor signalling dynamics stabilised by the deubiquitinase UCH37 promotes cell migratory responses, Int J Biochem Cell Biol, 43, 604, 10.1016\u002Fj.biocel.2010.12.018",{"doi":975},"10.1016\u002Fj.biocel.2010.12.018",{"id":19,"text":977,"url":19,"identifiers":978},"Chantry, 2005, The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling, Oncogene, 24, 8080, 10.1038\u002Fsj.onc.1208944",{"doi":979},"10.1038\u002Fsj.onc.1208944",{"id":19,"text":981,"url":19,"identifiers":982},"Takeshige, 2000, TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages, FEBS Lett, 467, 160, 10.1016\u002FS0014-5793(00)01146-7",{"doi":983},"10.1016\u002FS0014-5793(00)01146-7",{"id":19,"text":985,"url":19,"identifiers":986},"Landstrom, 2008, The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner, Nat Cell Biol, 10, 1199, 10.1038\u002Fncb1780",{"doi":987},"10.1038\u002Fncb1780",{"id":19,"text":989,"url":19,"identifiers":990},"Zou, 2014, PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry, Mol Cell, 53, 235, 10.1016\u002Fj.molcel.2013.11.002",{"doi":991},"10.1016\u002Fj.molcel.2013.11.002",{"id":19,"text":993,"url":19,"identifiers":994},"Rape, 2010, The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome, Genes Dev, 24, 1434, 10.1101\u002Fgad.1925010",{"doi":995},"10.1101\u002Fgad.1925010",{"id":19,"text":997,"url":19,"identifiers":998},"Sun, 2009, Nonproteolytic functions of ubiquitin in cell signaling, Mol Cell, 33, 275, 10.1016\u002Fj.molcel.2009.01.014",{"doi":999},"10.1016\u002Fj.molcel.2009.01.014",{"id":19,"text":1001,"url":19,"identifiers":1002},"Weiss, 2014, In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer, Nat Med, 20, 1138, 10.1038\u002Fnm.3679",{"doi":1003},"10.1038\u002Fnm.3679",{"id":1005,"createTime":1006,"updateTime":1006,"relativeEntities":1007,"slug":1008,"properties":1009,"entityType":87,"verifyStatus":88,"verifyTime":1006,"verifyNote":89,"syncStatus":18,"languages":1024,"translateLanguages":19,"viewCount":20,"primaryUrl":1025,"fullTextUrl":19,"authors":1026,"publicationType":442,"publisherRelationship":1388,"citationCount":1412,"citationInfo":1413,"publishDate":1424,"publishYear":1425,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":1426,"isForceReanalyzing":585},"29188dde-4c5c-41fa-9a31-6050273335b4","2024-09-11T23:58:06.672+00:00",[],"GSK-3-as-potential-target-for-therapeutic-intervention-in-cancer",{"mag":1010,"keywords":1012,"pmc":1013,"openalex":1015,"abstract":1017,"title":1018,"pm":1020,"doi":1022},{"VOID":1011},"1716978847",{},{"VOID":1014},"4102778",{"VOID":1016},"W1716978847",{},{"EN":1019},"GSK-3 as potential target for therapeutic intervention in cancer",{"VOID":1021},"24931005",{"VOID":1023},"10.18632\u002Foncotarget.2037",[91],"https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.2037",[1027,1046,1067,1087,1109,1130,1149,1164,1181,1203,1225,1255,1272,1289,1312,1334,1352,1367],{"id":1028,"sortIndex":398,"researcher":19,"roles":1029,"affiliations":1030,"properties":1041},"365a2228-6909-4431-aff0-9bd0c5a40288",[],[1031],{"id":1032,"sortIndex":20,"affiliation":1033,"properties":19},"23351c1a-08c3-4cc0-be59-5cfa03fe4660",{"id":1034,"createTime":1035,"updateTime":1035,"relativeEntities":1036,"slug":1037,"properties":1038,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"5f6ccc5f-365c-48b9-abf9-986a5fe89141","2024-09-11T23:58:06.818+00:00",[],"Department-of-Cell-Stress-Biology-Roswell-Park-Cancer-Institute-Buffalo-NY-USA",{"title":1039},{"EN":1040},"Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA",{"openalex":1042,"title":1044},{"VOID":1043},"A5087207105",{"EN":1045},"Zoya N. Demidenko",{"id":1047,"sortIndex":20,"researcher":19,"roles":1048,"affiliations":1049,"properties":1060},"29bcd6a8-bb92-4da0-b827-c3f44e043385",[],[1050],{"id":1051,"sortIndex":20,"affiliation":1052,"properties":19},"c9e3b1b2-09f6-420e-b081-065662545185",{"id":1053,"createTime":1054,"updateTime":1054,"relativeEntities":1055,"slug":1056,"properties":1057,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"55506a81-b998-487f-8415-e0d54ef22adc","2024-09-11T23:58:06.695+00:00",[],"Department-of-Microbiology-Immunology-Brody-School-of-Medicine-at-East-Carolina-University-Greenville-NC-27858-USA-",{"title":1058},{"EN":1059},"Department of Microbiology & Immunology, Brody School of Medicine at East Carolina University Greenville, NC 27858, USA.",{"openalex":1061,"orcid":1063,"title":1065},{"VOID":1062},"A5030391285",{"VOID":1064},"https:\u002F\u002Forcid.org\u002F0000-0001-6027-3156",{"EN":1066},"James A. McCubrey",{"id":1068,"sortIndex":350,"researcher":19,"roles":1069,"affiliations":1070,"properties":1082},"5fe5ffda-1f37-42ea-bd2d-5474df7b7093",[],[1071],{"id":1072,"sortIndex":20,"affiliation":1073,"properties":19},"058c4f0d-f795-4f79-8aa7-f2b944409fb5",{"id":1074,"createTime":1075,"updateTime":1076,"relativeEntities":1077,"slug":1078,"properties":1079,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"1ab4a913-0775-4090-a0ec-73c24e58d359","2024-01-04T17:32:31.928+00:00","2024-09-11T23:58:06.681+00:00",[],"Department-of-Microbiology-and-Immunology-Brody-School-of-Medicine-at-East-Carolina-University-Greenville-NC-USA",{"title":1080},{"VI":1081},"Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC, USA",{"openalex":1083,"title":1085},{"VOID":1084},"A5068920075",{"EN":1086},"Melissa L. Sokolosky",{"id":1088,"sortIndex":285,"researcher":19,"roles":1089,"affiliations":1090,"properties":1102},"22dac1fd-8738-4a26-a94f-da3cf50cd947",[],[1091],{"id":1092,"sortIndex":20,"affiliation":1093,"properties":19},"c83c4449-47de-4a98-9ab8-b638682708da",{"id":1094,"createTime":1095,"updateTime":1096,"relativeEntities":1097,"slug":1098,"properties":1099,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"e8578983-c9d8-470a-8096-46e5f401eec5","2023-12-14T03:49:32.700+00:00","2024-09-11T23:58:06.829+00:00",[],"Department-of-Bio-Medical-Sciences-University-of-Catania-Catania-Italy",{"title":1100},{"VI":1101},"Department of Bio-Medical Sciences, University of Catania, Catania, Italy",{"openalex":1103,"orcid":1105,"title":1107},{"VOID":1104},"A5105878418",{"VOID":1106},"https:\u002F\u002Forcid.org\u002F0000-0002-4570-8462",{"EN":1108},"Ferdinando Nicoletti",{"id":1110,"sortIndex":267,"researcher":19,"roles":1111,"affiliations":1112,"properties":1123},"cb59d18f-2884-416d-a5e4-9f46ce6fc79e",[],[1113],{"id":1114,"sortIndex":20,"affiliation":1115,"properties":19},"56c1e6a5-930f-4030-94e6-367a688ebb04",{"id":1116,"createTime":1117,"updateTime":1117,"relativeEntities":1118,"slug":1119,"properties":1120,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"9c0e8a78-f8dc-4095-a1bb-544cdad6fdaf","2024-09-11T23:58:06.853+00:00",[],"Experimental-Oncology-1-CRO-IRCCS-National-Cancer-Institute-Aviano-Pordenone-Italy",{"title":1121},{"EN":1122},"Experimental Oncology 1, CRO IRCCS, National Cancer Institute, Aviano, Pordenone, Italy",{"openalex":1124,"orcid":1126,"title":1128},{"VOID":1125},"A5018685447",{"VOID":1127},"https:\u002F\u002Forcid.org\u002F0000-0002-6642-5592",{"EN":1129},"Roberta Maestro",{"id":1131,"sortIndex":225,"researcher":19,"roles":1132,"affiliations":1133,"properties":1144},"b6fca69f-4ef4-4b84-b60b-e34d61a91cce",[],[1134],{"id":1135,"sortIndex":20,"affiliation":1136,"properties":19},"3464d940-d442-45ff-ab40-a3b2ab8ffb1f",{"id":1137,"createTime":1138,"updateTime":1138,"relativeEntities":1139,"slug":1140,"properties":1141,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"d0d906ee-36cd-42e6-a155-1bd951269e9d","2024-09-11T23:58:06.721+00:00",[],"Department-of-Oncology-Brody-School-of-Medicine-at-East-Carolina-University-Greenville-NC-USA",{"title":1142},{"EN":1143},"Department of Oncology, Brody School of Medicine at East Carolina University Greenville, NC, USA",{"openalex":1145,"title":1147},{"VOID":1146},"A5060316880",{"EN":1148},"F. E. Bertrand",{"id":1150,"sortIndex":112,"researcher":19,"roles":1151,"affiliations":1152,"properties":1159},"1df96cf8-c58c-44e4-8a6b-619531274c67",[],[1153],{"id":1154,"sortIndex":20,"affiliation":1155,"properties":19},"a11ce66c-fa1e-4abd-8c21-82e9b5dfa08a",{"id":1074,"createTime":1075,"updateTime":1076,"relativeEntities":1156,"slug":1078,"properties":1157,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":1158},{"VI":1081},{"openalex":1160,"title":1162},{"VOID":1161},"A5091807722",{"EN":1163},"Linda S. Steelman",{"id":1165,"sortIndex":422,"researcher":19,"roles":1166,"affiliations":1167,"properties":1174},"4e6deebe-c6aa-4527-b2e0-6468332a6735",[],[1168],{"id":1169,"sortIndex":20,"affiliation":1170,"properties":19},"82dabb8a-1003-4568-9f2d-eeee4f43a135",{"id":1074,"createTime":1075,"updateTime":1076,"relativeEntities":1171,"slug":1078,"properties":1172,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":1173},{"VI":1081},{"openalex":1175,"orcid":1177,"title":1179},{"VOID":1176},"A5059966547",{"VOID":1178},"https:\u002F\u002Forcid.org\u002F0000-0002-6483-4560",{"EN":1180},"Nicole D. Armstrong",{"id":1182,"sortIndex":374,"researcher":19,"roles":1183,"affiliations":1184,"properties":1196},"42f2cbda-3f35-44e7-836c-81f8e201f723",[],[1185],{"id":1186,"sortIndex":20,"affiliation":1187,"properties":19},"97dbd2de-1757-4a6e-bd80-cd282cac3513",{"id":1188,"createTime":1189,"updateTime":1190,"relativeEntities":1191,"slug":1192,"properties":1193,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"78ce4217-9617-4e33-8f86-52f1940a2379","2024-04-11T04:28:07.583+00:00","2024-09-11T23:58:06.713+00:00",[],"Department-of-Animal-Molecular-Physiology-Institute-of-Experimental-Biology-Wroclaw-University-Wroclaw-Poland",{"title":1194},{"EN":1195},"Department of Animal Molecular Physiology, Institute of Experimental Biology, Wroclaw University, Wroclaw, Poland",{"openalex":1197,"orcid":1199,"title":1201},{"VOID":1198},"A5038928679",{"VOID":1200},"https:\u002F\u002Forcid.org\u002F0000-0001-9367-0270",{"EN":1202},"Agnieszka Gizak",{"id":1204,"sortIndex":96,"researcher":19,"roles":1205,"affiliations":1206,"properties":1218},"b8b36bad-4026-4102-bb7b-9ac5ea66baea",[],[1207],{"id":1208,"sortIndex":20,"affiliation":1209,"properties":19},"40a8bfa0-ad3d-422b-b31b-5ed0f0999c81",{"id":1210,"createTime":1211,"updateTime":1212,"relativeEntities":1213,"slug":1214,"properties":1215,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"8d4bf6c0-3af0-4f06-a2db-f672fde2d2d0","2024-01-01T07:07:03.834+00:00","2024-09-11T23:58:06.776+00:00",[],"Biomedical-Department-of-Internal-Medicine-and-Specialties-University-of-Palermo-Palermo-Italy",{"title":1216},{"VI":1217},"Biomedical Department of Internal Medicine and Specialties, University of Palermo, Palermo, Italy",{"openalex":1219,"orcid":1221,"title":1223},{"VOID":1220},"A5082733849",{"VOID":1222},"https:\u002F\u002Forcid.org\u002F0000-0002-8731-8577",{"EN":1224},"Giuseppe Montalto",{"id":1226,"sortIndex":177,"researcher":19,"roles":1227,"affiliations":1228,"properties":1250},"c38494ea-71b1-46f3-a5f3-2a38a4700814",[],[1229,1239],{"id":1230,"sortIndex":112,"affiliation":1231,"properties":19},"6bdcc66b-5493-4c2a-bc4f-962f16478d9d",{"id":1232,"createTime":1233,"updateTime":1233,"relativeEntities":1234,"slug":1235,"properties":1236,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"767259e5-c574-4964-a533-f082f870ce4a","2024-09-11T23:58:06.734+00:00",[],"Sanct-Josef-Hospital-Cloppenburg-Department-of-Hematology-and-Oncology-Cloppenburg-Germany",{"title":1237},{"EN":1238},"Sanct-Josef-Hospital Cloppenburg, Department of Hematology and Oncology, Cloppenburg, Germany",{"id":1240,"sortIndex":20,"affiliation":1241,"properties":19},"933eb2a0-843b-412c-b4b6-07214ba8d474",{"id":1242,"createTime":1243,"updateTime":1244,"relativeEntities":1245,"slug":1246,"properties":1247,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"4f1b1c78-bbde-4439-ad69-f7a4964e056f","2024-01-04T14:45:17.483+00:00","2024-09-11T23:58:06.732+00:00",[],"Department-of-Medicine-University-of-G%C3%B6ttingen-G%C3%B6ttingen-Germany",{"title":1248},{"VI":1249},"Department of Medicine, University of Göttingen, Göttingen, Germany",{"openalex":1251,"title":1253},{"VOID":1252},"A5004269669",{"EN":1254},"Jörg Bäsecke",{"id":1256,"sortIndex":201,"researcher":19,"roles":1257,"affiliations":1258,"properties":1265},"3fa995f9-6524-44f1-9b24-f2765f97d6b6",[],[1259],{"id":1260,"sortIndex":20,"affiliation":1261,"properties":19},"8d50d7a1-341a-414e-9da6-125fef83ef53",{"id":1094,"createTime":1095,"updateTime":1096,"relativeEntities":1262,"slug":1098,"properties":1263,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":1264},{"VI":1101},{"openalex":1266,"orcid":1268,"title":1270},{"VOID":1267},"A5015437100",{"VOID":1269},"https:\u002F\u002Forcid.org\u002F0000-0002-7232-7737",{"EN":1271},"Massimo Libra",{"id":1273,"sortIndex":130,"researcher":19,"roles":1274,"affiliations":1275,"properties":1282},"77658f33-9a46-4d35-8a9e-10cc5fb46263",[],[1276],{"id":1277,"sortIndex":20,"affiliation":1278,"properties":19},"4b3f1957-9728-4554-a208-21c973004f6d",{"id":1188,"createTime":1189,"updateTime":1190,"relativeEntities":1279,"slug":1192,"properties":1280,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":1281},{"EN":1195},{"openalex":1283,"orcid":1285,"title":1287},{"VOID":1284},"A5064634385",{"VOID":1286},"https:\u002F\u002Forcid.org\u002F0000-0002-3823-3163",{"EN":1288},"Dariusz Rakus",{"id":1290,"sortIndex":1291,"researcher":19,"roles":1292,"affiliations":1293,"properties":1305},"802ab380-45c8-4fd5-898d-5ee5ebc4d7a5",17,[],[1294],{"id":1295,"sortIndex":20,"affiliation":1296,"properties":19},"c957ff83-4be8-4bea-8902-f4e9aff1e549",{"id":1297,"createTime":1298,"updateTime":1299,"relativeEntities":1300,"slug":1301,"properties":1302,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"854063ca-bfa7-4220-a900-8ce430ef8998","2024-02-08T01:42:24.275+00:00","2024-10-14T11:54:21.843+00:00",[],"Consiglio-Nazionale-delle-Ricerche-Istituto-di-Biomedicina-e-Immunologia-Molecolare-Alberto-Monroy-Palermo-Italy",{"title":1303},{"VI":1304},"Consiglio Nazionale delle Ricerche, Istituto di Biomedicina e Immunologia Molecolare “Alberto Monroy”, Palermo, Italy",{"openalex":1306,"orcid":1308,"title":1310},{"VOID":1307},"A5070243247",{"VOID":1309},"https:\u002F\u002Forcid.org\u002F0000-0003-4923-7220",{"EN":1311},"Melchiorre Cervello",{"id":1313,"sortIndex":470,"researcher":19,"roles":1314,"affiliations":1315,"properties":1327},"1d401ed9-a71f-420a-9998-61ba0d21d2a9",[],[1316],{"id":1317,"sortIndex":20,"affiliation":1318,"properties":19},"ae820297-ca02-41d2-8f05-86b7da8c0191",{"id":1319,"createTime":1320,"updateTime":1321,"relativeEntities":1322,"slug":1323,"properties":1324,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"4c3e2075-bb11-4ea2-90fb-673db5716d27","2024-01-18T18:21:49.783+00:00","2024-09-11T23:58:06.767+00:00",[],"Dipartimento-Di-Scienze-Biomediche-E-Neuromotorie-Universit%C3%A0-Di-Bologna-Bologna-Italy",{"title":1325},{"VI":1326},"Dipartimento Di Scienze Biomediche E Neuromotorie, Università Di Bologna, Bologna, Italy",{"openalex":1328,"orcid":1330,"title":1332},{"VOID":1329},"A5019461184",{"VOID":1331},"https:\u002F\u002Forcid.org\u002F0000-0002-9206-8277",{"EN":1333},"Lucio Cocco",{"id":1335,"sortIndex":1336,"researcher":19,"roles":1337,"affiliations":1338,"properties":1345},"1183e10a-fa54-4b53-8b8f-d4812f8b56fb",16,[],[1339],{"id":1340,"sortIndex":20,"affiliation":1341,"properties":19},"b8e41533-a2b5-43b3-80c5-0f92a05c0a46",{"id":1319,"createTime":1320,"updateTime":1321,"relativeEntities":1342,"slug":1323,"properties":1343,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":1344},{"VI":1326},{"openalex":1346,"orcid":1348,"title":1350},{"VOID":1347},"A5037164805",{"VOID":1349},"https:\u002F\u002Forcid.org\u002F0000-0001-5196-7260",{"EN":1351},"Alberto M. Martelli",{"id":1353,"sortIndex":249,"researcher":19,"roles":1354,"affiliations":1355,"properties":1362},"588300a8-0588-4eee-8bf3-c8d525ddf69d",[],[1356],{"id":1357,"sortIndex":20,"affiliation":1358,"properties":19},"95ab5123-f1d3-460e-a589-db32ad798fea",{"id":1074,"createTime":1075,"updateTime":1076,"relativeEntities":1359,"slug":1078,"properties":1360,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":1361},{"VI":1081},{"openalex":1363,"title":1365},{"VOID":1364},"A5001922162",{"EN":1366},"Steve L. Abrams",{"id":1368,"sortIndex":326,"researcher":19,"roles":1369,"affiliations":1370,"properties":1381},"8c56bcce-6290-4b4b-9b21-0a055cb774a4",[],[1371],{"id":1372,"sortIndex":20,"affiliation":1373,"properties":19},"8e651664-9358-43bd-a7ea-48a14b61412c",{"id":1374,"createTime":1375,"updateTime":1375,"relativeEntities":1376,"slug":1377,"properties":1378,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"395349fc-48b4-4a50-a89c-8f52cc4e42ef","2024-09-11T23:58:06.794+00:00",[],"Department-of-Medical-Oncology-Mayo-Clinic-Cancer-Center-Rochester-MN-USA",{"title":1379},{"EN":1380},"Department of Medical Oncology, Mayo Clinic Cancer Center, Rochester, MN, USA",{"openalex":1382,"orcid":1384,"title":1386},{"VOID":1383},"A5024598480",{"VOID":1385},"https:\u002F\u002Forcid.org\u002F0000-0003-4436-4634",{"EN":1387},"Antonino B. D’Assoro",{"url":19,"publisher":1389,"properties":1405},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1390,"slug":10,"properties":1391,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":1395,"manageAffiliations":1396,"indexDatabases":1397,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":1392,"issn":1393,"title":1394},{"VOID":13},{"VOID":15},{"EN":10},[],[],[1398],{"id":44,"indexDatabase":1399,"url":57,"indexYears":58,"academicFieldIds":1404,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":1400,"label":1401,"description":1402,"key":54,"publicationTags":1403,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":1406,"pages":1408,"issue":1410},{"VOID":1407},"5",{"VOID":1409},"2881-2911",{"VOID":1411},"10",443,{"total":1412,"publishYear":19,"statisticByYear":1414},{"2014":422,"2015":1415,"2016":1416,"2017":1417,"2018":1418,"2019":1419,"2020":1420,"2021":1421,"2022":1421,"2023":1422,"2024":1423},46,54,45,61,51,52,37,34,23,"2014-05-30",2014,[1427,1431,1435,1439,1443,1447,1451,1455,1459,1463,1467,1471,1475,1479,1483,1487,1491,1495,1499,1503,1506,1510,1514,1518,1522,1526,1530,1534,1538,1542,1545,1549,1553,1557,1561,1564,1568,1572,1576,1580,1584,1588,1592,1596,1600,1604,1608,1612,1616,1620,1624,1628,1632,1636,1640,1643,1647,1651,1655,1659,1663,1667,1671,1675,1679,1683,1687,1691,1695,1699,1703,1705,1709,1713,1717,1721,1725,1729,1733,1736,1740,1744,1748,1752,1756,1760,1763,1767,1771,1775,1779,1783,1787,1790,1794,1798,1802,1806,1810,1814,1818,1822,1826,1830,1834,1838,1842,1846,1850,1854,1858,1862,1866,1870,1874,1878,1882,1886,1890,1894,1898,1902,1906,1910,1914,1918,1922,1926,1930,1934,1938,1942,1945,1949,1953,1957,1961,1964,1968,1972,1976,1980,1984,1988,1992,1995,1999,2003,2006,2010,2014,2018,2022,2026,2030,2034,2038,2042,2046,2050,2054,2058,2062,2066,2070,2074,2078,2082,2086,2090,2094,2097,2101,2105,2109,2112,2116,2120,2124,2128,2132,2136,2140,2144,2148,2152,2155,2159,2163,2167,2170,2173,2177,2181,2185,2189,2193,2197,2201,2204,2208,2212,2216,2220,2224,2228,2232,2236,2240,2244,2247,2251,2255,2259,2263,2266,2270,2274,2278,2282,2286,2290,2294,2298,2302,2306,2310,2314,2318,2322,2326,2330,2334,2338,2342,2346,2350,2354,2358,2362,2365,2367,2369,2373,2377,2381,2385,2389,2393,2397,2401,2405,2409,2413,2417,2421,2423,2425,2429,2433,2437,2441,2445,2449,2453,2457,2461,2465,2469,2473,2477,2481,2485,2489,2493,2497,2501,2504,2507,2511,2515,2519,2523,2527,2531,2535,2539,2542,2544,2548,2552,2556,2560,2564,2568,2572,2576,2580,2584,2588,2592,2596,2600,2604,2608,2612,2616,2620,2624,2628,2632,2634,2638,2642],{"id":19,"text":1428,"url":19,"identifiers":1429},"Cohen, 1980, Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase, Eur J Biochem, 107, 519, 10.1111\u002Fj.1432-1033.1980.tb06059.x",{"doi":1430},"10.1111\u002Fj.1432-1033.1980.tb06059.x",{"id":19,"text":1432,"url":19,"identifiers":1433},"Woodgett, 1990, Molecular cloning and expression of glycogen synthase kinase-3\u002Ffactor A, EMBO J, 9, 2431, 10.1002\u002Fj.1460-2075.1990.tb07419.x",{"doi":1434},"10.1002\u002Fj.1460-2075.1990.tb07419.x",{"id":19,"text":1436,"url":19,"identifiers":1437},"Li, 2012, GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease, Reviews in the Neurosciences, 23, 1, 10.1515\u002Frns.2011.061",{"doi":1438},"10.1515\u002Frns.2011.061",{"id":19,"text":1440,"url":19,"identifiers":1441},"Gattaz, 2012, Does lithium prevent Alzheimer's disease?, Drugs & Aging, 29, 335, 10.2165\u002F11599180-000000000-00000",{"doi":1442},"10.2165\u002F11599180-000000000-00000",{"id":19,"text":1444,"url":19,"identifiers":1445},"Agam, 2011, The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseases, Current Pharmaceutical Design, 17, 2264, 10.2174\u002F138161211797052484",{"doi":1446},"10.2174\u002F138161211797052484",{"id":19,"text":1448,"url":19,"identifiers":1449},"Sollott, 2009, Role of glycogen synthase kinase-3[beta] in cardioprotection, Circulation Research, 104, 1240, 10.1161\u002FCIRCRESAHA.109.197996",{"doi":1450},"10.1161\u002FCIRCRESAHA.109.197996",{"id":19,"text":1452,"url":19,"identifiers":1453},"Shimura, 2011, Acquired radioresistance of cancer and the AKT\u002FGSK3beta\u002Fcyclin D1 overexpression cycle, Journal of Radiation Research, 52, 539, 10.1269\u002Fjrr.11098",{"doi":1454},"10.1269\u002Fjrr.11098",{"id":19,"text":1456,"url":19,"identifiers":1457},"Lu, 2011, Overexpression of glycogen synthase kinase-3 in ovarian carcinoma cells with acquired paclitaxel resistance, International Journal of Gynecological Cancer, 21, 439, 10.1097\u002FIGC.0b013e31820d7366",{"doi":1458},"10.1097\u002FIGC.0b013e31820d7366",{"id":19,"text":1460,"url":19,"identifiers":1461},"Tomita, 2012, GSK-3 inhibition in vitro and in vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC), Biochemical & Biophysical Research Communications, 423, 490, 10.1016\u002Fj.bbrc.2012.05.147",{"doi":1462},"10.1016\u002Fj.bbrc.2012.05.147",{"id":19,"text":1464,"url":19,"identifiers":1465},"Thamilselvan, 2011, Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 beta\u002Fbeta-catenin pathway, International Journal of Cancer, 129, 2916, 10.1002\u002Fijc.25949",{"doi":1466},"10.1002\u002Fijc.25949",{"id":19,"text":1468,"url":19,"identifiers":1469},"Bone, 2011, Controlling embryonic stem cell proliferation and pluripotency: the role of PI3K- and GSK-3-dependent signalling, Biochemical Society Transactions, 39, 674, 10.1042\u002FBST0390674",{"doi":1470},"10.1042\u002FBST0390674",{"id":19,"text":1472,"url":19,"identifiers":1473},"So, 2012, Selective treatment of mixed-lineage leukemia leukemic stem cells through targeting glycogen synthase kinase 3 and the canonical Wnt\u002F[beta]-catenin pathway, Current Opinion in Hematology, 19, 280, 10.1097\u002FMOH.0b013e3283545615",{"doi":1474},"10.1097\u002FMOH.0b013e3283545615",{"id":19,"text":1476,"url":19,"identifiers":1477},"Smith, 2010, The ground state of pluripotency, Biochemical Society Transactions, 38, 1027, 10.1042\u002FBST0381027",{"doi":1478},"10.1042\u002FBST0381027",{"id":19,"text":1480,"url":19,"identifiers":1481},"Zhou, 2010, GSK3 signalling in neural development, Nature Reviews Neuroscience, 11, 539, 10.1038\u002Fnrn2870",{"doi":1482},"10.1038\u002Fnrn2870",{"id":19,"text":1484,"url":19,"identifiers":1485},"Force, 2011, Targeting GSK-3 family members in the heart: a very sharp double-edged sword, Journal of Molecular & Cellular Cardiology, 51, 607, 10.1016\u002Fj.yjmcc.2010.11.020",{"doi":1486},"10.1016\u002Fj.yjmcc.2010.11.020",{"id":19,"text":1488,"url":19,"identifiers":1489},"Zhu, 2011, beta-catenin as a potential key target for tumor suppression, International Journal of Cancer, 129, 1541, 10.1002\u002Fijc.26102",{"doi":1490},"10.1002\u002Fijc.26102",{"id":19,"text":1492,"url":19,"identifiers":1493},"Martinez, 2011, The potential role of glycogen synthase kinase 3 inhibitors as amyotrophic lateral sclerosis pharmacological therapy, Current Medicinal Chemistry, 18, 3028, 10.2174\u002F092986711796391697",{"doi":1494},"10.2174\u002F092986711796391697",{"id":19,"text":1496,"url":19,"identifiers":1497},"Gao, 2011, GSK-3beta activity and hyperdopamine-dependent behaviors, Neurosci Biobehav Rev, 35, 645, 10.1016\u002Fj.neubiorev.2010.08.001",{"doi":1498},"10.1016\u002Fj.neubiorev.2010.08.001",{"id":19,"text":1500,"url":19,"identifiers":1501},"Martin, 2011, Glycogen synthase kinase 3: a point of convergence for the host inflammatory response, Cytokine, 53, 130, 10.1016\u002Fj.cyto.2010.10.009",{"doi":1502},"10.1016\u002Fj.cyto.2010.10.009",{"id":19,"text":1504,"url":19,"identifiers":1505},"Christensen, 2010, Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings, Journal of Nephrology, 23, S43",{},{"id":19,"text":1507,"url":19,"identifiers":1508},"Dolnikov, 2010, Using small molecule GSK3beta inhibitors to treat inflammation, Current Medicinal Chemistry, 17, 2873, 10.2174\u002F092986710792065090",{"doi":1509},"10.2174\u002F092986710792065090",{"id":19,"text":1511,"url":19,"identifiers":1512},"Gomez, 2010, QSAR, docking, and CoMFA studies of GSK3 inhibitors, Current Pharmaceutical Design, 16, 2666, 10.2174\u002F138161210792389225",{"doi":1513},"10.2174\u002F138161210792389225",{"id":19,"text":1515,"url":19,"identifiers":1516},"Weaver, 2010, The development of new therapeutics for Alzheimer's disease, Clinical Pharmacology & Therapeutics, 88, 475, 10.1038\u002Fclpt.2010.165",{"doi":1517},"10.1038\u002Fclpt.2010.165",{"id":19,"text":1519,"url":19,"identifiers":1520},"Henriksen, 2010, Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes, Current Diabetes Reviews, 6, 285, 10.2174\u002F157339910793360888",{"doi":1521},"10.2174\u002F157339910793360888",{"id":19,"text":1523,"url":19,"identifiers":1524},"Javitch, 2010, Signaling pathways in schizophrenia: emerging targets and therapeutic strategies, Trends in Pharmacological Sciences, 31, 381, 10.1016\u002Fj.tips.2010.05.004",{"doi":1525},"10.1016\u002Fj.tips.2010.05.004",{"id":19,"text":1527,"url":19,"identifiers":1528},"Yoon, 2010, Roles of GSK3 in metabolic shift toward abnormal anabolism in cell senescence, Annals of the New York Academy of Sciences, 1201, 65, 10.1111\u002Fj.1749-6632.2010.05617.x",{"doi":1529},"10.1111\u002Fj.1749-6632.2010.05617.x",{"id":19,"text":1531,"url":19,"identifiers":1532},"Woodgett, 2000, Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation, Nature, 406, 86, 10.1038\u002F35017574",{"doi":1533},"10.1038\u002F35017574",{"id":19,"text":1535,"url":19,"identifiers":1536},"Woodgett, 2008, Glycogen synthase kinase-3 and cancer: good cop, bad cop?, Cancer Cell, 14, 351, 10.1016\u002Fj.ccr.2008.10.013",{"doi":1537},"10.1016\u002Fj.ccr.2008.10.013",{"id":19,"text":1539,"url":19,"identifiers":1540},"Woodgett, 2003, GSK-3: tricks of the trade for a multi-tasking kinase, J Cell Sci, 116, 1175, 10.1242\u002Fjcs.00384",{"doi":1541},"10.1242\u002Fjcs.00384",{"id":19,"text":1543,"url":19,"identifiers":1544},"Sutherland, 2011, What are the bona fide GSK3 substrates?, International journal of Alzheimer's Disease, 23 pages",{},{"id":19,"text":1546,"url":19,"identifiers":1547},"Woodgett, 2007, Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism, Cell Metab, 6, 329, 10.1016\u002Fj.cmet.2007.08.013",{"doi":1548},"10.1016\u002Fj.cmet.2007.08.013",{"id":19,"text":1550,"url":19,"identifiers":1551},"Woodgett, 2009, Abnormalities in brain structure and behavior in GSK-3alpha mutant mice, Mol Brain, 2, 35, 10.1186\u002F1756-6606-2-35",{"doi":1552},"10.1186\u002F1756-6606-2-35",{"id":19,"text":1554,"url":19,"identifiers":1555},"Sutherland, 2010, J Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain, Neurochem, 115, 974, 10.1111\u002Fj.1471-4159.2010.06988.x",{"doi":1556},"10.1111\u002Fj.1471-4159.2010.06988.x",{"id":19,"text":1558,"url":19,"identifiers":1559},"Stegmaier, 2012, The intersection of genetic and chemical genomic screens identifies GSK-3alpha as a target in human acute myeloid leukemia, J Clin Invest, 122, 935, 10.1172\u002FJCI46465",{"doi":1560},"10.1172\u002FJCI46465",{"id":19,"text":1562,"url":19,"identifiers":1563},"Mills, 2000, Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A, Proc Natl Acad Sci USA, 24, 11960",{},{"id":19,"text":1565,"url":19,"identifiers":1566},"Mostov, 2007, Polarity proteins PAR6 and aPKC regulate cell death through GSK-3beta in 3D epithelial morphogenesis, J Cell Sci, 120, 2309, 10.1242\u002Fjcs.007443",{"doi":1567},"10.1242\u002Fjcs.007443",{"id":19,"text":1569,"url":19,"identifiers":1570},"Hemmings, 1995, Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B, Nature, 378, 785, 10.1038\u002F378785a0",{"doi":1571},"10.1038\u002F378785a0",{"id":19,"text":1573,"url":19,"identifiers":1574},"Woodgett, 1994, Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation, Biochem J, 303, 701, 10.1042\u002Fbj3030701",{"doi":1575},"10.1042\u002Fbj3030701",{"id":19,"text":1577,"url":19,"identifiers":1578},"Cohen, 1993, Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling, Biochem J, 296, 15, 10.1042\u002Fbj2960015",{"doi":1579},"10.1042\u002Fbj2960015",{"id":19,"text":1581,"url":19,"identifiers":1582},"Woodgett, 2006, Glycogen synthase kinase-3--an overview of an over-achieving protein kinase, Curr Drug Targets, 7, 1377, 10.2174\u002F1389450110607011377",{"doi":1583},"10.2174\u002F1389450110607011377",{"id":19,"text":1585,"url":19,"identifiers":1586},"Cohen, 1994, The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431cells, Biochem J, 303, 27, 10.1042\u002Fbj3030027",{"doi":1587},"10.1042\u002Fbj3030027",{"id":19,"text":1589,"url":19,"identifiers":1590},"Saltiel, 1998, The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells, J Biol Chem, 273, 14063, 10.1074\u002Fjbc.273.23.14063",{"doi":1591},"10.1074\u002Fjbc.273.23.14063",{"id":19,"text":1593,"url":19,"identifiers":1594},"Biondi, 2001, A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation, Mol Cell, 7, 1321, 10.1016\u002FS1097-2765(01)00253-2",{"doi":1595},"10.1016\u002FS1097-2765(01)00253-2",{"id":19,"text":1597,"url":19,"identifiers":1598},"Zhao, 2009, Structural basis for the complete loss of GSK3beta catalytic activity due to R96 mutation investigated by molecular dynamics study, Proteins, 75, 671, 10.1002\u002Fprot.22279",{"doi":1599},"10.1002\u002Fprot.22279",{"id":19,"text":1601,"url":19,"identifiers":1602},"Cohen, 2004, Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event, Biochem J, 377, 249, 10.1042\u002Fbj20031259",{"doi":1603},"10.1042\u002Fbj20031259",{"id":19,"text":1605,"url":19,"identifiers":1606},"Woodgett, 1993, Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation, EMBO J, 12, 803, 10.1002\u002Fj.1460-2075.1993.tb05715.x",{"doi":1607},"10.1002\u002Fj.1460-2075.1993.tb05715.x",{"id":19,"text":1609,"url":19,"identifiers":1610},"Lee, 2000, Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration, Proc Natl Acad Sci USA, 97, 11074, 10.1073\u002Fpnas.190297597",{"doi":1611},"10.1073\u002Fpnas.190297597",{"id":19,"text":1613,"url":19,"identifiers":1614},"Jope, 2001, Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta, J Biol Chem, 276, 37436, 10.1074\u002Fjbc.M105725200",{"doi":1615},"10.1074\u002Fjbc.M105725200",{"id":19,"text":1617,"url":19,"identifiers":1618},"Lee, 2010, Antidiabetic effect of propolis: reduction of expression of glucose-6-phosphatase through inhibition of Y279 and Y216 autophosphorylation of GSK-3α\u002Fβ in HepG2 cells, Phytother Res, 24, 1554, 10.1002\u002Fptr.3147",{"doi":1619},"10.1002\u002Fptr.3147",{"id":19,"text":1621,"url":19,"identifiers":1622},"Gajkowska, 2009, Alzheimer's disease genetic mutation evokes ultrastructural alterations: correlation to an intracellular Abeta deposition and the level of GSK-3beta-P(Y216) phosphorylated form, Neurotoxicology, 30, 581, 10.1016\u002Fj.neuro.2009.05.008",{"doi":1623},"10.1016\u002Fj.neuro.2009.05.008",{"id":19,"text":1625,"url":19,"identifiers":1626},"Ossowska, 2011, Glycogen synthase kinase 3β and its phosphorylated form (Y216) in the paraquat-induced model of parkinsonism, Neurotox Res, 19, 162, 10.1007\u002Fs12640-010-9153-7",{"doi":1627},"10.1007\u002Fs12640-010-9153-7",{"id":19,"text":1629,"url":19,"identifiers":1630},"Pei, 2011, Interplay between glycogen synthase kinase-3β and tau in the cerebellum of Hsp27 transgenic mouse, J Neurosci Res, 89, 1267, 10.1002\u002Fjnr.22660",{"doi":1631},"10.1002\u002Fjnr.22660",{"id":19,"text":1633,"url":19,"identifiers":1634},"Johnson, 2001, Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2, Biochem Biophys Res Commun, 284, 485, 10.1006\u002Fbbrc.2001.4986",{"doi":1635},"10.1006\u002Fbbrc.2001.4986",{"id":19,"text":1637,"url":19,"identifiers":1638},"Moolenaar, 2006, GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction, Mol Biol Cell, 17, 1834, 10.1091\u002Fmbc.e05-07-0688",{"doi":1639},"10.1091\u002Fmbc.e05-07-0688",{"id":19,"text":1641,"url":19,"identifiers":1642},"Wandosell, 2011, Deconstructing GSK-3: The fine regulation of its activity, Int J Alzheimers Dis, 2011, 479249",{},{"id":19,"text":1644,"url":19,"identifiers":1645},"Johnson, 1999, Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase, J Neurochem, 72, 576, 10.1046\u002Fj.1471-4159.1999.0720576.x",{"doi":1646},"10.1046\u002Fj.1471-4159.1999.0720576.x",{"id":19,"text":1648,"url":19,"identifiers":1649},"Rincon, 2008, Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation, Science, 320, 667, 10.1126\u002Fscience.1156037",{"doi":1650},"10.1126\u002Fscience.1156037",{"id":19,"text":1652,"url":19,"identifiers":1653},"Iqbal, 2000, Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain, FEBS Lett, 485, 87, 10.1016\u002FS0014-5793(00)02203-1",{"doi":1654},"10.1016\u002FS0014-5793(00)02203-1",{"id":19,"text":1656,"url":19,"identifiers":1657},"Kimmel, 2002, Receptor-dependent and tyrosine phosphatase-mediated inhibition of GSK3 regulates cell fate choice, Dev Cell, 3, 523, 10.1016\u002FS1534-5807(02)00269-1",{"doi":1658},"10.1016\u002FS1534-5807(02)00269-1",{"id":19,"text":1660,"url":19,"identifiers":1661},"Cooper, 2011, A GSK-3-mediated transcriptional network maintains repression of immediate early genes in quiescent cells, Cell Cycle, 10, 3072, 10.4161\u002Fcc.10.18.17321",{"doi":1662},"10.4161\u002Fcc.10.18.17321",{"id":19,"text":1664,"url":19,"identifiers":1665},"Yoon, 2011, Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation, Proc Natl Acad Sci USA, 108, 1204, 10.1073\u002Fpnas.1110195108",{"doi":1666},"10.1073\u002Fpnas.1110195108",{"id":19,"text":1668,"url":19,"identifiers":1669},"Yoon, 2012, Glycogen synthase kinase (GSK)-3 and mammalian target of rapamycin complex 1 (mTORC1) cooperate to regulate protein S6 kinase 1 (S6K1), Cell Cycle, 11, 1053, 10.4161\u002Fcc.11.6.19784",{"doi":1670},"10.4161\u002Fcc.11.6.19784",{"id":19,"text":1672,"url":19,"identifiers":1673},"Measday, 2012, The Mck1 GSK-3 kinase inhibits the activity of Clb2-Cdk1 post-nuclear division, Cell Cycle, 11, 3421, 10.4161\u002Fcc.21731",{"doi":1674},"10.4161\u002Fcc.21731",{"id":19,"text":1676,"url":19,"identifiers":1677},"Cleary, 2008, Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy, Nature, 455, 1205, 10.1038\u002Fnature07284",{"doi":1678},"10.1038\u002Fnature07284",{"id":19,"text":1680,"url":19,"identifiers":1681},"Dimmeler, 2002, Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation, J Biol Chem, 277, 9684, 10.1074\u002Fjbc.M106157200",{"doi":1682},"10.1074\u002Fjbc.M106157200",{"id":19,"text":1684,"url":19,"identifiers":1685},"Sherr, 1998, Glycogen synthase kinase- 3beta regulates cyclin D1 proteolysis and subcellular localization, Genes Dev, 12, 3499, 10.1101\u002Fgad.12.22.3499",{"doi":1686},"10.1101\u002Fgad.12.22.3499",{"id":19,"text":1688,"url":19,"identifiers":1689},"Roberts, 2003, Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation, Mol Cell, 12, 381, 10.1016\u002FS1097-2765(03)00287-9",{"doi":1690},"10.1016\u002FS1097-2765(03)00287-9",{"id":19,"text":1692,"url":19,"identifiers":1693},"Paramio, 2002, Expression, localization, and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesis, Mol Carcinog, 35, 180, 10.1002\u002Fmc.10087",{"doi":1694},"10.1002\u002Fmc.10087",{"id":19,"text":1696,"url":19,"identifiers":1697},"Mishra, 2010, Glycogen synthase kinase 3 beta: can it be a target for oral cancer?, Molecular Cancer, 9, 144, 10.1186\u002F1476-4598-9-144",{"doi":1698},"10.1186\u002F1476-4598-9-144",{"id":19,"text":1700,"url":19,"identifiers":1701},"Nakayama, 2004, Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7, EMBO J, 23, 2116, 10.1038\u002Fsj.emboj.7600217",{"doi":1702},"10.1038\u002Fsj.emboj.7600217",{"id":19,"text":1531,"url":19,"identifiers":1704},{"doi":1533},{"id":19,"text":1706,"url":19,"identifiers":1707},"Perkins, 2010, Phosphorylation of the p52 NF-kappaB subunit, Cell Cycle, 9, 4774, 10.4161\u002Fcc.9.24.14246",{"doi":1708},"10.4161\u002Fcc.9.24.14246",{"id":19,"text":1710,"url":19,"identifiers":1711},"Ozawa, 2008, Snail regulates cell-matrix adhesion by regulation of the expression of integrins and basement membrane proteins, J Biol Chem, 283, 23514, 10.1074\u002Fjbc.M801125200",{"doi":1712},"10.1074\u002Fjbc.M801125200",{"id":19,"text":1714,"url":19,"identifiers":1715},"Weiss, 2006, A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells, Nat Cell Biol, 8, 1398, 10.1038\u002Fncb1508",{"doi":1716},"10.1038\u002Fncb1508",{"id":19,"text":1718,"url":19,"identifiers":1719},"Nye, 2002, Glycogen synthase kinase-3beta modulates notch signaling and stability, Curr Biol, 12, 1006, 10.1016\u002FS0960-9822(02)00888-6",{"doi":1720},"10.1016\u002FS0960-9822(02)00888-6",{"id":19,"text":1722,"url":19,"identifiers":1723},"Datta, 2011, Role of STRAP in regulating GSK3beta function and Notch3 stabilization, Cell Cycle, 10, 1639, 10.4161\u002Fcc.10.10.15630",{"doi":1724},"10.4161\u002Fcc.10.10.15630",{"id":19,"text":1726,"url":19,"identifiers":1727},"Wickrema, 2002, Regulation of myeloma cell growth through Akt\u002FGsk3\u002Fforkhead signaling pathway, Biochem Biophys Res Commun, 297, 760, 10.1016\u002FS0006-291X(02)02278-7",{"doi":1728},"10.1016\u002FS0006-291X(02)02278-7",{"id":19,"text":1730,"url":19,"identifiers":1731},"MacDougald, 1999, Glycogen synthase kinase 3 is an insulin-regulated C\u002FEBPalpha kinase, Mol Cell Biol, 19, 8433, 10.1128\u002FMCB.19.12.8433",{"doi":1732},"10.1128\u002FMCB.19.12.8433",{"id":19,"text":1734,"url":19,"identifiers":1735},"Sassone-Corsi, 1993, Negative regulation of Jun\u002FAP-1: conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy, Oncogene, 8, 841",{},{"id":19,"text":1737,"url":19,"identifiers":1738},"Kracht, 2004, Phosphorylation of serine 468 by GSK-3beta regulates basal p65 NF-kappaB activity, J Biol Chem, 279, 49571, 10.1074\u002Fjbc.C400442200",{"doi":1739},"10.1074\u002Fjbc.C400442200",{"id":19,"text":1741,"url":19,"identifiers":1742},"Wang, 2009, Bleomycin-induced nuclear factor kappaB activation in human bronchial epithelial cells involves the phosphorylation of glycogen synthase kinase 3beta, Toxicol Lett, 187, 194, 10.1016\u002Fj.toxlet.2009.02.023",{"doi":1743},"10.1016\u002Fj.toxlet.2009.02.023",{"id":19,"text":1745,"url":19,"identifiers":1746},"Maggirwar, 2003, Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling, Mol Cell Biol, 23, 4649, 10.1128\u002FMCB.23.13.4649-4662.2003",{"doi":1747},"10.1128\u002FMCB.23.13.4649-4662.2003",{"id":19,"text":1749,"url":19,"identifiers":1750},"Koromilas, 2004, Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta, Genes Dev, 18, 261, 10.1101\u002Fgad.1165804",{"doi":1751},"10.1101\u002Fgad.1165804",{"id":19,"text":1753,"url":19,"identifiers":1754},"Maurer, 2011, GSK-3 turns p53 deadly, Cell Cycle, 10, 3621, 10.4161\u002Fcc.10.21.17852",{"doi":1755},"10.4161\u002Fcc.10.21.17852",{"id":19,"text":1757,"url":19,"identifiers":1758},"Yook, 2011, A p53\u002FmiRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition, J Cell Biol, 195, 417, 10.1083\u002Fjcb.201103097",{"doi":1759},"10.1083\u002Fjcb.201103097",{"id":19,"text":1761,"url":19,"identifiers":1762},"Weiss, 2011, p53 and microRNA-34 are suppressors of canonical Wnt signaling, Sci Signal, 4, ra71",{},{"id":19,"text":1764,"url":19,"identifiers":1765},"Villa-Moruzzi, 2005, Regulation of FAK Ser-722 phosphorylation and kinase activity by GSK3 and PP1 during cell spreading and migration, Biochem J, 391, 359, 10.1042\u002FBJ20050282",{"doi":1766},"10.1042\u002FBJ20050282",{"id":19,"text":1768,"url":19,"identifiers":1769},"García De Herreros, 2000, The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells, Nat Cell Biol, 2, 84, 10.1038\u002F35000034",{"doi":1770},"10.1038\u002F35000034",{"id":19,"text":1772,"url":19,"identifiers":1773},"Mercurio, 2005, Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition, J Cell Biol, 168, 29, 10.1083\u002Fjcb.200409067",{"doi":1774},"10.1083\u002Fjcb.200409067",{"id":19,"text":1776,"url":19,"identifiers":1777},"Bauer, 2009, P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation, Carcinogenesis, 30, 1781, 10.1093\u002Fcarcin\u002Fbgp175",{"doi":1778},"10.1093\u002Fcarcin\u002Fbgp175",{"id":19,"text":1780,"url":19,"identifiers":1781},"Du, 2013, Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT\u002FGSK-3β-mediated stabilization of snail in colorectal cancer, PLoS One, 8, e56664, 10.1371\u002Fjournal.pone.0056664",{"doi":1782},"10.1371\u002Fjournal.pone.0056664",{"id":19,"text":1784,"url":19,"identifiers":1785},"Jiang, 2013, Glycogen synthase kinase-3beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer, Eur J Cancer, 49, 2734, 10.1016\u002Fj.ejca.2013.03.014",{"doi":1786},"10.1016\u002Fj.ejca.2013.03.014",{"id":19,"text":1788,"url":19,"identifiers":1789},"Wang, 2012, Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase\u002FAkt signaling facilitates liver cancer progression, Hepatology, 55, 1787, 10.1002\u002Fhep.25596",{"doi":919},{"id":19,"text":1791,"url":19,"identifiers":1792},"Gu, 2012, Hepatitis B virus X protein promotes hepatoma cell invasion and metastasization by stabilizing Snail protein, Cancer Sci, 103, 2072, 10.1111\u002Fcas.12017",{"doi":1793},"10.1111\u002Fcas.12017",{"id":19,"text":1795,"url":19,"identifiers":1796},"Guan, 2014, Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt\u002FGSK-3β\u002FSnail signaling, Hepatology, 59, 531, 10.1002\u002Fhep.26677",{"doi":1797},"10.1002\u002Fhep.26677",{"id":19,"text":1799,"url":19,"identifiers":1800},"El-Rifai, 2008, t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism, Cancer Res, 68, 395, 10.1158\u002F0008-5472.CAN-07-1580",{"doi":1801},"10.1158\u002F0008-5472.CAN-07-1580",{"id":19,"text":1803,"url":19,"identifiers":1804},"Hung, 2007, Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization, Molecular & Cellular Biology, 27, 4006, 10.1128\u002FMCB.00620-06",{"doi":1805},"10.1128\u002FMCB.00620-06",{"id":19,"text":1807,"url":19,"identifiers":1808},"Davis, 2009, Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis, Mol Cell Biol, 29, 3845, 10.1128\u002FMCB.00279-09",{"doi":1809},"10.1128\u002FMCB.00279-09",{"id":19,"text":1811,"url":19,"identifiers":1812},"Wei, 2011, Mcl-1 ubiquitination and destruction, Oncotarget, 2, 239, 10.18632\u002Foncotarget.242",{"doi":1813},"10.18632\u002Foncotarget.242",{"id":19,"text":1815,"url":19,"identifiers":1816},"Craig, 2012, Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer, PLoS One, 7, e47060, 10.1371\u002Fjournal.pone.0047060",{"doi":1817},"10.1371\u002Fjournal.pone.0047060",{"id":19,"text":1819,"url":19,"identifiers":1820},"Rathmell, 2007, Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1, Molecular & Cellular Biology, 27, 4328, 10.1128\u002FMCB.00153-07",{"doi":1821},"10.1128\u002FMCB.00153-07",{"id":19,"text":1823,"url":19,"identifiers":1824},"Lin, 2011, Increased galectin-3 facilitates leukemia cell survival from apoptotic stimuli, Biochem Biophys Res Commun, 412, 334, 10.1016\u002Fj.bbrc.2011.07.099",{"doi":1825},"10.1016\u002Fj.bbrc.2011.07.099",{"id":19,"text":1827,"url":19,"identifiers":1828},"Hong, 2012, GSK3beta regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl, Cell Cycle, 11, 532, 10.4161\u002Fcc.11.3.19051",{"doi":1829},"10.4161\u002Fcc.11.3.19051",{"id":19,"text":1831,"url":19,"identifiers":1832},"Lin, 2012, Anesthetic propofol causes glycogen synthase kinase-3[beta]-regulated lysosomal\u002Fmitochondrial apoptosis in macrophages, Anesthesiology, 116, 868, 10.1097\u002FALN.0b013e31824af68a",{"doi":1833},"10.1097\u002FALN.0b013e31824af68a",{"id":19,"text":1835,"url":19,"identifiers":1836},"Ten Dijke, 2011, GSK3beta inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb, Mol Biol Cell, 22, 3533, 10.1091\u002Fmbc.e11-06-0483",{"doi":1837},"10.1091\u002Fmbc.e11-06-0483",{"id":19,"text":1839,"url":19,"identifiers":1840},"Boucher, 2012, Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms, Carcinogenesis, 33, 529, 10.1093\u002Fcarcin\u002Fbgr309",{"doi":1841},"10.1093\u002Fcarcin\u002Fbgr309",{"id":19,"text":1843,"url":19,"identifiers":1844},"Heidenreich, 2004, Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis, Journal of Neuroscience, 24, 9993, 10.1523\u002FJNEUROSCI.2057-04.2004",{"doi":1845},"10.1523\u002FJNEUROSCI.2057-04.2004",{"id":19,"text":1847,"url":19,"identifiers":1848},"Yu, 2005, Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells, Cancer Res, 65, 9012, 10.1158\u002F0008-5472.CAN-05-1226",{"doi":1849},"10.1158\u002F0008-5472.CAN-05-1226",{"id":19,"text":1851,"url":19,"identifiers":1852},"Pouponnot, 2007, GSK-3-mediated phosphorylation enhances Maf-transforming activity, Mol Cell, 28, 584, 10.1016\u002Fj.molcel.2007.11.009",{"doi":1853},"10.1016\u002Fj.molcel.2007.11.009",{"id":19,"text":1855,"url":19,"identifiers":1856},"Blok, 2010, Wnt\u002FB-catenin and sex hormone signaling in endometrial homeostasis and cancer, Oncotarget, 1, 674, 10.18632\u002Foncotarget.201",{"doi":1857},"10.18632\u002Foncotarget.201",{"id":19,"text":1859,"url":19,"identifiers":1860},"Wang, 2010, Jagged1 expression regulated by Notch3 and Wnt\u002Fbeta-catenin signaling pathways in ovarian cancer, Oncotarget, 1, 210, 10.18632\u002Foncotarget.127",{"doi":1861},"10.18632\u002Foncotarget.127",{"id":19,"text":1863,"url":19,"identifiers":1864},"Lorenzi, 2010, Drug discovery approaches to target Wnt signaling in cancer stem cells, Oncotarget, 1, 563, 10.18632\u002Foncotarget.191",{"doi":1865},"10.18632\u002Foncotarget.191",{"id":19,"text":1867,"url":19,"identifiers":1868},"Morrisey, 2011, Wnt and Kras signaling-dark siblings in lung cancer, Oncotarget, 2, 569, 10.18632\u002Foncotarget.305",{"doi":1869},"10.18632\u002Foncotarget.305",{"id":19,"text":1871,"url":19,"identifiers":1872},"Rao, 2011, Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1, Oncotarget, 2, 1028, 10.18632\u002Foncotarget.367",{"doi":1873},"10.18632\u002Foncotarget.367",{"id":19,"text":1875,"url":19,"identifiers":1876},"Jung, 2012, Human telomerase reverse transcriptase (hTERT) is a target gene of beta-catenin in human colorectal tumors, Cell Cycle, 11, 3331, 10.4161\u002Fcc.21790",{"doi":1877},"10.4161\u002Fcc.21790",{"id":19,"text":1879,"url":19,"identifiers":1880},"Dalton, 2012, Reconciling the different roles of Gsk3beta in “naive” and “primed” pluripotent stem cells, Cell Cycle, 11, 2991, 10.4161\u002Fcc.21110",{"doi":1881},"10.4161\u002Fcc.21110",{"id":19,"text":1883,"url":19,"identifiers":1884},"Chien, 2012, Regulating the response to targeted MEK inhibition in melanoma: Enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt\u002Fbeta-catenin activation, Cell Cycle, 11, 3724, 10.4161\u002Fcc.21645",{"doi":1885},"10.4161\u002Fcc.21645",{"id":19,"text":1887,"url":19,"identifiers":1888},"Yook, 2012, MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling, Cell Cycle, 11, 1273, 10.4161\u002Fcc.19618",{"doi":1889},"10.4161\u002Fcc.19618",{"id":19,"text":1891,"url":19,"identifiers":1892},"Sgambato, 2012, The tumor suppressor HINT1 regulates MITF and beta-catenin transcriptional activity in melanoma cells, Cell Cycle, 11, 2206, 10.4161\u002Fcc.20765",{"doi":1893},"10.4161\u002Fcc.20765",{"id":19,"text":1895,"url":19,"identifiers":1896},"Borkan, 2011, Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress, Kidney Int, 79, 1207, 10.1038\u002Fki.2010.532",{"doi":1897},"10.1038\u002Fki.2010.532",{"id":19,"text":1899,"url":19,"identifiers":1900},"Rakus, 2012, Muscle FBPase binds to cardiomyocyte mitochondria under glycogen synthase kinase-3 inhibition or elevation of cellular Ca2+ level, FEBS Lett, 586, 13, 10.1016\u002Fj.febslet.2011.11.032",{"doi":1901},"10.1016\u002Fj.febslet.2011.11.032",{"id":19,"text":1903,"url":19,"identifiers":1904},"Luo, 2009, Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy, Cancer Lett, 273, 194, 10.1016\u002Fj.canlet.2008.05.045",{"doi":1905},"10.1016\u002Fj.canlet.2008.05.045",{"id":19,"text":1907,"url":19,"identifiers":1908},"Minamoto, 2005, Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation, Biochem Biophys Res Commun, 334, 1365, 10.1016\u002Fj.bbrc.2005.07.041",{"doi":1909},"10.1016\u002Fj.bbrc.2005.07.041",{"id":19,"text":1911,"url":19,"identifiers":1912},"Billadeau, 2005, Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells, Cancer Res, 65, 2076, 10.1158\u002F0008-5472.CAN-04-3642",{"doi":1913},"10.1158\u002F0008-5472.CAN-04-3642",{"id":19,"text":1915,"url":19,"identifiers":1916},"Wang, 2012, shRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer, Cancer Letters, 316, 178, 10.1016\u002Fj.canlet.2011.10.033",{"doi":1917},"10.1016\u002Fj.canlet.2011.10.033",{"id":19,"text":1919,"url":19,"identifiers":1920},"Seldin, 2005, Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis, Cancer Res, 65, 5792, 10.1158\u002F0008-5472.CAN-05-1021",{"doi":1921},"10.1158\u002F0008-5472.CAN-05-1021",{"id":19,"text":1923,"url":19,"identifiers":1924},"Luo, 2007, The role of glycogen synthase kinase 3beta in the transformation of epidermal cells, Cancer Res, 67, 7756, 10.1158\u002F0008-5472.CAN-06-4665",{"doi":1925},"10.1158\u002F0008-5472.CAN-06-4665",{"id":19,"text":1927,"url":19,"identifiers":1928},"Meric-Bernstam, 2005, Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity, Cancer Res, 65, 1961, 10.1158\u002F0008-5472.CAN-04-2501",{"doi":1929},"10.1158\u002F0008-5472.CAN-04-2501",{"id":19,"text":1931,"url":19,"identifiers":1932},"Dolcetti, 2008, GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma, Cell Cycle, 7, 2813, 10.4161\u002Fcc.7.18.6733",{"doi":1933},"10.4161\u002Fcc.7.18.6733",{"id":19,"text":1935,"url":19,"identifiers":1936},"Xu, 2006, Adiponectin modulates the glycogen synthase kinase-3beta\u002Fbetacatenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice, Cancer Res, 66, 11462, 10.1158\u002F0008-5472.CAN-06-1969",{"doi":1937},"10.1158\u002F0008-5472.CAN-06-1969",{"id":19,"text":1939,"url":19,"identifiers":1940},"Bartek, 1994, Cyclin D1 protein expression and function in human breast cancer, Int J Cancer, 57, 353, 10.1002\u002Fijc.2910570311",{"doi":1941},"10.1002\u002Fijc.2910570311",{"id":19,"text":1943,"url":19,"identifiers":1944},"Peters, 1994, Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining, Cancer Res, 54, 1812",{},{"id":19,"text":1946,"url":19,"identifiers":1947},"Peters, 1995, Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer, Cancer Lett, 90, 43, 10.1016\u002F0304-3835(94)03676-A",{"doi":1948},"10.1016\u002F0304-3835(94)03676-A",{"id":19,"text":1950,"url":19,"identifiers":1951},"Hung, 2000, Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression, Proc Natl Acad Sci USA, 97, 4262, 10.1073\u002Fpnas.060025397",{"doi":1952},"10.1073\u002Fpnas.060025397",{"id":19,"text":1954,"url":19,"identifiers":1955},"Costantini, 2001, Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice, J Cell Biol, 155, 1055, 10.1083\u002Fjcb.200107066",{"doi":1956},"10.1083\u002Fjcb.200107066",{"id":19,"text":1958,"url":19,"identifiers":1959},"Seldin, 2001, Protein kinase CK2: signaling and tumorigenesis in the mammary gland, Mol Cell Biochem, 227, 153, 10.1023\u002FA:1013108822847",{"doi":1960},"10.1023\u002FA:1013108822847",{"id":19,"text":1962,"url":19,"identifiers":1963},"McCubrey, 2014, Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells, Cell Cycle",{},{"id":19,"text":1965,"url":19,"identifiers":1966},"Larsson, 2000, c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover, Blood, 95, 2104, 10.1182\u002Fblood.V95.6.2104",{"doi":1967},"10.1182\u002Fblood.V95.6.2104",{"id":19,"text":1969,"url":19,"identifiers":1970},"Penn, 2002, The myc oncogene: MarvelouslY Complex, Adv Cancer Res, 84, 81, 10.1016\u002FS0065-230X(02)84004-0",{"doi":1971},"10.1016\u002FS0065-230X(02)84004-0",{"id":19,"text":1973,"url":19,"identifiers":1974},"Hann, 2003, Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization, J Biol Chem, 278, 51606, 10.1074\u002Fjbc.M310722200",{"doi":1975},"10.1074\u002Fjbc.M310722200",{"id":19,"text":1977,"url":19,"identifiers":1978},"Zhou, 2008, DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein, Mol Cancer, 7, 32, 10.1186\u002F1476-4598-7-32",{"doi":1979},"10.1186\u002F1476-4598-7-32",{"id":19,"text":1981,"url":19,"identifiers":1982},"Gonzalez-Baron, 2000, beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome, Virchows Arch, 437, 599, 10.1007\u002Fs004280000266",{"doi":1983},"10.1007\u002Fs004280000266",{"id":19,"text":1985,"url":19,"identifiers":1986},"Alkalay, 2002, Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway, Genes Dev, 16, 1066, 10.1101\u002Fgad.230302",{"doi":1987},"10.1101\u002Fgad.230302",{"id":19,"text":1989,"url":19,"identifiers":1990},"Yura, 2005, Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma, J Cancer Res Clin Oncol, 131, 773, 10.1007\u002Fs00432-005-0027-y",{"doi":1991},"10.1007\u002Fs00432-005-0027-y",{"id":19,"text":1993,"url":19,"identifiers":1994},"Lin, 2003, Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer, Int J Oncol, 23, 1001",{},{"id":19,"text":1996,"url":19,"identifiers":1997},"McCubrey, 2011, Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy, Oncotarget, 2, 538, 10.18632\u002Foncotarget.302",{"doi":1998},"10.18632\u002Foncotarget.302",{"id":19,"text":2000,"url":19,"identifiers":2001},"McCubrey, 2011, Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells, Oncotarget, 2, 610, 10.18632\u002Foncotarget.315",{"doi":2002},"10.18632\u002Foncotarget.315",{"id":19,"text":2004,"url":19,"identifiers":2005},"Libra, 2012, Gene alterations in the PI3K\u002FPTEN\u002FAKT pathway as a mechanism of drug-resistance, Int J Oncol, 40, 639",{},{"id":19,"text":2007,"url":19,"identifiers":2008},"McCubrey, 2011, Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells, Cell Cycle, 10, 3003, 10.4161\u002Fcc.10.17.17119",{"doi":2009},"10.4161\u002Fcc.10.17.17119",{"id":19,"text":2011,"url":19,"identifiers":2012},"McCubrey, 2011, Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K\u002FPTEN\u002FAkt\u002FmTOR pathway, Leukemia, 25, 1064, 10.1038\u002Fleu.2011.46",{"doi":2013},"10.1038\u002Fleu.2011.46",{"id":19,"text":2015,"url":19,"identifiers":2016},"Milella, 2011, Roles of the Raf\u002FMEK\u002FERK and PI3K\u002FPTEN\u002FAkt\u002FmTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging, Aging, 3, 192, 10.18632\u002Faging.100296",{"doi":2017},"10.18632\u002Faging.100296",{"id":19,"text":2019,"url":19,"identifiers":2020},"Vogt, 2011, Phosphorylation of AKT: a mutational analysis, Oncotarget, 2, 467, 10.18632\u002Foncotarget.293",{"doi":2021},"10.18632\u002Foncotarget.293",{"id":19,"text":2023,"url":19,"identifiers":2024},"Zawel, 2010, P3Kalpha: a driver of tumor metastasis?, Oncotarget, 1, 315, 10.18632\u002Foncotarget.162",{"doi":2025},"10.18632\u002Foncotarget.162",{"id":19,"text":2027,"url":19,"identifiers":2028},"Zhou, 2010, PI3Kalpha inhibitors that inhibit metastasis, Oncotarget, 1, 339, 10.18632\u002Foncotarget.166",{"doi":2029},"10.18632\u002Foncotarget.166",{"id":19,"text":2031,"url":19,"identifiers":2032},"Arteaga, 2011, Will PI3K pathway inhibitors be effective as single agents in patients with cancer?, Oncotarget, 2, 1314, 10.18632\u002Foncotarget.409",{"doi":2033},"10.18632\u002Foncotarget.409",{"id":19,"text":2035,"url":19,"identifiers":2036},"Rajewsky, 2012, Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells, Oncotarget, 3, 1066, 10.18632\u002Foncotarget.726",{"doi":2037},"10.18632\u002Foncotarget.726",{"id":19,"text":2039,"url":19,"identifiers":2040},"Baiocchi, 2012, Novel targeted therapies for mantle cell lymphoma, Oncotarget, 3, 203, 10.18632\u002Foncotarget.426",{"doi":2041},"10.18632\u002Foncotarget.426",{"id":19,"text":2043,"url":19,"identifiers":2044},"Di Cristofano, 2011, Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors, Oncotarget, 2, 1109, 10.18632\u002Foncotarget.380",{"doi":2045},"10.18632\u002Foncotarget.380",{"id":19,"text":2047,"url":19,"identifiers":2048},"Riggins, 2011, Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells, Oncotarget, 2, 833, 10.18632\u002Foncotarget.346",{"doi":2049},"10.18632\u002Foncotarget.346",{"id":19,"text":2051,"url":19,"identifiers":2052},"Backer, 2010, A beta version of life: p110beta takes center stage, Oncotarget, 1, 729, 10.18632\u002Foncotarget.207",{"doi":2053},"10.18632\u002Foncotarget.207",{"id":19,"text":2055,"url":19,"identifiers":2056},"Hoellenriegel, 2011, Phosphoinositide 3'-kinase delta: turning off BCR signaling in chronic lymphocytic leukemia, Oncotarget, 2, 737, 10.18632\u002Foncotarget.341",{"doi":2057},"10.18632\u002Foncotarget.341",{"id":19,"text":2059,"url":19,"identifiers":2060},"Egan, 2011, Elevated PI3K signaling drives multiple breast cancer subtypes, Oncotarget, 2, 435, 10.18632\u002Foncotarget.285",{"doi":2061},"10.18632\u002Foncotarget.285",{"id":19,"text":2063,"url":19,"identifiers":2064},"Ittmann, 2011, INPP4B: the new kid on the PI3K block, Oncotarget, 2, 321, 10.18632\u002Foncotarget.260",{"doi":2065},"10.18632\u002Foncotarget.260",{"id":19,"text":2067,"url":19,"identifiers":2068},"McCubrey, 2012, Dual Inhibitors of phosphatidylinositol 3-kinase and mammalian target of rapamycin: a novel therapeutic strategy for acute leukemia treatment?, Oncotarget, 3, 371, 10.18632\u002Foncotarget.477",{"doi":2069},"10.18632\u002Foncotarget.477",{"id":19,"text":2071,"url":19,"identifiers":2072},"McCubrey, 2012, Targeting the liver Kinase B1\u002FAMP-dependent kinase pathway as a therapeutic strategy for hematological malignancies, Expert Opinion Therapeutic Targets, 16, 729, 10.1517\u002F14728222.2012.694869",{"doi":2073},"10.1517\u002F14728222.2012.694869",{"id":19,"text":2075,"url":19,"identifiers":2076},"Sabatini, 2009, DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival, Cell, 137, 873, 10.1016\u002Fj.cell.2009.03.046",{"doi":2077},"10.1016\u002Fj.cell.2009.03.046",{"id":19,"text":2079,"url":19,"identifiers":2080},"Martelli, 2012, A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients withacute myeloid leukemia, Oncotarget, 3, 1615, 10.18632\u002Foncotarget.762",{"doi":2081},"10.18632\u002Foncotarget.762",{"id":19,"text":2083,"url":19,"identifiers":2084},"Martelli, 2012, Harnessing the PI3K\u002FAkt\u002FmTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels, Oncotarget, 3, 811, 10.18632\u002Foncotarget.579",{"doi":2085},"10.18632\u002Foncotarget.579",{"id":19,"text":2087,"url":19,"identifiers":2088},"Martelli, 2014, Multifaceted roles of GSK-3 and Wnt\u002Fβ-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention, Leukemia, 28, 15, 10.1038\u002Fleu.2013.184",{"doi":2089},"10.1038\u002Fleu.2013.184",{"id":19,"text":2091,"url":19,"identifiers":2092},"Martelli, 2012, AMP-dependent kinase\u002Fmammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications, Leukemia, 26, 91, 10.1038\u002Fleu.2011.269",{"doi":2093},"10.1038\u002Fleu.2011.269",{"id":19,"text":2095,"url":19,"identifiers":2096},"McCubrey, 2012, Targeting the liver kinase B1\u002FAMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies, Expert Opin Ther Targets, 16, 729, 10.1517\u002F14728222.2012.694869",{"doi":2073},{"id":19,"text":2098,"url":19,"identifiers":2099},"Habib, 2011, Mechanism of activation of AMPK and upregulation of OGG1 by rapamycin in cancer cells, Oncotarget, 2, 958, 10.18632\u002Foncotarget.381",{"doi":2100},"10.18632\u002Foncotarget.381",{"id":19,"text":2102,"url":19,"identifiers":2103},"Clevers, 2009, LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism, Physiol Rev, 89, 777, 10.1152\u002Fphysrev.00026.2008",{"doi":2104},"10.1152\u002Fphysrev.00026.2008",{"id":19,"text":2106,"url":19,"identifiers":2107},"Haramis, 2011, Insights from model organisms on the functions of the tumor suppressor protein LKB1: zebrafish chips in, Aging, 3, 363, 10.18632\u002Faging.100319",{"doi":2108},"10.18632\u002Faging.100319",{"id":19,"text":2110,"url":19,"identifiers":2111},"Lawler, 2010, microRNA-451: A conditional switch controlling glioma cell proliferation and migration, Cell Cycle, 9, 2742",{},{"id":19,"text":2113,"url":19,"identifiers":2114},"Thor, 2011, Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2\u002FIGF-1 receptor interactions, Cell Cycle, 10, 2959, 10.4161\u002Fcc.10.17.16359",{"doi":2115},"10.4161\u002Fcc.10.17.16359",{"id":19,"text":2117,"url":19,"identifiers":2118},"Menendez, 2011, Metformin activates an ataxia telangiectasia mutated (ATM)\u002FChk2-regulated DNA damage-like response, Cell Cycle, 10, 1499, 10.4161\u002Fcc.10.9.15423",{"doi":2119},"10.4161\u002Fcc.10.9.15423",{"id":19,"text":2121,"url":19,"identifiers":2122},"Pollak, 2011, Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet, Cell Cycle, 10, 2770, 10.4161\u002Fcc.10.16.16219",{"doi":2123},"10.4161\u002Fcc.10.16.16219",{"id":19,"text":2125,"url":19,"identifiers":2126},"Menendez, 2011, Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFbeta-induced oncomiR miRNA-181a, Cell Cycle, 10, 1144, 10.4161\u002Fcc.10.7.15210",{"doi":2127},"10.4161\u002Fcc.10.7.15210",{"id":19,"text":2129,"url":19,"identifiers":2130},"McCubrey, 2012, Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine, Cell Cycle, 11, 4447, 10.4161\u002Fcc.22786",{"doi":2131},"10.4161\u002Fcc.22786",{"id":19,"text":2133,"url":19,"identifiers":2134},"Goncharova, 2009, PI3K\u002FmTORC1 activation in hamartoma syndromes: therapeutic prospects, Cell Cycle, 8, 403, 10.4161\u002Fcc.8.3.7555",{"doi":2135},"10.4161\u002Fcc.8.3.7555",{"id":19,"text":2137,"url":19,"identifiers":2138},"Tamanoi, 2009, Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein, J Biol Chem, 284, 12783, 10.1074\u002Fjbc.M809207200",{"doi":2139},"10.1074\u002Fjbc.M809207200",{"id":19,"text":2141,"url":19,"identifiers":2142},"Tafuri, 2012, Mutations and deregulation of Ras\u002FRaf\u002FMEK\u002FERK and PI3K\u002FPTEN\u002FAkt\u002FmTOR cascades which alter therapy response, Oncotarget, 3, 954, 10.18632\u002Foncotarget.652",{"doi":2143},"10.18632\u002Foncotarget.652",{"id":19,"text":2145,"url":19,"identifiers":2146},"McCubrey, Steelman, Chappell, Abrams, Montalto, Cervello, Nicoletti, Fagone, Malaponte, Mazzarino, Candido, Libra, Bäsecke, Mijatovic, Maksimovic-Ivanic, Cocco, et al. Oncotarget. 2012; 3:1068–1111.",{"doi":2147},"10.18632\u002Foncotarget.659",{"id":19,"text":2149,"url":19,"identifiers":2150},"Montalto, 2012, Targeted therapy for hepatocellular carcinoma: novel agents on the horizon, Oncotarget, 3, 236, 10.18632\u002Foncotarget.466",{"doi":2151},"10.18632\u002Foncotarget.466",{"id":19,"text":2153,"url":19,"identifiers":2154},"Pandolfi, 2008, Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer, J Clin Invest, 118, 3065",{},{"id":19,"text":2156,"url":19,"identifiers":2157},"Bouscary, 2009, Targeting translation in acute myeloid leukemia: a new paradigm for therapy?, Cell Cycle, 8, 3893, 10.4161\u002Fcc.8.23.10091",{"doi":2158},"10.4161\u002Fcc.8.23.10091",{"id":19,"text":2160,"url":19,"identifiers":2161},"Martin, 2011, Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response, J Immunol, 186, 5217, 10.4049\u002Fjimmunol.1002513",{"doi":2162},"10.4049\u002Fjimmunol.1002513",{"id":19,"text":2164,"url":19,"identifiers":2165},"Guan, 2006, TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth, Cell, 126, 955, 10.1016\u002Fj.cell.2006.06.055",{"doi":2166},"10.1016\u002Fj.cell.2006.06.055",{"id":19,"text":2168,"url":19,"identifiers":2169},"Sun, 2014, Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growth, Cancer Res",{},{"id":19,"text":2171,"url":19,"identifiers":2172},"Klein, 2009, Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice, J Clin Invest, 119, 3519",{},{"id":19,"text":2174,"url":19,"identifiers":2175},"Morrison, 2006, Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells, Nature, 441, 475, 10.1038\u002Fnature04703",{"doi":2176},"10.1038\u002Fnature04703",{"id":19,"text":2178,"url":19,"identifiers":2179},"Zheng, 2008, TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species, J Exp Med, 205, 2397, 10.1084\u002Fjem.20081297",{"doi":2180},"10.1084\u002Fjem.20081297",{"id":19,"text":2182,"url":19,"identifiers":2183},"Morrison, 2010, mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion, Cell Stem Cell, 7, 593, 10.1016\u002Fj.stem.2010.09.015",{"doi":2184},"10.1016\u002Fj.stem.2010.09.015",{"id":19,"text":2186,"url":19,"identifiers":2187},"Scadden, 2006, The hematopoietic stem cell in its place, Nat Immunol, 7, 333, 10.1038\u002Fni1331",{"doi":2188},"10.1038\u002Fni1331",{"id":19,"text":2190,"url":19,"identifiers":2191},"Depinho, 2010, Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells, Nature, 468, 701, 10.1038\u002Fnature09595",{"doi":2192},"10.1038\u002Fnature09595",{"id":19,"text":2194,"url":19,"identifiers":2195},"Bardeesy, 2010, The Lkb1 metabolic sensor maintains haematopoietic stem cell survival, Nature, 468, 659, 10.1038\u002Fnature09572",{"doi":2196},"10.1038\u002Fnature09572",{"id":19,"text":2198,"url":19,"identifiers":2199},"DePinho, 2009, mTORC1 signaling governs hematopoietic stem cell quiescence, Cell Cycle, 8, 1003, 10.4161\u002Fcc.8.7.8045",{"doi":2200},"10.4161\u002Fcc.8.7.8045",{"id":19,"text":2202,"url":19,"identifiers":2203},"Zheng, 2009, mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells, Sci Signal, 2, ra75",{},{"id":19,"text":2205,"url":19,"identifiers":2206},"Klein, 2012, Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways, Nat Med, 18, 1778, 10.1038\u002Fnm.2984",{"doi":2207},"10.1038\u002Fnm.2984",{"id":19,"text":2209,"url":19,"identifiers":2210},"Pandolfi, 2012, A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance, Nat Med, 18, 1350, 10.1038\u002Fnm.2882",{"doi":2211},"10.1038\u002Fnm.2882",{"id":19,"text":2213,"url":19,"identifiers":2214},"Vanden Heuvel, 2007, Modulation of PPAR activity via phosphorylation, Biochim Biophys Acta, 1771, 952, 10.1016\u002Fj.bbalip.2007.04.018",{"doi":2215},"10.1016\u002Fj.bbalip.2007.04.018",{"id":19,"text":2217,"url":19,"identifiers":2218},"Arch, 2007, Thermogenic and metabolic antiobesity drugs: rationale and opportunities, Diabetes Obes Metab, 9, 259, 10.1111\u002Fj.1463-1326.2006.00608.x",{"doi":2219},"10.1111\u002Fj.1463-1326.2006.00608.x",{"id":19,"text":2221,"url":19,"identifiers":2222},"Evans, 2008, AMPK and PPARdelta agonists are exercise mimetics, Cell, 134, 405, 10.1016\u002Fj.cell.2008.06.051",{"doi":2223},"10.1016\u002Fj.cell.2008.06.051",{"id":19,"text":2225,"url":19,"identifiers":2226},"Pandolfi, 2008, PML targeting eradicates quiescent leukaemia-initiating cells, Nature, 453, 1072, 10.1038\u002Fnature07016",{"doi":2227},"10.1038\u002Fnature07016",{"id":19,"text":2229,"url":19,"identifiers":2230},"Pandolfi, 2006, PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR, Nature, 442, 779, 10.1038\u002Fnature05029",{"doi":2231},"10.1038\u002Fnature05029",{"id":19,"text":2233,"url":19,"identifiers":2234},"Pandolfi, 2011, Pml represses tumour progression through inhibition of mTOR, EMBO Mol Med, 3, 249, 10.1002\u002Femmm.201100130",{"doi":2235},"10.1002\u002Femmm.201100130",{"id":19,"text":2237,"url":19,"identifiers":2238},"Brivanlou, 2004, Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor, Nat Med, 10, 55, 10.1038\u002Fnm979",{"doi":2239},"10.1038\u002Fnm979",{"id":19,"text":2241,"url":19,"identifiers":2242},"Woodgett, 2007, Functional redundancy of GSK-3alpha and GSK-3beta in Wnt\u002Fbeta-catenin signaling shown by using an allelic series of embryonic stem cell lines, Dev Cell, 12, 957, 10.1016\u002Fj.devcel.2007.04.001",{"doi":2243},"10.1016\u002Fj.devcel.2007.04.001",{"id":19,"text":2245,"url":19,"identifiers":2246},"Restifo, 2009, Pharmacologic induction of CD8+ T cell memory: better living through chemistry, Sci Transl Med, 1, 11ps12",{},{"id":19,"text":2248,"url":19,"identifiers":2249},"Roederer, 2011, A human memory T cell subset with stem cell-like properties, Nat Med, 17, 1290, 10.1038\u002Fnm.2446",{"doi":2250},"10.1038\u002Fnm.2446",{"id":19,"text":2252,"url":19,"identifiers":2253},"Restifo, 2012, Paths to stemness: building the ultimate antitumour T cell, Nat Rev Cancer, 12, 671, 10.1038\u002Fnrc3322",{"doi":2254},"10.1038\u002Fnrc3322",{"id":19,"text":2256,"url":19,"identifiers":2257},"Nusse, 2012, Wnt\u002Fβ-catenin signaling and disease, Cell, 149, 1192, 10.1016\u002Fj.cell.2012.05.012",{"doi":2258},"10.1016\u002Fj.cell.2012.05.012",{"id":19,"text":2260,"url":19,"identifiers":2261},"Moon, 2013, WNT signalling pathways as therapeutic targets in cancer, Nat Rev Cancer, 13, 11, 10.1038\u002Fnrc3419",{"doi":2262},"10.1038\u002Fnrc3419",{"id":19,"text":2264,"url":19,"identifiers":2265},"Wynshaw-Boris, 2012, Wnt signaling in mammalian development: lessons from mouse genetics, Cold Spring Harb Perspect Biol, 4",{},{"id":19,"text":2267,"url":19,"identifiers":2268},"Clevers, 2002, Wnt signaling controls the phosphorylation status of beta-catenin, J Biol Chem, 277, 17901, 10.1074\u002Fjbc.M111635200",{"doi":2269},"10.1074\u002Fjbc.M111635200",{"id":19,"text":2271,"url":19,"identifiers":2272},"Vidal-Puig, 2002, Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45, Biochem Biophys Res Commun, 294, 324, 10.1016\u002FS0006-291X(02)00485-0",{"doi":2273},"10.1016\u002FS0006-291X(02)00485-0",{"id":19,"text":2275,"url":19,"identifiers":2276},"Reith, 2002, Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells, J Biol Chem, 277, 23330, 10.1074\u002Fjbc.M201364200",{"doi":2277},"10.1074\u002Fjbc.M201364200",{"id":19,"text":2279,"url":19,"identifiers":2280},"He, 2002, Control of beta-. catenin phosphorylation\u002Fdegradation by a dual-kinase mechanism, Cell, 108, 837, 10.1016\u002FS0092-8674(02)00685-2",{"doi":2281},"10.1016\u002FS0092-8674(02)00685-2",{"id":19,"text":2283,"url":19,"identifiers":2284},"Sakanaka, 2002, Phosphorylation and regulation of beta-catenin by casein kinase I epsilon, J Biochem, 132, 697, 10.1093\u002Foxfordjournals.jbchem.a003276",{"doi":2285},"10.1093\u002Foxfordjournals.jbchem.a003276",{"id":19,"text":2287,"url":19,"identifiers":2288},"Ishimoto, 2002, Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila, EMBO J, 21, 1733, 10.1093\u002Femboj\u002F21.7.1733",{"doi":2289},"10.1093\u002Femboj\u002F21.7.1733",{"id":19,"text":2291,"url":19,"identifiers":2292},"Kikuchi, 1998, Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin, EMBO J, 17, 1371, 10.1093\u002Femboj\u002F17.5.1371",{"doi":2293},"10.1093\u002Femboj\u002F17.5.1371",{"id":19,"text":2295,"url":19,"identifiers":2296},"Costantini, 1999, A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression, Biochem Biophys Res Commun, 266, 28, 10.1006\u002Fbbrc.1999.1760",{"doi":2297},"10.1006\u002Fbbrc.1999.1760",{"id":19,"text":2299,"url":19,"identifiers":2300},"Kikuchi, 1999, Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability, J Biol Chem, 274, 10681, 10.1074\u002Fjbc.274.16.10681",{"doi":2301},"10.1074\u002Fjbc.274.16.10681",{"id":19,"text":2303,"url":19,"identifiers":2304},"Polakis, 1996, Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly, Science, 272, 1023, 10.1126\u002Fscience.272.5264.1023",{"doi":2305},"10.1126\u002Fscience.272.5264.1023",{"id":19,"text":2307,"url":19,"identifiers":2308},"Birchmeier, 2002, The ankyrin repeat protein Diversin recruits Casein kinase I epsilon to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt\u002FJNK signaling, Genes Dev, 16, 2073, 10.1101\u002Fgad.230402",{"doi":2309},"10.1101\u002Fgad.230402",{"id":19,"text":2311,"url":19,"identifiers":2312},"Reith, 2001, The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation, Structure, 9, 1143, 10.1016\u002FS0969-2126(01)00679-7",{"doi":2313},"10.1016\u002FS0969-2126(01)00679-7",{"id":19,"text":2315,"url":19,"identifiers":2316},"Kimelman, 2002, Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin, J Biol Chem, 277, 16147, 10.1074\u002Fjbc.M112363200",{"doi":2317},"10.1074\u002Fjbc.M112363200",{"id":19,"text":2319,"url":19,"identifiers":2320},"Dale, 2002, The regulation of glycogen synthase kinase-3 nuclear export by Frat\u002FGBP, J Biol Chem, 277, 43844, 10.1074\u002Fjbc.M207265200",{"doi":2321},"10.1074\u002Fjbc.M207265200",{"id":19,"text":2323,"url":19,"identifiers":2324},"McCormick, 2000, Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling, J Biol Chem, 275, 32475, 10.1074\u002Fjbc.M005342200",{"doi":2325},"10.1074\u002Fjbc.M005342200",{"id":19,"text":2327,"url":19,"identifiers":2328},"Wu, 1999, Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation, J Biol Chem, 274, 30419, 10.1074\u002Fjbc.274.43.30419",{"doi":2329},"10.1074\u002Fjbc.274.43.30419",{"id":19,"text":2331,"url":19,"identifiers":2332},"He, 2005, A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation, Nature, 438, 873, 10.1038\u002Fnature04185",{"doi":2333},"10.1038\u002Fnature04185",{"id":19,"text":2335,"url":19,"identifiers":2336},"He, 2008, Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation\u002Factivation via frizzled, dishevelled and axin functions, Development, 135, 367, 10.1242\u002Fdev.013540",{"doi":2337},"10.1242\u002Fdev.013540",{"id":19,"text":2339,"url":19,"identifiers":2340},"He, 2009, Wnt\u002Fbeta-catenin signaling: components, mechanisms, and diseases, Dev Cell, 17, 9, 10.1016\u002Fj.devcel.2009.06.016",{"doi":2341},"10.1016\u002Fj.devcel.2009.06.016",{"id":19,"text":2343,"url":19,"identifiers":2344},"Niehrs, 2005, Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction, Nature, 438, 867, 10.1038\u002Fnature04170",{"doi":2345},"10.1038\u002Fnature04170",{"id":19,"text":2347,"url":19,"identifiers":2348},"Pan, 2010, GSK3: a multifaceted kinase in Wnt signaling, Trends Biochem Sci, 35, 161, 10.1016\u002Fj.tibs.2009.10.002",{"doi":2349},"10.1016\u002Fj.tibs.2009.10.002",{"id":19,"text":2351,"url":19,"identifiers":2352},"Moon, 2007, Wilms tumor suppressor WTX negatively regulates WNT\u002Fbeta-catenin signaling, Science, 316, 1043, 10.1126\u002Fscience\u002F1141515",{"doi":2353},"10.1126\u002Fscience\u002F1141515",{"id":19,"text":2355,"url":19,"identifiers":2356},"Klein, 2012, Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity, J Biol Chem, 287, 3823, 10.1074\u002Fjbc.M111.323337",{"doi":2357},"10.1074\u002Fjbc.M111.323337",{"id":19,"text":2359,"url":19,"identifiers":2360},"Capeau, 2002, Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells, Hepatology, 36, 1528, 10.1002\u002Fhep.1840360630",{"doi":2361},"10.1002\u002Fhep.1840360630",{"id":19,"text":2363,"url":19,"identifiers":2364},"Shan, 2013, The correlation between TSC2 and GSK3β levels, and outcomes of patients with hepatocellular carcinoma treated by hepatectomy, Hepatol Res",{},{"id":19,"text":2363,"url":19,"identifiers":2366},{},{"id":19,"text":2359,"url":19,"identifiers":2368},{"doi":2361},{"id":19,"text":2370,"url":19,"identifiers":2371},"Hung, 2005, Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin, Mol Cell, 19, 159, 10.1016\u002Fj.molcel.2005.06.009",{"doi":2372},"10.1016\u002Fj.molcel.2005.06.009",{"id":19,"text":2374,"url":19,"identifiers":2375},"Schaller, 2006, Glycogen synthase kinase 3-beta and extracellular signal-regulated kinase-dependent phosphorylation of paxillin regulates cytoskeletal rearrangement, Mol Cell Biol, 26, 2857, 10.1128\u002FMCB.26.7.2857-2868.2006",{"doi":2376},"10.1128\u002FMCB.26.7.2857-2868.2006",{"id":19,"text":2378,"url":19,"identifiers":2379},"Tang, 2011, Enhancement of canonical Wnt\u002Fβ-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells, PLoS One, 6, e27496, 10.1371\u002Fjournal.pone.0027496",{"doi":2380},"10.1371\u002Fjournal.pone.0027496",{"id":19,"text":2382,"url":19,"identifiers":2383},"Ko, 2013, SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B\u002Fglycogen synthase kinase-3β\u002Fβ-catenin signaling, Hepatology, 57, 2287, 10.1002\u002Fhep.26278",{"doi":2384},"10.1002\u002Fhep.26278",{"id":19,"text":2386,"url":19,"identifiers":2387},"Verdin, 2013, The sirtuins, oxidative stress and aging: an emerging link, Aging, 5, 144, 10.18632\u002Faging.100544",{"doi":2388},"10.18632\u002Faging.100544",{"id":19,"text":2390,"url":19,"identifiers":2391},"Minamoto, 2007, Inhibition of GSK-3beta activity attenuates proliferation of human colon cancer cells in rodents, Cancer Sci, 98, 1388, 10.1111\u002Fj.1349-7006.2007.00545.x",{"doi":2392},"10.1111\u002Fj.1349-7006.2007.00545.x",{"id":19,"text":2394,"url":19,"identifiers":2395},"Chen, 2007, Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells, Mol Cancer Ther, 6, 1151, 10.1158\u002F1535-7163.MCT-06-0665",{"doi":2396},"10.1158\u002F1535-7163.MCT-06-0665",{"id":19,"text":2398,"url":19,"identifiers":2399},"Herlyn, 2007, An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells, Cancer Res, 67, 209, 10.1158\u002F0008-5472.CAN-06-1538",{"doi":2400},"10.1158\u002F0008-5472.CAN-06-1538",{"id":19,"text":2402,"url":19,"identifiers":2403},"Minamoto, 2009, Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma, Clin Cancer Res, 15, 887, 10.1158\u002F1078-0432.CCR-08-0760",{"doi":2404},"10.1158\u002F1078-0432.CCR-08-0760",{"id":19,"text":2406,"url":19,"identifiers":2407},"Hamada, 2013, Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling, Carcinogenesis, 34, 2206, 10.1093\u002Fcarcin\u002Fbgt182",{"doi":2408},"10.1093\u002Fcarcin\u002Fbgt182",{"id":19,"text":2410,"url":19,"identifiers":2411},"Minamoto, 2013, Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy, PLoS One, 8, e55289, 10.1371\u002Fjournal.pone.0055289",{"doi":2412},"10.1371\u002Fjournal.pone.0055289",{"id":19,"text":2414,"url":19,"identifiers":2415},"Minamoto, 2009, Deregulated GSK3beta sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase, Clin Cancer Res, 15, 6810, 10.1158\u002F1078-0432.CCR-09-0973",{"doi":2416},"10.1158\u002F1078-0432.CCR-09-0973",{"id":19,"text":2418,"url":19,"identifiers":2419},"Desbois-Mouthon, 2009, Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells, Biochem Pharmacol, 77, 54, 10.1016\u002Fj.bcp.2008.09.026",{"doi":2420},"10.1016\u002Fj.bcp.2008.09.026",{"id":19,"text":2414,"url":19,"identifiers":2422},{"doi":2416},{"id":19,"text":2418,"url":19,"identifiers":2424},{"doi":2420},{"id":19,"text":2426,"url":19,"identifiers":2427},"De Robertis, 2007, Integrating patterning signals: Wnt\u002FGSK3 regulates the duration of the BMP\u002FSmad1 signal, Cell, 131, 980, 10.1016\u002Fj.cell.2007.09.027",{"doi":2428},"10.1016\u002Fj.cell.2007.09.027",{"id":19,"text":2430,"url":19,"identifiers":2431},"Curran, 2011, The Hedgehog's tale: developing strategies for targeting cancer, Nat Rev Cancer, 11, 493, 10.1038\u002Fnrc3079",{"doi":2432},"10.1038\u002Fnrc3079",{"id":19,"text":2434,"url":19,"identifiers":2435},"de Sauvage, 2011, Hedgehog fights back: mechanisms of acquired resistance against smoothened antagonists, Cancer Res, 71, 5057, 10.1158\u002F0008-5472.CAN-11-0923",{"doi":2436},"10.1158\u002F0008-5472.CAN-11-0923",{"id":19,"text":2438,"url":19,"identifiers":2439},"Miki, 2007, GSK3beta positively regulates Hedgehog signaling through Sufu in mammalian cells, Biochem Biophys Res Commun, 353, 501, 10.1016\u002Fj.bbrc.2006.12.058",{"doi":2440},"10.1016\u002Fj.bbrc.2006.12.058",{"id":19,"text":2442,"url":19,"identifiers":2443},"Zaphiropoulos, 1999, Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1, Nat Cell Biol, 1, 312, 10.1038\u002F13031",{"doi":2444},"10.1038\u002F13031",{"id":19,"text":2446,"url":19,"identifiers":2447},"Miki, 2009, Sufu recruits GSK3beta for efficient processing of Gli3, Biochem Biophys Res Commun, 387, 569, 10.1016\u002Fj.bbrc.2009.07.087",{"doi":2448},"10.1016\u002Fj.bbrc.2009.07.087",{"id":19,"text":2450,"url":19,"identifiers":2451},"Bray, 2006, Notch signalling: a simple pathway becomes complex, Nat Rev Mol Cell Biol, 7, 678, 10.1038\u002Fnrm2009",{"doi":2452},"10.1038\u002Fnrm2009",{"id":19,"text":2454,"url":19,"identifiers":2455},"Kopan, 1998, Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain, Nature, 393, 382, 10.1038\u002F30756",{"doi":2456},"10.1038\u002F30756",{"id":19,"text":2458,"url":19,"identifiers":2459},"Kopan, 1999, A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain, Nature, 398, 518, 10.1038\u002F19083",{"doi":2460},"10.1038\u002F19083",{"id":19,"text":2462,"url":19,"identifiers":2463},"Adachi, 1998, Nuclear access and action of notch in vivo, Cell, 93, 649, 10.1016\u002FS0092-8674(00)81193-9",{"doi":2464},"10.1016\u002FS0092-8674(00)81193-9",{"id":19,"text":2466,"url":19,"identifiers":2467},"Kageyama, 1999, Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation, EMBO J, 18, 2196, 10.1093\u002Femboj\u002F18.8.2196",{"doi":2468},"10.1093\u002Femboj\u002F18.8.2196",{"id":19,"text":2470,"url":19,"identifiers":2471},"Pourquié, 2000, Notch signalling is required for cyclic expression of the hairy-like gene HES1 in the presomitic mesoderm, Development, 127, 1421, 10.1242\u002Fdev.127.7.1421",{"doi":2472},"10.1242\u002Fdev.127.7.1421",{"id":19,"text":2474,"url":19,"identifiers":2475},"Shin, 2008, Down-regulation of Notch-dependent transcription by Akt in vitro, FEBS Lett, 582, 1693, 10.1016\u002Fj.febslet.2008.04.024",{"doi":2476},"10.1016\u002Fj.febslet.2008.04.024",{"id":19,"text":2478,"url":19,"identifiers":2479},"Shin, 2012, Glycogen synthase kinase 3-beta phosphorylates novel S\u002FT-P-S\u002FT domains in Notch1 intracellular domain and induces its nuclear localization, Biochem Biophys Res Commun, 423, 282, 10.1016\u002Fj.bbrc.2012.05.111",{"doi":2480},"10.1016\u002Fj.bbrc.2012.05.111",{"id":19,"text":2482,"url":19,"identifiers":2483},"Kim, 2009, Regulation of Notch1\u002FNICD and Hes1 expressions by GSK-3alpha\u002Fbeta, Mol Cells, 27, 15, 10.1007\u002Fs10059-009-0001-7",{"doi":2484},"10.1007\u002Fs10059-009-0001-7",{"id":19,"text":2486,"url":19,"identifiers":2487},"Kim, 2009, Beta-catenin modulates the level and transcriptional activity of Notch1\u002FNICD through its direct interaction, Biochim Biophys Acta, 1793, 290, 10.1016\u002Fj.bbamcr.2008.10.002",{"doi":2488},"10.1016\u002Fj.bbamcr.2008.10.002",{"id":19,"text":2490,"url":19,"identifiers":2491},"Bigas, 2003, Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways, J Biol Chem, 278, 32227, 10.1074\u002Fjbc.M304001200",{"doi":2492},"10.1074\u002Fjbc.M304001200",{"id":19,"text":2494,"url":19,"identifiers":2495},"Woodgett, 1996, Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells, Curr Biol, 6, 1664, 10.1016\u002FS0960-9822(02)70790-2",{"doi":2496},"10.1016\u002FS0960-9822(02)70790-2",{"id":19,"text":2498,"url":19,"identifiers":2499},"Howland, 2007, Lithium: underappreciated and underused?, J Psychosoc Nurs Ment Health Serv, 45, 13, 10.3928\u002F02793695-20070601-05",{"doi":2500},"10.3928\u002F02793695-20070601-05",{"id":19,"text":2502,"url":19,"identifiers":2503},"Calamandrei, 1981, Haematological effects of lithium carbonate: a study in 56 psychiatric patients, Haematologica, 66, 627",{},{"id":19,"text":2505,"url":19,"identifiers":2506},"Joyce, 1983, The hematopoietic effects of lithium, Semin Hematol, 20, 129",{},{"id":19,"text":2508,"url":19,"identifiers":2509},"Joyce, 1984, Sequential effects of lithium on haematopoiesis, Br J Haematol, 56, 307, 10.1111\u002Fj.1365-2141.1984.tb03958.x",{"doi":2510},"10.1111\u002Fj.1365-2141.1984.tb03958.x",{"id":19,"text":2512,"url":19,"identifiers":2513},"Meytes, 1998, Increased number of peripheral blood CD34+ cells in lithium-treated patients, Br J Haematol, 100, 219, 10.1046\u002Fj.1365-2141.1998.00537.x",{"doi":2514},"10.1046\u002Fj.1365-2141.1998.00537.x",{"id":19,"text":2516,"url":19,"identifiers":2517},"Melton, 1996, A molecular mechanism for the effect of lithium on development, Proc Natl Acad Sci USA, 93, 8455, 10.1073\u002Fpnas.93.16.8455",{"doi":2518},"10.1073\u002Fpnas.93.16.8455",{"id":19,"text":2520,"url":19,"identifiers":2521},"Klein, 1997, Activation of the Wnt signaling pathway: a molecular mechanism for lithium action, Dev Biol, 185, 82, 10.1006\u002Fdbio.1997.8552",{"doi":2522},"10.1006\u002Fdbio.1997.8552",{"id":19,"text":2524,"url":19,"identifiers":2525},"Klein, 2001, Molecular targets of lithium action, Annu Rev Pharmacol Toxicol, 41, 789, 10.1146\u002Fannurev.pharmtox.41.1.789",{"doi":2526},"10.1146\u002Fannurev.pharmtox.41.1.789",{"id":19,"text":2528,"url":19,"identifiers":2529},"Billadeau, 2008, Inhibition of glycogen synthase kinase-3, Methods Mol Biol, 468, 67, 10.1007\u002F978-1-59745-249-6_5",{"doi":2530},"10.1007\u002F978-1-59745-249-6_5",{"id":19,"text":2532,"url":19,"identifiers":2533},"Billadeau, 2007, Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells, Blood, 110, 735, 10.1182\u002Fblood-2006-12-060947",{"doi":2534},"10.1182\u002Fblood-2006-12-060947",{"id":19,"text":2536,"url":19,"identifiers":2537},"Feng, 2006, Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells, Cell Res, 16, 671, 10.1038\u002Fsj.cr.7310078",{"doi":2538},"10.1038\u002Fsj.cr.7310078",{"id":19,"text":2540,"url":19,"identifiers":2541},"Minamoto, 2007, Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents, Cancer Sci, 98, 1388, 10.1111\u002Fj.1349-7006.2007.00545.x",{"doi":2392},{"id":19,"text":2402,"url":19,"identifiers":2543},{"doi":2404},{"id":19,"text":2545,"url":19,"identifiers":2546},"Kjeldsen-Kragh, 2012, Glycogen synthase kinase-3 (GSK-3) inhibition induces apoptosis in leukemic cells through mitochondria-dependent pathway, Leuk Res, 36, 499, 10.1016\u002Fj.leukres.2011.11.013",{"doi":2547},"10.1016\u002Fj.leukres.2011.11.013",{"id":19,"text":2549,"url":19,"identifiers":2550},"Cheng, 2011, Involvement of glycogen synthase kinase-3β in arsenic trioxide-induced p21 expression, Toxicol Sci, 121, 101, 10.1093\u002Ftoxsci\u002Fkfr023",{"doi":2551},"10.1093\u002Ftoxsci\u002Fkfr023",{"id":19,"text":2553,"url":19,"identifiers":2554},"Coombes, 2006, Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells, Mol Cancer, 5, 40, 10.1186\u002F1476-4598-5-40",{"doi":2555},"10.1186\u002F1476-4598-5-40",{"id":19,"text":2557,"url":19,"identifiers":2558},"Reiss, 2007, Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3beta constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines, Oncogene, 26, 2308, 10.1038\u002Fsj.onc.1210018",{"doi":2559},"10.1038\u002Fsj.onc.1210018",{"id":19,"text":2561,"url":19,"identifiers":2562},"Cheng, 2005, Defining the role of Wnt\u002Fbeta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells, Stem Cells, 23, 1489, 10.1634\u002Fstemcells.2005-0034",{"doi":2563},"10.1634\u002Fstemcells.2005-0034",{"id":19,"text":2565,"url":19,"identifiers":2566},"Stanton, 2007, Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation, J Biol Chem, 282, 31703, 10.1074\u002Fjbc.M704287200",{"doi":2567},"10.1074\u002Fjbc.M704287200",{"id":19,"text":2569,"url":19,"identifiers":2570},"Woodgett, 2009, Exploring Pluripotency with Chemical Genetics, Cell Stem Cell, 4, 98, 10.1016\u002Fj.stem.2009.01.005",{"doi":2571},"10.1016\u002Fj.stem.2009.01.005",{"id":19,"text":2573,"url":19,"identifiers":2574},"Emerson, 2006, Phosphoinositide 3-kinase and Akt are essential for Sonic hedgehog signaling, Proc Nat Acad Sci USA, 103, 4505, 10.1073\u002Fpnas.0504337103",{"doi":2575},"10.1073\u002Fpnas.0504337103",{"id":19,"text":2577,"url":19,"identifiers":2578},"Welham, 2009, Involvement of GSK-3 in regulation of murine embryonic stem cell self-renewal revealed by a series of bisindolylmaleimides, Chem Biol, 16, 15, 10.1016\u002Fj.chembiol.2008.11.003",{"doi":2579},"10.1016\u002Fj.chembiol.2008.11.003",{"id":19,"text":2581,"url":19,"identifiers":2582},"Minamoto, 2009, An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta, Anticancer Agents Med Chem, 9, 1114, 10.2174\u002F187152009789734982",{"doi":2583},"10.2174\u002F187152009789734982",{"id":19,"text":2585,"url":19,"identifiers":2586},"Mire, 2008, GSK-3beta inhibition enhances sorafenib-induced apoptosis in melanoma cell lines, Journal of Biological Chemistry, 283, 726, 10.1074\u002Fjbc.M705343200",{"doi":2587},"10.1074\u002Fjbc.M705343200",{"id":19,"text":2589,"url":19,"identifiers":2590},"Manji, 2009, A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients, J Clin Psychiatry, 70, 699, 10.4088\u002FJCP.07m03745",{"doi":2591},"10.4088\u002FJCP.07m03745",{"id":19,"text":2593,"url":19,"identifiers":2594},"Hong, 2011, Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression, Cancer Biol Ther, 12, 288, 10.4161\u002Fcbt.12.4.15961",{"doi":2595},"10.4161\u002Fcbt.12.4.15961",{"id":19,"text":2597,"url":19,"identifiers":2598},"Bhat, 2013, AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans, J Neurochem, 125, 446, 10.1111\u002Fjnc.12203",{"doi":2599},"10.1111\u002Fjnc.12203",{"id":19,"text":2601,"url":19,"identifiers":2602},"Jonsson, 2012, GSK-3 inhibition by an orally active small molecule increases bone mass in rats, Bone, 50, 619, 10.1016\u002Fj.bone.2011.11.007",{"doi":2603},"10.1016\u002Fj.bone.2011.11.007",{"id":19,"text":2605,"url":19,"identifiers":2606},"Greengard, 2003, GSK-3-selective inhibitors derived from Tyrian purple indirubins, Chem Biol, 10, 1255, 10.1016\u002Fj.chembiol.2003.11.010",{"doi":2607},"10.1016\u002Fj.chembiol.2003.11.010",{"id":19,"text":2609,"url":19,"identifiers":2610},"MacDougald, 2005, Regulation of osteoblastogenesis and bone mass by Wnt10b, Proc Natl Acad Sci U S A, 102, 3324, 10.1073\u002Fpnas.0408742102",{"doi":2611},"10.1073\u002Fpnas.0408742102",{"id":19,"text":2613,"url":19,"identifiers":2614},"Harrison, 2003, Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo, Diabetes, 52, 588, 10.2337\u002Fdiabetes.52.3.588",{"doi":2615},"10.2337\u002Fdiabetes.52.3.588",{"id":19,"text":2617,"url":19,"identifiers":2618},"Cassidy, 2013, Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure, Drug Metab Dispos, 41, 714, 10.1124\u002Fdmd.112.048488",{"doi":2619},"10.1124\u002Fdmd.112.048488",{"id":19,"text":2621,"url":19,"identifiers":2622},"Lang, 2012, GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells, Mol Cancer Res, 10, 1065, 10.1158\u002F1541-7786.MCR-11-0387",{"doi":2623},"10.1158\u002F1541-7786.MCR-11-0387",{"id":19,"text":2625,"url":19,"identifiers":2626},"Semenzato, 2010, Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death, BMC Cancer, 10, 526, 10.1186\u002F1471-2407-10-526",{"doi":2627},"10.1186\u002F1471-2407-10-526",{"id":19,"text":2629,"url":19,"identifiers":2630},"Thotala, 2011, GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line, J Neurooncol, 104, 145, 10.1007\u002Fs11060-010-0491-3",{"doi":2631},"10.1007\u002Fs11060-010-0491-3",{"id":19,"text":2418,"url":19,"identifiers":2633},{"doi":2420},{"id":19,"text":2635,"url":19,"identifiers":2636},"Perez-Castillo, 2010, Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8, PLoS One, 5, e13879, 10.1371\u002Fjournal.pone.0013879",{"doi":2637},"10.1371\u002Fjournal.pone.0013879",{"id":19,"text":2639,"url":19,"identifiers":2640},"Chen, 2010, Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells, Biochem Biophys Res Commun, 391, 1049, 10.1016\u002Fj.bbrc.2009.12.017",{"doi":2641},"10.1016\u002Fj.bbrc.2009.12.017",{"id":19,"text":2643,"url":19,"identifiers":2644},"León, 2013, Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study, J Alzheimers Dis, 33, 205",{},{"id":2646,"createTime":2647,"updateTime":2647,"relativeEntities":2648,"slug":2649,"properties":2650,"entityType":87,"verifyStatus":88,"verifyTime":2665,"verifyNote":89,"syncStatus":18,"languages":2666,"translateLanguages":19,"viewCount":20,"primaryUrl":2667,"fullTextUrl":19,"authors":2668,"publicationType":442,"publisherRelationship":2941,"citationCount":2963,"citationInfo":2964,"publishDate":855,"publishYear":856,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":2970,"isForceReanalyzing":585},"eebbde7e-612a-4929-b082-a48ba7d8c535","2024-09-17T23:57:37.108+00:00",[],"Long-noncoding-RNA-H19-indicates-a-poor-prognosis-of-colorectal-cancer-and-promotes-tumor-growth-by-recruiting-and-binding-to-eIF4A3",{"mag":2651,"keywords":2653,"pmc":2654,"openalex":2656,"abstract":2658,"title":2659,"pm":2661,"doi":2663},{"VOID":2652},"2300010382",{},{"VOID":2655},"5008352",{"VOID":2657},"W2300010382",{},{"EN":2660},"Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3",{"VOID":2662},"26989025",{"VOID":2664},"10.18632\u002Foncotarget.8063","2024-09-17T23:57:37.107+00:00",[91],"https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.8063",[2669,2700,2722,2739,2767,2790,2807,2824,2841,2863,2886,2903,2926],{"id":2670,"sortIndex":267,"researcher":19,"roles":2671,"affiliations":2672,"properties":2695},"62c1395b-91de-4d6c-acdc-3c44b3d6c3d3",[],[2673,2684],{"id":2674,"sortIndex":20,"affiliation":2675,"properties":19},"64af09ca-6214-4c6e-a8c4-bacbad631d35",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2679,"slug":2680,"properties":2681,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"649ebc05-7796-41f0-a304-3c8c88741684","2023-12-27T17:16:00.044+00:00","2024-09-17T23:57:37.124+00:00",[],"Department-of-Biochemistry-and-Molecular-Biology-Harbin-Medical-University-Harbin-China",{"title":2682},{"VI":2683},"Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China",{"id":2685,"sortIndex":112,"affiliation":2686,"properties":19},"60aaf0f4-2a03-4265-ae35-751ca6a68dfb",{"id":2687,"createTime":2688,"updateTime":2689,"relativeEntities":2690,"slug":2691,"properties":2692,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"79d5ccd6-c39e-484d-8c37-7d085c0f9338","2024-01-12T15:39:31.474+00:00","2024-09-17T23:57:37.306+00:00",[],"Department-of-Pathophysiology-Harbin-Medical-University-Harbin-China",{"title":2693},{"VI":2694},"Department of Pathophysiology, Harbin Medical University, Harbin, China",{"openalex":2696,"title":2698},{"VOID":2697},"A5100534499",{"EN":2699},"Changqing Xu",{"id":2701,"sortIndex":225,"researcher":19,"roles":2702,"affiliations":2703,"properties":2715},"9fc31f9e-af14-4622-b2ca-1892ce82a5d5",[],[2704],{"id":2705,"sortIndex":20,"affiliation":2706,"properties":19},"b3c863b1-41b8-4349-aa2b-0dbcbb9ccda7",{"id":2707,"createTime":2708,"updateTime":2709,"relativeEntities":2710,"slug":2711,"properties":2712,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"7b060650-e137-4cc4-b830-7bcabe532f51","2023-12-18T09:34:36.609+00:00","2024-09-17T23:57:37.175+00:00",[],"Department-of-General-Surgery-the-Second-Affiliated-Hospital-of-Harbin-Medical-University-Harbin-China",{"title":2713},{"VI":2714},"Department of General Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China",{"openalex":2716,"orcid":2718,"title":2720},{"VOID":2717},"A5100377174",{"VOID":2719},"https:\u002F\u002Forcid.org\u002F0000-0002-5909-6014",{"EN":2721},"Meng Wang",{"id":2723,"sortIndex":350,"researcher":19,"roles":2724,"affiliations":2725,"properties":2732},"63ef16eb-e5b7-40fa-a9c7-7c0568aded96",[],[2726],{"id":2727,"sortIndex":20,"affiliation":2728,"properties":19},"196fde20-27dd-47df-9ac3-5729ba5682c2",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2729,"slug":2680,"properties":2730,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2731},{"VI":2683},{"openalex":2733,"orcid":2735,"title":2737},{"VOID":2734},"A5083604223",{"VOID":2736},"https:\u002F\u002Forcid.org\u002F0000-0002-4073-8443",{"EN":2738},"Ya Xu",{"id":2740,"sortIndex":422,"researcher":19,"roles":2741,"affiliations":2742,"properties":2760},"e2f75194-d58b-41e8-b0de-40c32bdce52d",[],[2743,2754],{"id":2744,"sortIndex":112,"affiliation":2745,"properties":19},"88f1f656-f26f-434b-b39d-5eb9564dd002",{"id":2746,"createTime":2747,"updateTime":2748,"relativeEntities":2749,"slug":2750,"properties":2751,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"f2013eab-9fd5-48a7-aa9a-23fa72ba590b","2024-01-10T06:53:16.719+00:00","2024-09-17T23:57:37.150+00:00",[],"Heilongjiang-Academy-of-Medical-Sciences-Harbin-China",{"title":2752},{"VI":2753},"Heilongjiang Academy of Medical Sciences, Harbin, China",{"id":2755,"sortIndex":20,"affiliation":2756,"properties":19},"9a2cb0cf-8e9f-4028-b980-b0f0d9e71c76",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2757,"slug":2680,"properties":2758,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2759},{"VI":2683},{"openalex":2761,"orcid":2763,"title":2765},{"VOID":2762},"A5029629091",{"VOID":2764},"https:\u002F\u002Forcid.org\u002F0000-0002-0374-5089",{"EN":2766},"Yu Qiao",{"id":2768,"sortIndex":130,"researcher":19,"roles":2769,"affiliations":2770,"properties":2783},"bee51dbf-dfc2-4c4a-a568-877cd786797b",[],[2771,2777],{"id":2772,"sortIndex":112,"affiliation":2773,"properties":19},"83334458-facb-45a2-8125-561ec3b52927",{"id":2746,"createTime":2747,"updateTime":2748,"relativeEntities":2774,"slug":2750,"properties":2775,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2776},{"VI":2753},{"id":2778,"sortIndex":20,"affiliation":2779,"properties":19},"eea67b6c-d930-418f-9cfa-08ee0f9281bc",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2780,"slug":2680,"properties":2781,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2782},{"VI":2683},{"openalex":2784,"orcid":2786,"title":2788},{"VOID":2785},"A5070158905",{"VOID":2787},"https:\u002F\u002Forcid.org\u002F0000-0001-7315-8835",{"EN":2789},"Ning Ma",{"id":2791,"sortIndex":285,"researcher":19,"roles":2792,"affiliations":2793,"properties":2800},"d9a4d455-f881-4305-91a6-599e83f54042",[],[2794],{"id":2795,"sortIndex":20,"affiliation":2796,"properties":19},"2fd1776e-52fa-4eda-bc03-132bccfc22e0",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2797,"slug":2680,"properties":2798,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2799},{"VI":2683},{"openalex":2801,"orcid":2803,"title":2805},{"VOID":2802},"A5080525975",{"VOID":2804},"https:\u002F\u002Forcid.org\u002F0000-0001-5547-5255",{"EN":2806},"Guixiang Lv",{"id":2808,"sortIndex":326,"researcher":19,"roles":2809,"affiliations":2810,"properties":2817},"7594e996-38aa-4c77-8ed3-5df52485a060",[],[2811],{"id":2812,"sortIndex":20,"affiliation":2813,"properties":19},"857a55a4-8f3c-4f4e-bfef-63316772dfc7",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2814,"slug":2680,"properties":2815,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2816},{"VI":2683},{"openalex":2818,"orcid":2820,"title":2822},{"VOID":2819},"A5100421923",{"VOID":2821},"https:\u002F\u002Forcid.org\u002F0000-0002-5162-6041",{"EN":2823},"Jun He",{"id":2825,"sortIndex":201,"researcher":19,"roles":2826,"affiliations":2827,"properties":2834},"f86e2429-839d-49c1-920d-06e35dd23cf6",[],[2828],{"id":2829,"sortIndex":20,"affiliation":2830,"properties":19},"7b3ea522-7ced-44c2-8675-8b1346a6ee09",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2831,"slug":2680,"properties":2832,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2833},{"VI":2683},{"openalex":2835,"orcid":2837,"title":2839},{"VOID":2836},"A5101407345",{"VOID":2838},"https:\u002F\u002Forcid.org\u002F0000-0001-7108-9127",{"EN":2840},"Qian Sun",{"id":2842,"sortIndex":177,"researcher":19,"roles":2843,"affiliations":2844,"properties":2856},"c947de6b-8f04-435c-8ab2-edeb0d14381e",[],[2845],{"id":2846,"sortIndex":20,"affiliation":2847,"properties":19},"0037d225-3343-4d73-95a1-a11709d62e5b",{"id":2848,"createTime":2849,"updateTime":2850,"relativeEntities":2851,"slug":2852,"properties":2853,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"ecd84f3d-82ec-420a-86ea-342bbded765a","2023-12-09T03:17:31.478+00:00","2024-09-17T23:57:37.264+00:00",[],"Department-of-Gastrointestinal-Medical-Oncology-The-Affiliated-Tumor-Hospital-of-Harbin-Medical-University-Harbin-China",{"title":2854},{"VI":2855},"Department of Gastrointestinal Medical Oncology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China",{"openalex":2857,"orcid":2859,"title":2861},{"VOID":2858},"A5100763082",{"VOID":2860},"https:\u002F\u002Forcid.org\u002F0000-0001-6876-7361",{"EN":2862},"Tao Ji",{"id":2864,"sortIndex":112,"researcher":19,"roles":2865,"affiliations":2866,"properties":2879},"77d5858d-a230-43ce-b208-31cad4d7be3f",[],[2867,2873],{"id":2868,"sortIndex":112,"affiliation":2869,"properties":19},"0edb8a95-1430-4796-b4c7-558ce16d28d1",{"id":2746,"createTime":2747,"updateTime":2748,"relativeEntities":2870,"slug":2750,"properties":2871,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2872},{"VI":2753},{"id":2874,"sortIndex":20,"affiliation":2875,"properties":19},"34a17a4a-8550-4a09-b1d6-3baf06a1277a",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2876,"slug":2680,"properties":2877,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2878},{"VI":2683},{"openalex":2880,"orcid":2882,"title":2884},{"VOID":2881},"A5073759462",{"VOID":2883},"https:\u002F\u002Forcid.org\u002F0000-0001-6334-3228",{"EN":2885},"Xu Gao",{"id":2887,"sortIndex":249,"researcher":19,"roles":2888,"affiliations":2889,"properties":2896},"e35d6e3d-23be-4aef-9bbf-62cd4b081fa0",[],[2890],{"id":2891,"sortIndex":20,"affiliation":2892,"properties":19},"f973325f-36dd-4513-8fac-dd20233812f5",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2893,"slug":2680,"properties":2894,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2895},{"VI":2683},{"openalex":2897,"orcid":2899,"title":2901},{"VOID":2898},"A5076834193",{"VOID":2900},"https:\u002F\u002Forcid.org\u002F0000-0003-1221-7429",{"EN":2902},"Jing Yang",{"id":2904,"sortIndex":20,"researcher":19,"roles":2905,"affiliations":2906,"properties":2919},"607e16ef-ca09-4864-9f34-c268ddcfed38",[],[2907,2913],{"id":2908,"sortIndex":20,"affiliation":2909,"properties":19},"02554200-c67f-4478-bf07-f9caaec87a3e",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2910,"slug":2680,"properties":2911,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2912},{"VI":2683},{"id":2914,"sortIndex":112,"affiliation":2915,"properties":19},"6269e261-d0fb-4f6b-824e-ec875a1ace05",{"id":2746,"createTime":2747,"updateTime":2748,"relativeEntities":2916,"slug":2750,"properties":2917,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2918},{"VI":2753},{"openalex":2920,"orcid":2922,"title":2924},{"VOID":2921},"A5066622454",{"VOID":2923},"https:\u002F\u002Forcid.org\u002F0000-0003-3775-4028",{"EN":2925},"Dong Han",{"id":2927,"sortIndex":96,"researcher":19,"roles":2928,"affiliations":2929,"properties":2936},"2de16954-da7e-4d72-9636-8d9a23296b28",[],[2930],{"id":2931,"sortIndex":20,"affiliation":2932,"properties":19},"8453292d-91ef-40f4-8073-f04398043832",{"id":2676,"createTime":2677,"updateTime":2678,"relativeEntities":2933,"slug":2680,"properties":2934,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":2935},{"VI":2683},{"openalex":2937,"title":2939},{"VOID":2938},"A5030331230",{"EN":2940},"Nazhen Dong",{"url":19,"publisher":2942,"properties":2958},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2943,"slug":10,"properties":2944,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":2948,"manageAffiliations":2949,"indexDatabases":2950,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":2945,"issn":2946,"title":2947},{"VOID":13},{"VOID":15},{"EN":10},[],[],[2951],{"id":44,"indexDatabase":2952,"url":57,"indexYears":58,"academicFieldIds":2957,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":2953,"label":2954,"description":2955,"key":54,"publicationTags":2956,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":2959,"pages":2960,"issue":2962},{"VOID":462},{"VOID":2961},"22159-22173",{"VOID":851},185,{"total":2963,"publishYear":19,"statisticByYear":2965},{"2016":1336,"2017":2966,"2018":2967,"2019":2968,"2020":2969,"2021":2969,"2022":285,"2023":470,"2024":96},30,28,29,26,[2971,2974,2978,2982,2985,2989,2993,2996,3000,3004,3008,3012,3016,3019,3023,3027,3031,3034,3038,3042,3046,3050,3054,3058,3062,3066,3070,3074,3078,3082,3086,3090,3094,3098,3102,3106,3110,3114,3118,3122,3126,3130,3134,3138,3142,3146,3150,3154],{"id":19,"text":2972,"url":19,"identifiers":2973},"Pisani, 2005, Global cancer statistics, 2002, CA, 55, 74",{},{"id":19,"text":2975,"url":19,"identifiers":2976},"Terdiman, 2003, Colorectal cancer screening: scientific review, Jama, 289, 1288, 10.1001\u002Fjama.289.10.1288",{"doi":2977},"10.1001\u002Fjama.289.10.1288",{"id":19,"text":2979,"url":19,"identifiers":2980},"Mayer, 2008, Systemic treatment of colorectal cancer, Gastroenterology, 134, 1296, 10.1053\u002Fj.gastro.2008.02.098",{"doi":2981},"10.1053\u002Fj.gastro.2008.02.098",{"id":19,"text":2983,"url":19,"identifiers":2984},"Carmichael, 2010, Long noncoding RNAs in mammalian cells: what, where, and why?, Wiley interdisciplinary reviews, RNA, 1, 2",{},{"id":19,"text":2986,"url":19,"identifiers":2987},"Reik, 2009, Evolution and functions of long noncoding RNAs, Cell, 136, 629, 10.1016\u002Fj.cell.2009.02.006",{"doi":2988},"10.1016\u002Fj.cell.2009.02.006",{"id":19,"text":2990,"url":19,"identifiers":2991},"Chang, 2011, Molecular mechanisms of long noncoding RNAs, Molecular cell, 43, 904, 10.1016\u002Fj.molcel.2011.08.018",{"doi":2992},"10.1016\u002Fj.molcel.2011.08.018",{"id":19,"text":2994,"url":19,"identifiers":2995},"Wu W, 2013, Understanding the Role of Long Noncoding RNAs in the Cancer Genome, 1",{},{"id":19,"text":2997,"url":19,"identifiers":2998},"Diederichs, 2012, The hallmarks of cancer: a long non-coding RNA point of view, RNA biology, 9, 703, 10.4161\u002Frna.20481",{"doi":2999},"10.4161\u002Frna.20481",{"id":19,"text":3001,"url":19,"identifiers":3002},"Chinnaiyan, 2011, The emergence of lncRNAs in cancer biology, Cancer discovery, 1, 391, 10.1158\u002F2159-8290.CD-11-0209",{"doi":3003},"10.1158\u002F2159-8290.CD-11-0209",{"id":19,"text":3005,"url":19,"identifiers":3006},"Vingron, 2009, Expression profile and transcription factor binding site exploration of imprinted genes in human and mouse, BMC genomics, 10, 144, 10.1186\u002F1471-2164-10-144",{"doi":3007},"10.1186\u002F1471-2164-10-144",{"id":19,"text":3009,"url":19,"identifiers":3010},"Walter, 2000, Sequence and functional comparison in the Beckwith-Wiedemann region: implications for a novel imprinting centre and extended imprinting, Human molecular genetics, 9, 2691, 10.1093\u002Fhmg\u002F9.18.2691",{"doi":3011},"10.1093\u002Fhmg\u002F9.18.2691",{"id":19,"text":3013,"url":19,"identifiers":3014},"Ma, 2012, Enemy or partner: relationship between intronic micrornas and their host genes, IUBMB life, 64, 835, 10.1002\u002Fiub.1079",{"doi":3015},"10.1002\u002Fiub.1079",{"id":19,"text":3017,"url":19,"identifiers":3018},"Feinberg, 2002, Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2, Cancer research, 62, 6442",{},{"id":19,"text":3020,"url":19,"identifiers":3021},"Kwok, 2010, Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer, Carcinogenesis, 31, 350, 10.1093\u002Fcarcin\u002Fbgp181",{"doi":3022},"10.1093\u002Fcarcin\u002Fbgp181",{"id":19,"text":3024,"url":19,"identifiers":3025},"Galun, 2007, The H19 non-coding RNA is essential for human tumor growth, PloS one, 2, e845, 10.1371\u002Fjournal.pone.0000845",{"doi":3026},"10.1371\u002Fjournal.pone.0000845",{"id":19,"text":3028,"url":19,"identifiers":3029},"Ayesh, 1998, Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma, Molecular pathology, 51, 21, 10.1136\u002Fmp.51.1.21",{"doi":3030},"10.1136\u002Fmp.51.1.21",{"id":19,"text":3032,"url":19,"identifiers":3033},"Takagi, 1996, Loss of H19 imprinting in esophageal cancer, Cancer research, 56, 480",{},{"id":19,"text":3035,"url":19,"identifiers":3036},"Ariel, 1999, Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer, European journal of obstetrics, gynecology, and reproductive biology, 85, 7, 10.1016\u002FS0301-2115(98)00275-9",{"doi":3037},"10.1016\u002FS0301-2115(98)00275-9",{"id":19,"text":3039,"url":19,"identifiers":3040},"Adriaenssens, 2005, H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1, The Journal of biological chemistry, 280, 29625, 10.1074\u002Fjbc.M504033200",{"doi":3041},"10.1074\u002Fjbc.M504033200",{"id":19,"text":3043,"url":19,"identifiers":3044},"Curgy, 2002, Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells, Carcinogenesis, 23, 1885, 10.1093\u002Fcarcin\u002F23.11.1885",{"doi":3045},"10.1093\u002Fcarcin\u002F23.11.1885",{"id":19,"text":3047,"url":19,"identifiers":3048},"Adriaenssens, 2015, H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b, Oncotarget, 6, 29209, 10.18632\u002Foncotarget.4976",{"doi":3049},"10.18632\u002Foncotarget.4976",{"id":19,"text":3051,"url":19,"identifiers":3052},"Yang, 2007, Examination of IGF2 and H19 loss of imprinting in bladder cancer, Cancer research, 67, 10753, 10.1158\u002F0008-5472.CAN-07-0329",{"doi":3053},"10.1158\u002F0008-5472.CAN-07-0329",{"id":19,"text":3055,"url":19,"identifiers":3056},"Qiu, 2013, Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression, Cancer letters, 333, 213, 10.1016\u002Fj.canlet.2013.01.033",{"doi":3057},"10.1016\u002Fj.canlet.2013.01.033",{"id":19,"text":3059,"url":19,"identifiers":3060},"Gao, 2014, Intragenic microRNA and long non-coding RNA: novel potential regulator of IGF2-H19 imprinting region, Evolution & development, 16, 1, 10.1111\u002Fede.12057",{"doi":3061},"10.1111\u002Fede.12057",{"id":19,"text":3063,"url":19,"identifiers":3064},"Khalil, 2012, Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs, Nucleic acids research, 40, 6391, 10.1093\u002Fnar\u002Fgks296",{"doi":3065},"10.1093\u002Fnar\u002Fgks296",{"id":19,"text":3067,"url":19,"identifiers":3068},"Chang, 2012, Genome regulation by long noncoding RNAs, Annual review of biochemistry, 81, 145, 10.1146\u002Fannurev-biochem-051410-092902",{"doi":3069},"10.1146\u002Fannurev-biochem-051410-092902",{"id":19,"text":3071,"url":19,"identifiers":3072},"Sun, 2013, Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis, Molecular cell, 49, 1083, 10.1016\u002Fj.molcel.2013.01.010",{"doi":3073},"10.1016\u002Fj.molcel.2013.01.010",{"id":19,"text":3075,"url":19,"identifiers":3076},"Sun, 2013, H19 inhibits RNA polymerase II-mediated transcription by disrupting the hnRNP U-actin complex, Biochimica et biophysica acta, 1830, 4899, 10.1016\u002Fj.bbagen.2013.06.026",{"doi":3077},"10.1016\u002Fj.bbagen.2013.06.026",{"id":19,"text":3079,"url":19,"identifiers":3080},"Moore, 2007, The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression, Cell, 130, 179, 10.1016\u002Fj.cell.2007.05.028",{"doi":3081},"10.1016\u002Fj.cell.2007.05.028",{"id":19,"text":3083,"url":19,"identifiers":3084},"Kurokawa, 2011, Long noncoding RNA as a regulator for transcription, Progress in molecular and subcellular biology, 51, 29, 10.1007\u002F978-3-642-16502-3_2",{"doi":3085},"10.1007\u002F978-3-642-16502-3_2",{"id":19,"text":3087,"url":19,"identifiers":3088},"Lipovich, 2010, Genome-wide computational identification and manual annotation of human long noncoding RNA genes, Rna, 16, 1478, 10.1261\u002Frna.1951310",{"doi":3089},"10.1261\u002Frna.1951310",{"id":19,"text":3091,"url":19,"identifiers":3092},"You, 2014, Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675, PloS one, 9, e86295, 10.1371\u002Fjournal.pone.0086295",{"doi":3093},"10.1371\u002Fjournal.pone.0086295",{"id":19,"text":3095,"url":19,"identifiers":3096},"Yu, 2014, lncRNA H19\u002FmiR-675 axis represses prostate cancer metastasis by targeting TGFBI, The FEBS journal, 281, 3766, 10.1111\u002Ffebs.12902",{"doi":3097},"10.1111\u002Ffebs.12902",{"id":19,"text":3099,"url":19,"identifiers":3100},"Sun, 2013, Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma, Carcinogenesis, 34, 577, 10.1093\u002Fcarcin\u002Fbgs381",{"doi":3101},"10.1093\u002Fcarcin\u002Fbgs381",{"id":19,"text":3103,"url":19,"identifiers":3104},"Cullen, 2007, The imprinted H19 noncoding RNA is a primary microRNA precursor, Rna, 13, 313, 10.1261\u002Frna.351707",{"doi":3105},"10.1261\u002Frna.351707",{"id":19,"text":3107,"url":19,"identifiers":3108},"Chang, 2010, Long noncoding RNA in genome regulation: prospects and mechanisms, RNA biology, 7, 582, 10.4161\u002Frna.7.5.13216",{"doi":3109},"10.4161\u002Frna.7.5.13216",{"id":19,"text":3111,"url":19,"identifiers":3112},"Gao, 2015, Long noncoding RNAs: novel players in colorectal cancer, Cancer letters, 361, 13, 10.1016\u002Fj.canlet.2015.03.002",{"doi":3113},"10.1016\u002Fj.canlet.2015.03.002",{"id":19,"text":3115,"url":19,"identifiers":3116},"Gropp, 2015, The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells, Oncotarget, 6, 34691, 10.18632\u002Foncotarget.5787",{"doi":3117},"10.18632\u002Foncotarget.5787",{"id":19,"text":3119,"url":19,"identifiers":3120},"Lu, 2015, CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc, Oncotarget, 6, 40775, 10.18632\u002Foncotarget.5805",{"doi":3121},"10.18632\u002Foncotarget.5805",{"id":19,"text":3123,"url":19,"identifiers":3124},"Hochberg, 2016, The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision, Oncotarget, 7, 3748, 10.18632\u002Foncotarget.6387",{"doi":3125},"10.18632\u002Foncotarget.6387",{"id":19,"text":3127,"url":19,"identifiers":3128},"Waye, 2015, The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer, Oncotarget, 6, 22513, 10.18632\u002Foncotarget.4154",{"doi":3129},"10.18632\u002Foncotarget.4154",{"id":19,"text":3131,"url":19,"identifiers":3132},"Shiekhattar, 2015, The many faces of long noncoding RNAs, The FEBS J, 282, 1647, 10.1111\u002Ffebs.13101",{"doi":3133},"10.1111\u002Ffebs.13101",{"id":19,"text":3135,"url":19,"identifiers":3136},"Lu, 2015, miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer, Oncotarget, 6, 31958, 10.18632\u002Foncotarget.5579",{"doi":3137},"10.18632\u002Foncotarget.5579",{"id":19,"text":3139,"url":19,"identifiers":3140},"Le Hir, 2005, The exon junction core complex is locked onto RNA by inhibition of eIF4AIII ATPase activity, Nature structural & molecular biology, 12, 861, 10.1038\u002Fnsmb990",{"doi":3141},"10.1038\u002Fnsmb990",{"id":19,"text":3143,"url":19,"identifiers":3144},"Moore, 2005, Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core, Rna, 11, 1869, 10.1261\u002Frna.2155905",{"doi":3145},"10.1261\u002Frna.2155905",{"id":19,"text":3147,"url":19,"identifiers":3148},"Moore, 2000, The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions, The EMBO journal, 19, 6860, 10.1093\u002Femboj\u002F19.24.6860",{"doi":3149},"10.1093\u002Femboj\u002F19.24.6860",{"id":19,"text":3151,"url":19,"identifiers":3152},"Moore, 2004, eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay, Nature structural & molecular biology, 11, 346, 10.1038\u002Fnsmb750",{"doi":3153},"10.1038\u002Fnsmb750",{"id":19,"text":3155,"url":19,"identifiers":3156},"Izaurralde, 2005, Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species, Current opinion in cell biology, 17, 316, 10.1016\u002Fj.ceb.2005.04.005",{"doi":3157},"10.1016\u002Fj.ceb.2005.04.005",{"id":3159,"createTime":3160,"updateTime":3160,"relativeEntities":3161,"slug":3162,"properties":3163,"entityType":87,"verifyStatus":88,"verifyTime":3178,"verifyNote":89,"syncStatus":18,"languages":3179,"translateLanguages":19,"viewCount":20,"primaryUrl":3180,"fullTextUrl":19,"authors":3181,"publicationType":442,"publisherRelationship":3512,"citationCount":3536,"citationInfo":3537,"publishDate":3539,"publishYear":3540,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":3541,"isForceReanalyzing":585},"f5a263ea-a57c-40c0-b65b-c4a98e03656b","2024-09-17T23:57:09.236+00:00",[],"The-miR-486-5p-plays-a-causative-role-in-prostate-cancer-through-negative-regulation-of-multiple-tumor-suppressor-pathways",{"mag":3164,"keywords":3166,"pmc":3167,"openalex":3169,"abstract":3171,"title":3172,"pm":3174,"doi":3176},{"VOID":3165},"2746886110",{},{"VOID":3168},"5641172",{"VOID":3170},"W2746886110",{},{"EN":3173},"The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways",{"VOID":3175},"29069829",{"VOID":3177},"10.18632\u002Foncotarget.20427","2024-09-17T23:57:09.235+00:00",[91],"https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.20427",[3182,3225,3246,3275,3302,3351,3380,3402,3431,3460,3489],{"id":3183,"sortIndex":249,"researcher":19,"roles":3184,"affiliations":3185,"properties":3218},"91dd5fec-4a9b-425a-97fd-28c0c72ad0ea",[],[3186,3196,3207],{"id":3187,"sortIndex":20,"affiliation":3188,"properties":19},"fff40539-4d28-4fba-88a3-6b83b4147b4d",{"id":3189,"createTime":3190,"updateTime":3190,"relativeEntities":3191,"slug":3192,"properties":3193,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"674fa022-f632-4516-89a3-1bad34578cb7","2024-09-17T23:57:09.261+00:00",[],"Department-of-Urology-Drum-Tower-Hospital-Affiliated-with-Nanjing-University-School-of-Medicine-Institute-of-Urology-Nanjing-University-Nanjing-210008-China",{"title":3194},{"EN":3195},"Department of Urology, Drum Tower Hospital Affiliated with Nanjing University School of Medicine, Institute of Urology, Nanjing University, Nanjing 210008, China",{"id":3197,"sortIndex":225,"affiliation":3198,"properties":19},"139d05cf-8cab-44ea-90ca-015ee1c396a0",{"id":3199,"createTime":3200,"updateTime":3201,"relativeEntities":3202,"slug":3203,"properties":3204,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"533ba89e-c3d5-40f8-a173-2bc443978580","2023-12-11T19:28:36.927+00:00","2024-09-17T23:57:09.281+00:00",[],"School-of-Medicine-Nanjing-University-Nanjing-210093-China",{"title":3205},{"VI":3206},"School of Medicine, Nanjing University, Nanjing 210093, China",{"id":3208,"sortIndex":112,"affiliation":3209,"properties":19},"6377611f-67a7-4b24-891b-c206890c739f",{"id":3210,"createTime":3211,"updateTime":3212,"relativeEntities":3213,"slug":3214,"properties":3215,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"bb76a24e-f2d5-4f9a-bba6-b57dfe9f3c7d","2023-12-11T14:45:31.018+00:00","2024-09-17T23:57:09.273+00:00",[],"Nanjing-University-Nanjing-210008-China",{"title":3216},{"VI":3217},"Nanjing University, Nanjing, 210008, China",{"openalex":3219,"orcid":3221,"title":3223},{"VOID":3220},"A5100449704",{"VOID":3222},"https:\u002F\u002Forcid.org\u002F0009-0001-9332-4930",{"EN":3224},"Shiwei Zhang",{"id":3226,"sortIndex":422,"researcher":19,"roles":3227,"affiliations":3228,"properties":3239},"3503da59-8438-4238-bddb-ddf42b677248",[],[3229],{"id":3230,"sortIndex":20,"affiliation":3231,"properties":19},"8c5c2a86-b615-4318-9f8f-2ccfe4c4125e",{"id":3232,"createTime":3233,"updateTime":3233,"relativeEntities":3234,"slug":3235,"properties":3236,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"f85fe41b-4b18-4841-babc-bf5c8153a774","2024-09-17T23:57:09.360+00:00",[],"Center-of-Drug-Discovery-State-Key-Laboratory-of-Natural-Medicines-China-Pharmaceutical-University-Nanjing-211198-China",{"title":3237},{"EN":3238},"Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China",{"openalex":3240,"orcid":3242,"title":3244},{"VOID":3241},"A5106671337",{"VOID":3243},"https:\u002F\u002Forcid.org\u002F0000-0002-3910-9156",{"EN":3245},"Xin Su",{"id":3247,"sortIndex":285,"researcher":19,"roles":3248,"affiliations":3249,"properties":3268},"a81ed8b9-06b8-4d21-8e8c-045300da3d72",[],[3250,3256,3262],{"id":3251,"sortIndex":20,"affiliation":3252,"properties":19},"906c256d-4e06-41d8-a111-16e6ee180f87",{"id":3189,"createTime":3190,"updateTime":3190,"relativeEntities":3253,"slug":3192,"properties":3254,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3255},{"EN":3195},{"id":3257,"sortIndex":112,"affiliation":3258,"properties":19},"07fbeb4f-c454-4079-801b-d618f89fa139",{"id":3210,"createTime":3211,"updateTime":3212,"relativeEntities":3259,"slug":3214,"properties":3260,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3261},{"VI":3217},{"id":3263,"sortIndex":225,"affiliation":3264,"properties":19},"dc813550-db65-45ab-95b9-27d8eefb9f12",{"id":3199,"createTime":3200,"updateTime":3201,"relativeEntities":3265,"slug":3203,"properties":3266,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3267},{"VI":3206},{"openalex":3269,"orcid":3271,"title":3273},{"VOID":3270},"A5030336149",{"VOID":3272},"https:\u002F\u002Forcid.org\u002F0000-0002-3121-5157",{"EN":3274},"Hongqian Guo",{"id":3276,"sortIndex":112,"researcher":19,"roles":3277,"affiliations":3278,"properties":3297},"1e7f762f-30ed-4323-a772-eba5cd415887",[],[3279,3285,3291],{"id":3280,"sortIndex":112,"affiliation":3281,"properties":19},"d68a3274-b3ef-4432-975d-60dd9d5117b5",{"id":3210,"createTime":3211,"updateTime":3212,"relativeEntities":3282,"slug":3214,"properties":3283,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3284},{"VI":3217},{"id":3286,"sortIndex":225,"affiliation":3287,"properties":19},"06eb7785-9367-4dea-922e-d2b10a6c786e",{"id":3199,"createTime":3200,"updateTime":3201,"relativeEntities":3288,"slug":3203,"properties":3289,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3290},{"VI":3206},{"id":3292,"sortIndex":20,"affiliation":3293,"properties":19},"3c963eaf-778e-49c4-955a-6d1b55ff0788",{"id":3189,"createTime":3190,"updateTime":3190,"relativeEntities":3294,"slug":3192,"properties":3295,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3296},{"EN":3195},{"openalex":3298,"title":3300},{"VOID":3299},"A5040069704",{"EN":3301},"Changwei Ji",{"id":3303,"sortIndex":267,"researcher":19,"roles":3304,"affiliations":3305,"properties":3344},"c3fc2607-a6cf-438a-aa3a-55c6d90c7b56",[],[3306,3312,3318,3328,3338],{"id":3307,"sortIndex":112,"affiliation":3308,"properties":19},"afcc5035-8df1-4c9f-b8af-8919e8405957",{"id":3189,"createTime":3190,"updateTime":3190,"relativeEntities":3309,"slug":3192,"properties":3310,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3311},{"EN":3195},{"id":3313,"sortIndex":422,"affiliation":3314,"properties":19},"653ab212-e6fb-4c46-98f6-cef49aaf58fa",{"id":3210,"createTime":3211,"updateTime":3212,"relativeEntities":3315,"slug":3214,"properties":3316,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3317},{"VI":3217},{"id":3319,"sortIndex":225,"affiliation":3320,"properties":19},"2460aa0b-6d32-4a44-b220-26051c72dbf0",{"id":3321,"createTime":3322,"updateTime":3322,"relativeEntities":3323,"slug":3324,"properties":3325,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"9eb1858f-a445-4071-9a9a-f668bc2e894e","2024-09-17T23:57:09.509+00:00",[],"Jiangsu-Key-Laboratory-of-Molecular-Medicine-Nanjing-210002-China",{"title":3326},{"EN":3327},"Jiangsu Key Laboratory of Molecular Medicine, Nanjing 210002, China",{"id":3329,"sortIndex":20,"affiliation":3330,"properties":19},"77aa7f79-743f-49a9-ab88-fce8026fd664",{"id":3331,"createTime":3332,"updateTime":3332,"relativeEntities":3333,"slug":3334,"properties":3335,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"b8763c14-8faf-42f6-9251-c3215dcffa04","2024-09-17T23:57:09.498+00:00",[],"Department-of-Urology-Drum-Tower-Hospital-Affiliated-with-Nanjing-University-School-of-Medicine-Institute-of-Urology-",{"title":3336},{"EN":3337},"Department of Urology, Drum Tower Hospital Affiliated with Nanjing University School of Medicine, Institute of Urology,",{"id":3339,"sortIndex":350,"affiliation":3340,"properties":19},"096ca0d3-a8f9-40d4-a3b1-7bee0d293719",{"id":3199,"createTime":3200,"updateTime":3201,"relativeEntities":3341,"slug":3203,"properties":3342,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3343},{"VI":3206},{"openalex":3345,"orcid":3347,"title":3349},{"VOID":3346},"A5085149787",{"VOID":3348},"https:\u002F\u002Forcid.org\u002F0000-0001-7788-1334",{"EN":3350},"Huimei Chen",{"id":3352,"sortIndex":96,"researcher":19,"roles":3353,"affiliations":3354,"properties":3373},"831c4fdd-e93d-4e1b-b543-79fc1dca299e",[],[3355,3361,3367],{"id":3356,"sortIndex":225,"affiliation":3357,"properties":19},"dc9f8ce9-7c6c-4e17-aac9-e5954ef6f17c",{"id":3199,"createTime":3200,"updateTime":3201,"relativeEntities":3358,"slug":3203,"properties":3359,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3360},{"VI":3206},{"id":3362,"sortIndex":112,"affiliation":3363,"properties":19},"66542ce5-f84d-46a0-9301-090883bd4b2a",{"id":3210,"createTime":3211,"updateTime":3212,"relativeEntities":3364,"slug":3214,"properties":3365,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3366},{"VI":3217},{"id":3368,"sortIndex":20,"affiliation":3369,"properties":19},"17847a33-9ac2-44fb-8d11-b8081fee91cc",{"id":3189,"createTime":3190,"updateTime":3190,"relativeEntities":3370,"slug":3192,"properties":3371,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3372},{"EN":3195},{"openalex":3374,"orcid":3376,"title":3378},{"VOID":3375},"A5038970546",{"VOID":3377},"https:\u002F\u002Forcid.org\u002F0000-0002-4742-6194",{"EN":3379},"Guang‐Xiang Liu",{"id":3381,"sortIndex":225,"researcher":19,"roles":3382,"affiliations":3383,"properties":3395},"56e1bc03-3801-4ae0-95f0-ac59a863178d",[],[3384],{"id":3385,"sortIndex":20,"affiliation":3386,"properties":19},"5cfe6c2f-4a90-43b8-b919-56dd1033bba3",{"id":3387,"createTime":3388,"updateTime":3389,"relativeEntities":3390,"slug":3391,"properties":3392,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"0040b60f-23b5-4669-8d26-18f0551ae7e5","2023-12-06T10:17:06.718+00:00","2025-06-11T13:45:35.302+00:00",[],"School-of-Public-Health-Nanjing-Medical-University-Nanjing-211166-China",{"title":3393},{"VI":3394},"School of Public Health, Nanjing Medical University, Nanjing 211166, China",{"openalex":3396,"orcid":3398,"title":3400},{"VOID":3397},"A5078802814",{"VOID":3399},"https:\u002F\u002Forcid.org\u002F0000-0002-7175-5414",{"EN":3401},"Suhan Guo",{"id":3403,"sortIndex":350,"researcher":19,"roles":3404,"affiliations":3405,"properties":3424},"0fecd341-fab4-41d4-b529-7c72fc92ccd5",[],[3406,3412,3418],{"id":3407,"sortIndex":20,"affiliation":3408,"properties":19},"a688ab7b-f413-45be-bce0-463ce9519eb8",{"id":3189,"createTime":3190,"updateTime":3190,"relativeEntities":3409,"slug":3192,"properties":3410,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3411},{"EN":3195},{"id":3413,"sortIndex":225,"affiliation":3414,"properties":19},"055636a9-4ac9-4efa-9020-a00d417cfda5",{"id":3199,"createTime":3200,"updateTime":3201,"relativeEntities":3415,"slug":3203,"properties":3416,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3417},{"VI":3206},{"id":3419,"sortIndex":112,"affiliation":3420,"properties":19},"e0155c49-eefa-4d92-86ed-70f6e284a7e9",{"id":3210,"createTime":3211,"updateTime":3212,"relativeEntities":3421,"slug":3214,"properties":3422,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3423},{"VI":3217},{"openalex":3425,"orcid":3427,"title":3429},{"VOID":3426},"A5049162665",{"VOID":3428},"https:\u002F\u002Forcid.org\u002F0000-0002-4265-9730",{"EN":3430},"Xiaozhi Zhao",{"id":3432,"sortIndex":326,"researcher":19,"roles":3433,"affiliations":3434,"properties":3453},"9d8193c6-c929-4419-9bd5-067dff120768",[],[3435,3441,3447],{"id":3436,"sortIndex":112,"affiliation":3437,"properties":19},"ce3d3238-9cb9-4a0c-8fa7-9f22e21014db",{"id":3210,"createTime":3211,"updateTime":3212,"relativeEntities":3438,"slug":3214,"properties":3439,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3440},{"VI":3217},{"id":3442,"sortIndex":225,"affiliation":3443,"properties":19},"af31e84b-34ea-41bb-acf2-7ff63d456506",{"id":3199,"createTime":3200,"updateTime":3201,"relativeEntities":3444,"slug":3203,"properties":3445,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3446},{"VI":3206},{"id":3448,"sortIndex":20,"affiliation":3449,"properties":19},"e829cee0-c09a-40de-8898-349cdee85576",{"id":3189,"createTime":3190,"updateTime":3190,"relativeEntities":3450,"slug":3192,"properties":3451,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3452},{"EN":3195},{"openalex":3454,"orcid":3456,"title":3458},{"VOID":3455},"A5006322525",{"VOID":3457},"https:\u002F\u002Forcid.org\u002F0000-0002-3554-5145",{"EN":3459},"Xuefeng Qiu",{"id":3461,"sortIndex":20,"researcher":19,"roles":3462,"affiliations":3463,"properties":3482},"20ead5a5-c7ab-466d-86fe-c50f76048735",[],[3464,3470,3476],{"id":3465,"sortIndex":112,"affiliation":3466,"properties":19},"41897157-3a31-4e4c-8a82-ecff242b7b2b",{"id":3210,"createTime":3211,"updateTime":3212,"relativeEntities":3467,"slug":3214,"properties":3468,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3469},{"VI":3217},{"id":3471,"sortIndex":20,"affiliation":3472,"properties":19},"97a2d983-6dbf-4ded-b801-9c0e7cab5243",{"id":3189,"createTime":3190,"updateTime":3190,"relativeEntities":3473,"slug":3192,"properties":3474,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3475},{"EN":3195},{"id":3477,"sortIndex":225,"affiliation":3478,"properties":19},"c143b840-0790-4a5c-ae4b-aa049ebfec7f",{"id":3199,"createTime":3200,"updateTime":3201,"relativeEntities":3479,"slug":3203,"properties":3480,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3481},{"VI":3206},{"openalex":3483,"orcid":3485,"title":3487},{"VOID":3484},"A5100397410",{"VOID":3486},"https:\u002F\u002Forcid.org\u002F0000-0001-6788-2843",{"EN":3488},"Yang Yang",{"id":3490,"sortIndex":201,"researcher":19,"roles":3491,"affiliations":3492,"properties":3505},"7e3df714-18ec-44fe-bfc5-4e715c3abed0",[],[3493,3499],{"id":3494,"sortIndex":20,"affiliation":3495,"properties":19},"a28a9be3-9c9f-467a-8eb7-0a6249bcc66e",{"id":3189,"createTime":3190,"updateTime":3190,"relativeEntities":3496,"slug":3192,"properties":3497,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3498},{"EN":3195},{"id":3500,"sortIndex":112,"affiliation":3501,"properties":19},"430587d6-7436-4a59-be8d-840ec5db9804",{"id":3199,"createTime":3200,"updateTime":3201,"relativeEntities":3502,"slug":3203,"properties":3503,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3504},{"VI":3206},{"openalex":3506,"orcid":3508,"title":3510},{"VOID":3507},"A5100358805",{"VOID":3509},"https:\u002F\u002Forcid.org\u002F0000-0002-6869-0381",{"EN":3511},"Qing Zhang",{"url":19,"publisher":3513,"properties":3529},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":3514,"slug":10,"properties":3515,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":3519,"manageAffiliations":3520,"indexDatabases":3521,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":3516,"issn":3517,"title":3518},{"VOID":13},{"VOID":15},{"EN":10},[],[],[3522],{"id":44,"indexDatabase":3523,"url":57,"indexYears":58,"academicFieldIds":3528,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":3524,"label":3525,"description":3526,"key":54,"publicationTags":3527,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":3530,"pages":3532,"issue":3534},{"VOID":3531},"8",{"VOID":3533},"72835-72846",{"VOID":3535},"42",55,{"total":3536,"publishYear":19,"statisticByYear":3538},{"2018":96,"2019":285,"2020":130,"2021":267,"2022":285,"2023":350,"2024":249},"2017-09-22",2017,[3542,3546,3550,3554,3558,3562,3566,3570,3574,3578,3582,3586,3590,3594,3598,3602,3606,3610,3613,3617,3621,3625,3629,3633,3637,3641,3645,3649,3653,3657,3661,3665,3669,3673,3677,3681,3685,3689,3692,3696,3699,3703],{"id":19,"text":3543,"url":19,"identifiers":3544},"Jemal, 2015, Cancer statistics, 2015, CA Cancer J Clin, 65, 5, 10.3322\u002Fcaac.21254",{"doi":3545},"10.3322\u002Fcaac.21254",{"id":19,"text":3547,"url":19,"identifiers":3548},"Gray, 2008, Translating insights from the cancer genome into clinical practice, Nature, 452, 553, 10.1038\u002Fnature06914",{"doi":3549},"10.1038\u002Fnature06914",{"id":19,"text":3551,"url":19,"identifiers":3552},"Flohr, 2015, DNA-repair defects and olaparib in metastatic prostate cancer, N Engl J Med, 373, 1697, 10.1056\u002FNEJMoa1506859",{"doi":3553},"10.1056\u002FNEJMoa1506859",{"id":19,"text":3555,"url":19,"identifiers":3556},"Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038\u002Fnrg2634",{"doi":3557},"10.1038\u002Fnrg2634",{"id":19,"text":3559,"url":19,"identifiers":3560},"Croce, 2013, Clinical applications for microRNAs in cancer, Clin Pharmacol Ther, 93, 98, 10.1038\u002Fclpt.2012.192",{"doi":3561},"10.1038\u002Fclpt.2012.192",{"id":19,"text":3563,"url":19,"identifiers":3564},"Golub, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038\u002Fnature03702",{"doi":3565},"10.1038\u002Fnature03702",{"id":19,"text":3567,"url":19,"identifiers":3568},"Singh, 2016, Exploiting nanotechnology for the development of microRNA-based cancer therapeutics, J Biomed Nanotechnol, 12, 28, 10.1166\u002Fjbn.2016.2172",{"doi":3569},"10.1166\u002Fjbn.2016.2172",{"id":19,"text":3571,"url":19,"identifiers":3572},"Visakorpi, 2007, MicroRNA expression profiling in prostate cancer, Cancer Res, 67, 6130, 10.1158\u002F0008-5472.CAN-07-0533",{"doi":3573},"10.1158\u002F0008-5472.CAN-07-0533",{"id":19,"text":3575,"url":19,"identifiers":3576},"Visakorpi, 2015, MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2, Prostate, 75, 798, 10.1002\u002Fpros.22961",{"doi":3577},"10.1002\u002Fpros.22961",{"id":19,"text":3579,"url":19,"identifiers":3580},"Jeon, 2013, Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer, Proc Natl Acad Sci U S A, 110, 15043, 10.1073\u002Fpnas.1307107110",{"doi":3581},"10.1073\u002Fpnas.1307107110",{"id":19,"text":3583,"url":19,"identifiers":3584},"Ma, 2016, Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer, Oncotarget, 7, 34011, 10.18632\u002Foncotarget.8514",{"doi":3585},"10.18632\u002Foncotarget.8514",{"id":19,"text":3587,"url":19,"identifiers":3588},"Tan, 2011, Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer, Clin Cancer Res, 17, 2657, 10.1158\u002F1078-0432.CCR-10-3152",{"doi":3589},"10.1158\u002F1078-0432.CCR-10-3152",{"id":19,"text":3591,"url":19,"identifiers":3592},"Jung, 2012, miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose, Stem Cells Dev, 21, 1749, 10.1089\u002Fscd.2011.0429",{"doi":3593},"10.1089\u002Fscd.2011.0429",{"id":19,"text":3595,"url":19,"identifiers":3596},"Yang, 2014, MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells, Tumour Biol, 35, 11137, 10.1007\u002Fs13277-014-2412-0",{"doi":3597},"10.1007\u002Fs13277-014-2412-0",{"id":19,"text":3599,"url":19,"identifiers":3600},"Olson, 2010, Regulation of PI3-kinase\u002FAkt signaling by muscle-enriched microRNA-486, Proc Natl Acad Sci U S A, 107, 4218, 10.1073\u002Fpnas.1000300107",{"doi":3601},"10.1073\u002Fpnas.1000300107",{"id":19,"text":3603,"url":19,"identifiers":3604},"Hu, 2012, Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486, Kidney Int, 82, 401, 10.1038\u002Fki.2012.84",{"doi":3605},"10.1038\u002Fki.2012.84",{"id":19,"text":3607,"url":19,"identifiers":3608},"Ittmann, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science, 275, 1943, 10.1126\u002Fscience.275.5308.1943",{"doi":3609},"10.1126\u002Fscience.275.5308.1943",{"id":19,"text":3611,"url":19,"identifiers":3612},"Kobayashi, 2016, MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation, Biomarkers, 1",{},{"id":19,"text":3614,"url":19,"identifiers":3615},"Bhatia, 2015, MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors, Blood, 125, 1302, 10.1182\u002Fblood-2014-06-581926",{"doi":3616},"10.1182\u002Fblood-2014-06-581926",{"id":19,"text":3618,"url":19,"identifiers":3619},"Shen, 2010, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer, J Clin Oncol, 28, 1721, 10.1200\u002FJCO.2009.24.9342",{"doi":3620},"10.1200\u002FJCO.2009.24.9342",{"id":19,"text":3622,"url":19,"identifiers":3623},"Jiang, 2010, Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers, Int J Cancer, 127, 2870, 10.1002\u002Fijc.25289",{"doi":3624},"10.1002\u002Fijc.25289",{"id":19,"text":3626,"url":19,"identifiers":3627},"Cheng, 2008, MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN, Cancer Res, 68, 425, 10.1158\u002F0008-5472.CAN-07-2488",{"doi":3628},"10.1158\u002F0008-5472.CAN-07-2488",{"id":19,"text":3630,"url":19,"identifiers":3631},"Hui, 2012, MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma, PLoS One, 7, e44206, 10.1371\u002Fjournal.pone.0044206",{"doi":3632},"10.1371\u002Fjournal.pone.0044206",{"id":19,"text":3634,"url":19,"identifiers":3635},"Shi, 2015, miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome, Reprod Biomed Online, 31, 565, 10.1016\u002Fj.rbmo.2015.06.023",{"doi":3636},"10.1016\u002Fj.rbmo.2015.06.023",{"id":19,"text":3638,"url":19,"identifiers":3639},"Esmaeli, 2015, Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs, JAMA Ophthalmol, 133, 1109, 10.1001\u002Fjamaophthalmol.2015.2310",{"doi":3640},"10.1001\u002Fjamaophthalmol.2015.2310",{"id":19,"text":3642,"url":19,"identifiers":3643},"Dong, 2013, Deletion of hepatic FoxO1\u002F3\u002F4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis, PLoS One, 8, e74340, 10.1371\u002Fjournal.pone.0074340",{"doi":3644},"10.1371\u002Fjournal.pone.0074340",{"id":19,"text":3646,"url":19,"identifiers":3647},"Burgering, 2015, FOXO target gene CTDSP2 regulates cell cycle progression through Ras and p21(Cip1\u002FWaf1), Biochem J, 469, 289, 10.1042\u002FBJ20140831",{"doi":3648},"10.1042\u002FBJ20140831",{"id":19,"text":3650,"url":19,"identifiers":3651},"Lees, 2008, FoxO3a preferentially induces p27Kip1 expression while impairing muscle precursor cell-cycle progression, Muscle nerve, 37, 84, 10.1002\u002Fmus.20897",{"doi":3652},"10.1002\u002Fmus.20897",{"id":19,"text":3654,"url":19,"identifiers":3655},"Sikes, 2012, Increased TGF-beta1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2\u002F3 signaling, Prostate, 72, 1339, 10.1002\u002Fpros.22482",{"doi":3656},"10.1002\u002Fpros.22482",{"id":19,"text":3658,"url":19,"identifiers":3659},"Danielpour, 2009, Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells, Cancer Res, 69, 2185, 10.1158\u002F0008-5472.CAN-08-3961",{"doi":3660},"10.1158\u002F0008-5472.CAN-08-3961",{"id":19,"text":3662,"url":19,"identifiers":3663},"Semenza, 2014, Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology, Annu Rev Pathol, 9, 47, 10.1146\u002Fannurev-pathol-012513-104720",{"doi":3664},"10.1146\u002Fannurev-pathol-012513-104720",{"id":19,"text":3666,"url":19,"identifiers":3667},"Ratcliffe, 1999, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature, 399, 271, 10.1038\u002F20459",{"doi":3668},"10.1038\u002F20459",{"id":19,"text":3670,"url":19,"identifiers":3671},"Patel, 2015, HIF1alpha expression under normoxia in prostate cancer--which pathways to target?, J Urol, 193, 763, 10.1016\u002Fj.juro.2014.10.085",{"doi":3672},"10.1016\u002Fj.juro.2014.10.085",{"id":19,"text":3674,"url":19,"identifiers":3675},"Le QT Giaccia, 2009, Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation, Mol Cell, 35, 856, 10.1016\u002Fj.molcel.2009.09.006",{"doi":3676},"10.1016\u002Fj.molcel.2009.09.006",{"id":19,"text":3678,"url":19,"identifiers":3679},"Ragoussis, 2008, hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer, Clin Cancer Res, 14, 1340, 10.1158\u002F1078-0432.CCR-07-1755",{"doi":3680},"10.1158\u002F1078-0432.CCR-07-1755",{"id":19,"text":3682,"url":19,"identifiers":3683},"Ricci, 2011, miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity, Cell Death Differ, 18, 465, 10.1038\u002Fcdd.2010.119",{"doi":3684},"10.1038\u002Fcdd.2010.119",{"id":19,"text":3686,"url":19,"identifiers":3687},"Meng, 2014, Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis, Int J Oncol, 44, 2111, 10.3892\u002Fijo.2014.2368",{"doi":3688},"10.3892\u002Fijo.2014.2368",{"id":19,"text":3690,"url":19,"identifiers":3691},"Di, 2015, MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1alpha\u002FVEGF pathway, Int J Clin Exp Pathol, 8, 4735",{},{"id":19,"text":3693,"url":19,"identifiers":3694},"Kuo, 2010, MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis, Cancer Res, 70, 2675, 10.1158\u002F0008-5472.CAN-09-2448",{"doi":3695},"10.1158\u002F0008-5472.CAN-09-2448",{"id":19,"text":3697,"url":19,"identifiers":3698},"Russo, 2010, miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells, J Cell Physiol, 4, 242",{},{"id":19,"text":3700,"url":19,"identifiers":3701},"Takahashi, 2008, Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster, Cancer Res, 68, 5540, 10.1158\u002F0008-5472.CAN-07-6460",{"doi":3702},"10.1158\u002F0008-5472.CAN-07-6460",{"id":19,"text":3704,"url":19,"identifiers":3705},"Huang, 2012, TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer, J Biol Chem, 287, 2798, 10.1074\u002Fjbc.M111.258947",{"doi":3706},"10.1074\u002Fjbc.M111.258947",{"id":3708,"createTime":3709,"updateTime":3709,"relativeEntities":3710,"slug":3711,"properties":3712,"entityType":87,"verifyStatus":88,"verifyTime":3727,"verifyNote":89,"syncStatus":18,"languages":3728,"translateLanguages":19,"viewCount":20,"primaryUrl":3729,"fullTextUrl":19,"authors":3730,"publicationType":442,"publisherRelationship":3924,"citationCount":2967,"citationInfo":3947,"publishDate":3949,"publishYear":856,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":3950,"isForceReanalyzing":585},"10d75737-0165-4cb9-8744-5ae25b334c42","2024-09-17T23:57:07.258+00:00",[],"Estrogen-receptor-mediated-miR-486-5p-regulation-of-OLFM4-expression-in-ovarian-cancer",{"mag":3713,"keywords":3715,"pmc":3716,"openalex":3718,"abstract":3720,"title":3721,"pm":3723,"doi":3725},{"VOID":3714},"2291233398",{},{"VOID":3717},"4891143",{"VOID":3719},"W2291233398",{},{"EN":3722},"Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer",{"VOID":3724},"26871282",{"VOID":3726},"10.18632\u002Foncotarget.7236","2024-09-17T23:57:07.257+00:00",[91],"https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.7236",[3731,3750,3767,3788,3805,3822,3839,3854,3871,3892,3909],{"id":3732,"sortIndex":350,"researcher":19,"roles":3733,"affiliations":3734,"properties":3745},"cb017623-cec7-4f86-9483-191db4f61f05",[],[3735],{"id":3736,"sortIndex":20,"affiliation":3737,"properties":19},"7d04f527-adf4-4475-b499-7d0efb91caf5",{"id":3738,"createTime":3739,"updateTime":3739,"relativeEntities":3740,"slug":3741,"properties":3742,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"3500ab7b-6c98-4e4e-9276-2f1680483541","2024-09-17T23:57:07.372+00:00",[],"Department-of-Gynecology-and-Obstetrics-The-First-Affiliated-Hospital-Sun-Yat-sen-Zhongshan-University-Guangzhou-China",{"title":3743},{"EN":3744},"Department of Gynecology and Obstetrics, The First Affiliated Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China",{"openalex":3746,"title":3748},{"VOID":3747},"A5104198681",{"EN":3749},"Hongwei Shen",{"id":3751,"sortIndex":249,"researcher":19,"roles":3752,"affiliations":3753,"properties":3760},"0dcbf05d-64af-4047-a942-bdda3acc7b07",[],[3754],{"id":3755,"sortIndex":20,"affiliation":3756,"properties":19},"30035fcc-5539-4d15-a0ff-8448cb772fa7",{"id":3738,"createTime":3739,"updateTime":3739,"relativeEntities":3757,"slug":3741,"properties":3758,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3759},{"EN":3744},{"openalex":3761,"orcid":3763,"title":3765},{"VOID":3762},"A5101418005",{"VOID":3764},"https:\u002F\u002Forcid.org\u002F0000-0002-4996-4842",{"EN":3766},"Meng Xia",{"id":3768,"sortIndex":422,"researcher":19,"roles":3769,"affiliations":3770,"properties":3781},"7e555c38-75dc-42e1-b2f7-1456536fd14f",[],[3771],{"id":3772,"sortIndex":20,"affiliation":3773,"properties":19},"29cfad6a-229d-4b16-8dc8-465fbc19d29e",{"id":3774,"createTime":3775,"updateTime":3775,"relativeEntities":3776,"slug":3777,"properties":3778,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"e6992a22-141e-469a-9135-9e7c1b185475","2024-09-17T23:57:07.280+00:00",[],"Department-of-Pathology-The-First-Affiliated-Hospital-Sun-Yat-sen-Zhongshan-University-Guangzhou-China",{"title":3779},{"EN":3780},"Department of Pathology, The First Affiliated Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China",{"openalex":3782,"orcid":3784,"title":3786},{"VOID":3783},"A5018894950",{"VOID":3785},"https:\u002F\u002Forcid.org\u002F0000-0002-4268-6878",{"EN":3787},"Xubin Liu",{"id":3789,"sortIndex":267,"researcher":19,"roles":3790,"affiliations":3791,"properties":3798},"4d12ecec-dda8-4c3c-b643-d48748e4444e",[],[3792],{"id":3793,"sortIndex":20,"affiliation":3794,"properties":19},"e22e6e7d-2ffd-4086-aa37-daa16a91b71c",{"id":3774,"createTime":3775,"updateTime":3775,"relativeEntities":3795,"slug":3777,"properties":3796,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3797},{"EN":3780},{"openalex":3799,"orcid":3801,"title":3803},{"VOID":3800},"A5100784528",{"VOID":3802},"https:\u002F\u002Forcid.org\u002F0000-0001-8513-1883",{"EN":3804},"Li Yu",{"id":3806,"sortIndex":225,"researcher":19,"roles":3807,"affiliations":3808,"properties":3815},"2440b90b-e015-4708-ba39-2361c4ca2e47",[],[3809],{"id":3810,"sortIndex":20,"affiliation":3811,"properties":19},"bbae63dc-44f9-4898-8f95-db905b5e96f1",{"id":3774,"createTime":3775,"updateTime":3775,"relativeEntities":3812,"slug":3777,"properties":3813,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3814},{"EN":3780},{"openalex":3816,"orcid":3818,"title":3820},{"VOID":3817},"A5101679775",{"VOID":3819},"https:\u002F\u002Forcid.org\u002F0000-0001-6683-0697",{"EN":3821},"Shuang Liang",{"id":3823,"sortIndex":326,"researcher":19,"roles":3824,"affiliations":3825,"properties":3832},"365158f6-3c51-4f48-8de1-d662f3f7af19",[],[3826],{"id":3827,"sortIndex":20,"affiliation":3828,"properties":19},"94a2e804-161d-4690-af25-9900764913bb",{"id":3774,"createTime":3775,"updateTime":3775,"relativeEntities":3829,"slug":3777,"properties":3830,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3831},{"EN":3780},{"openalex":3833,"orcid":3835,"title":3837},{"VOID":3834},"A5102893539",{"VOID":3836},"https:\u002F\u002Forcid.org\u002F0000-0003-1524-8706",{"EN":3838},"Wenhui Zhang",{"id":3840,"sortIndex":201,"researcher":19,"roles":3841,"affiliations":3842,"properties":3849},"26370682-1b15-411c-970b-b559edfcee30",[],[3843],{"id":3844,"sortIndex":20,"affiliation":3845,"properties":19},"1e19f41a-ef95-4cf5-a3a2-f702cb776294",{"id":3774,"createTime":3775,"updateTime":3775,"relativeEntities":3846,"slug":3777,"properties":3847,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3848},{"EN":3780},{"openalex":3850,"title":3852},{"VOID":3851},"A5004216006",{"EN":3853},"Liantang Wang",{"id":3855,"sortIndex":96,"researcher":19,"roles":3856,"affiliations":3857,"properties":3864},"9ae9f85d-01ba-47f0-8afc-66a3475ec31a",[],[3858],{"id":3859,"sortIndex":20,"affiliation":3860,"properties":19},"8be6e797-c582-4aff-a502-694d9091c5b8",{"id":3738,"createTime":3739,"updateTime":3739,"relativeEntities":3861,"slug":3741,"properties":3862,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3863},{"EN":3744},{"openalex":3865,"orcid":3867,"title":3869},{"VOID":3866},"A5007862425",{"VOID":3868},"https:\u002F\u002Forcid.org\u002F0000-0001-9119-8478",{"EN":3870},"Xingyang Liu",{"id":3872,"sortIndex":285,"researcher":19,"roles":3873,"affiliations":3874,"properties":3885},"dfea2204-69e6-43c0-a7fd-905b825a5948",[],[3875],{"id":3876,"sortIndex":20,"affiliation":3877,"properties":19},"49b018e0-5800-4bf7-b8bf-1b0f154dd389",{"id":3878,"createTime":3879,"updateTime":3879,"relativeEntities":3880,"slug":3881,"properties":3882,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"763d204b-f33a-4b58-aa8a-1003596e947c","2024-09-17T23:57:19.596+00:00",[],"State-Key-Laboratory-for-Biocontrol-Guangdong-Key-Laboratory-of-Pharmaceutical-Functional-Genes-Department-of-Biochemistry-School-of-Life-Sciences-Sun-Yat-sen-Zhongshan-University-Guangzhou-China",{"title":3883},{"EN":3884},"State Key Laboratory for Biocontrol, Guangdong Key Laboratory of Pharmaceutical Functional Genes, Department of Biochemistry, School of Life Sciences, Sun Yat-sen (Zhongshan) University, Guangzhou, China",{"openalex":3886,"orcid":3888,"title":3890},{"VOID":3887},"A5044416428",{"VOID":3889},"https:\u002F\u002Forcid.org\u002F0000-0003-0732-377X",{"EN":3891},"Shangwu Chen",{"id":3893,"sortIndex":112,"researcher":19,"roles":3894,"affiliations":3895,"properties":3902},"8616fc83-64b4-44e0-9545-dfccf3278ac6",[],[3896],{"id":3897,"sortIndex":20,"affiliation":3898,"properties":19},"576973ba-2d0d-4501-bd76-0e17b8e4636f",{"id":3774,"createTime":3775,"updateTime":3775,"relativeEntities":3899,"slug":3777,"properties":3900,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3901},{"EN":3780},{"openalex":3903,"orcid":3905,"title":3907},{"VOID":3904},"A5100419116",{"VOID":3906},"https:\u002F\u002Forcid.org\u002F0000-0002-1372-7730",{"EN":3908},"Tian Tian",{"id":3910,"sortIndex":20,"researcher":19,"roles":3911,"affiliations":3912,"properties":3919},"7ac8fe66-6fdb-44fc-b02c-49579296279e",[],[3913],{"id":3914,"sortIndex":20,"affiliation":3915,"properties":19},"2854316d-c576-41c5-84a3-f34cff44203f",{"id":3774,"createTime":3775,"updateTime":3775,"relativeEntities":3916,"slug":3777,"properties":3917,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":3918},{"EN":3780},{"openalex":3920,"title":3922},{"VOID":3921},"A5003209377",{"EN":3923},"Hanyu Ma",{"url":19,"publisher":3925,"properties":3941},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":3926,"slug":10,"properties":3927,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":3931,"manageAffiliations":3932,"indexDatabases":3933,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":3928,"issn":3929,"title":3930},{"VOID":13},{"VOID":15},{"EN":10},[],[],[3934],{"id":44,"indexDatabase":3935,"url":57,"indexYears":58,"academicFieldIds":3940,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":3936,"label":3937,"description":3938,"key":54,"publicationTags":3939,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":3942,"pages":3943,"issue":3945},{"VOID":462},{"VOID":3944},"10594-10605",{"VOID":3946},"9",{"total":2967,"publishYear":19,"statisticByYear":3948},{"2016":112,"2017":422,"2018":350,"2019":225,"2020":201,"2021":96,"2022":422,"2023":112},"2016-03-01",[3951,3955,3959,3963,3966,3970,3974,3978,3982,3986,3990,3994,3998,4002,4006,4010,4014,4018,4022,4024,4026,4030,4033,4037,4041,4045,4049,4053,4057,4061,4065],{"id":19,"text":3952,"url":19,"identifiers":3953},"Hong, 2014, Circulating MicroRNAs in gynecological malignancies: from detection to prediction, Exp Hematol Oncol, 3, 14, 10.1186\u002F2162-3619-3-14",{"doi":3954},"10.1186\u002F2162-3619-3-14",{"id":19,"text":3956,"url":19,"identifiers":3957},"Shih Ie, 2004, Molecular genetic analysis of ovarian serous cystadenomas, Lab Invest, 84, 778, 10.1038\u002Flabinvest.3700103",{"doi":3958},"10.1038\u002Flabinvest.3700103",{"id":19,"text":3960,"url":19,"identifiers":3961},"Langdon, 2005, Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen, Endocr Relat Cancer, 12, 851, 10.1677\u002Ferc.1.01039",{"doi":3962},"10.1677\u002Ferc.1.01039",{"id":19,"text":3964,"url":19,"identifiers":3965},"Cajander, 2001, Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors, Int J Oncol, 19, 31",{},{"id":19,"text":3967,"url":19,"identifiers":3968},"Mylonas, 2010, Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary, Arch Gynecol Obstet, 281, 511, 10.1007\u002Fs00404-009-1185-y",{"doi":3969},"10.1007\u002Fs00404-009-1185-y",{"id":19,"text":3971,"url":19,"identifiers":3972},"Li, 2004, GW112, a novel antiapoptotic protein that promotes tumor growth, Cancer Res, 64, 2474, 10.1158\u002F0008-5472.CAN-03-3443",{"doi":3973},"10.1158\u002F0008-5472.CAN-03-3443",{"id":19,"text":3975,"url":19,"identifiers":3976},"Rodgers, 2002, Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development, Gene, 283, 83, 10.1016\u002FS0378-1119(01)00763-6",{"doi":3977},"10.1016\u002FS0378-1119(01)00763-6",{"id":19,"text":3979,"url":19,"identifiers":3980},"Tenen, 2004, pDP4, a novel glycoprotein secreted by mature granulocytes, is regulated by transcription factor PU. 1, Blood, 103, 4294, 10.1182\u002Fblood-2003-08-2688",{"doi":3981},"10.1182\u002Fblood-2003-08-2688",{"id":19,"text":3983,"url":19,"identifiers":3984},"Anholt, 2000, Characterization and differential expression of a human gene family of olfactomedin-related proteins, Genet Res, 76, 41, 10.1017\u002FS0016672300004584",{"doi":3985},"10.1017\u002FS0016672300004584",{"id":19,"text":3987,"url":19,"identifiers":3988},"Chen, 2011, Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers, Neoplasma, 58, 9, 10.4149\u002Fneo_2011_01_9",{"doi":3989},"10.4149\u002Fneo_2011_01_9",{"id":19,"text":3991,"url":19,"identifiers":3992},"Rodgers, 2007, Expression of hGC-1 is correlated with differentiation of gastric carcinoma, Histopathology, 51, 157, 10.1111\u002Fj.1365-2559.2007.02763.x",{"doi":3993},"10.1111\u002Fj.1365-2559.2007.02763.x",{"id":19,"text":3995,"url":19,"identifiers":3996},"Watanabe, 2007, Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells, Cancer Sci, 98, 334, 10.1111\u002Fj.1349-7006.2007.00397.x",{"doi":3997},"10.1111\u002Fj.1349-7006.2007.00397.x",{"id":19,"text":3999,"url":19,"identifiers":4000},"Watanabe, 2007, Specific overexpression of OLFM4(GW112\u002FHGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis, Cancer Sci, 98, 315, 10.1111\u002Fj.1349-7006.2006.00383.x",{"doi":4001},"10.1111\u002Fj.1349-7006.2006.00383.x",{"id":19,"text":4003,"url":19,"identifiers":4004},"Wang, 2011, OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer, J Cancer Res Clin Oncol, 137, 1713, 10.1007\u002Fs00432-011-1042-9",{"doi":4005},"10.1007\u002Fs00432-011-1042-9",{"id":19,"text":4007,"url":19,"identifiers":4008},"Rodgers, 2008, Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma, Clin Cancer Res, 14, 1041, 10.1158\u002F1078-0432.CCR-07-4125",{"doi":4009},"10.1158\u002F1078-0432.CCR-07-4125",{"id":19,"text":4011,"url":19,"identifiers":4012},"Rodgers, 2011, Olfactomedin 4 suppresses prostate cancer cell growth and metastasisnegative interaction with cathepsin D and SDF-1, Carcinogenesis, 32, 986, 10.1093\u002Fcarcin\u002Fbgr065",{"doi":4013},"10.1093\u002Fcarcin\u002Fbgr065",{"id":19,"text":4015,"url":19,"identifiers":4016},"Chen, 2011, Olfactomedin 4 is a marker for progression of cervical neoplasia, Int J Gynecol Cancer, 21, 367, 10.1097\u002FIGC.0b013e31820866fe",{"doi":4017},"10.1097\u002FIGC.0b013e31820866fe",{"id":19,"text":4019,"url":19,"identifiers":4020},"Yu, 2014, Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma, J Cell Mol Med, 18, 863, 10.1111\u002Fjcmm.12232",{"doi":4021},"10.1111\u002Fjcmm.12232",{"id":19,"text":3599,"url":19,"identifiers":4023},{"doi":3601},{"id":19,"text":3587,"url":19,"identifiers":4025},{"doi":3589},{"id":19,"text":4027,"url":19,"identifiers":4028},"Haier, 2009, Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas, Ann Surg Oncol, 16, 2339, 10.1245\u002Fs10434-009-0531-4",{"doi":4029},"10.1245\u002Fs10434-009-0531-4",{"id":19,"text":4031,"url":19,"identifiers":4032},"Litman, 2014, Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status, Cell Oncol (Dordr), 37, 215",{},{"id":19,"text":4034,"url":19,"identifiers":4035},"Jiang, 2014, Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer, Oncogene, 33, 1181, 10.1038\u002Fonc.2013.42",{"doi":4036},"10.1038\u002Fonc.2013.42",{"id":19,"text":4038,"url":19,"identifiers":4039},"Wang, 2015, MiR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON, Hepatol Res, 45, 1312, 10.1111\u002Fhepr.12500",{"doi":4040},"10.1111\u002Fhepr.12500",{"id":19,"text":4042,"url":19,"identifiers":4043},"Li, 2013, miR-486 sustains NF-kappaB activity by disrupting multiple NF-kappaB-negative feedback loops, Cell Res, 23, 274, 10.1038\u002Fcr.2012.174",{"doi":4044},"10.1038\u002Fcr.2012.174",{"id":19,"text":4046,"url":19,"identifiers":4047},"Xing, 2014, Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer, Mol Cancer, 13, 240, 10.1186\u002F1476-4598-13-240",{"doi":4048},"10.1186\u002F1476-4598-13-240",{"id":19,"text":4050,"url":19,"identifiers":4051},"Kuroda, 2012, TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma, Biochem Biophys Res Commun, 427, 355, 10.1016\u002Fj.bbrc.2012.09.063",{"doi":4052},"10.1016\u002Fj.bbrc.2012.09.063",{"id":19,"text":4054,"url":19,"identifiers":4055},"Ding, 2014, Estrogen combined with progesterone decreases cell proliferation and inhibits the expression of Bcl-2microRNA let-7a and miR-34b in ovarian cancer cells, Clin Transl Oncol, 16, 898, 10.1007\u002Fs12094-014-1166-x",{"doi":4056},"10.1007\u002Fs12094-014-1166-x",{"id":19,"text":4058,"url":19,"identifiers":4059},"Liu, 2014, microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor alpha-positive ovarian cancer cells, Mol Med Rep, 9, 1703, 10.3892\u002Fmmr.2014.2021",{"doi":4060},"10.3892\u002Fmmr.2014.2021",{"id":19,"text":4062,"url":19,"identifiers":4063},"Hua, 2014, Estrogen stimulates the invasion of ovarian cancer cellsactivation of the PI3K\u002FAKT pathway and regulation of its downstream targets Ecadherin and alphaactinin4, Mol Med Rep, 10, 2433, 10.3892\u002Fmmr.2014.2561",{"doi":4064},"10.3892\u002Fmmr.2014.2561",{"id":19,"text":4066,"url":19,"identifiers":4067},"Romano, 2010, Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling, Am J Pathol, 177, 2495, 10.2353\u002Fajpath.2010.100026",{"doi":4068},"10.2353\u002Fajpath.2010.100026",{"id":4070,"createTime":4071,"updateTime":4071,"relativeEntities":4072,"slug":4073,"properties":4074,"entityType":87,"verifyStatus":88,"verifyTime":4089,"verifyNote":89,"syncStatus":18,"languages":4090,"translateLanguages":19,"viewCount":20,"primaryUrl":4091,"fullTextUrl":19,"authors":4092,"publicationType":442,"publisherRelationship":4295,"citationCount":4318,"citationInfo":4319,"publishDate":4321,"publishYear":4322,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":4323,"isForceReanalyzing":585},"648dbbaf-5472-4378-8242-6491dc286b4d","2024-09-17T23:57:00.974+00:00",[],"MiR-486-as-an-effective-biomarker-in-cancer-diagnosis-and-prognosis-a-systematic-review-and-meta-analysis",{"mag":4075,"keywords":4077,"pmc":4078,"openalex":4080,"abstract":4082,"title":4083,"pm":4085,"doi":4087},{"VOID":4076},"2784118598",{},{"VOID":4079},"5862628",{"VOID":4081},"W2784118598",{},{"EN":4084},"MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis",{"VOID":4086},"29568407",{"VOID":4088},"10.18632\u002Foncotarget.24189","2024-09-17T23:57:00.973+00:00",[91],"https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.24189",[4093,4123,4157,4180,4203,4226,4249,4272],{"id":4094,"sortIndex":96,"researcher":19,"roles":4095,"affiliations":4096,"properties":4118},"fc6aa300-3d8c-41df-961f-73a3b15354e4",[],[4097,4107],{"id":4098,"sortIndex":112,"affiliation":4099,"properties":19},"8a4d4f3c-32ed-4a6c-b70b-9f2c973c7223",{"id":4100,"createTime":4101,"updateTime":4101,"relativeEntities":4102,"slug":4103,"properties":4104,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"986d9934-3502-4ba8-81f8-025fad5fb67e","2024-09-17T23:57:01.031+00:00",[],"Key-Laboratory-of-Cancer-Etiology-and-Prevention-China-Medical-University-Liaoning-Province-Department-of-Education-Shenyang-China",{"title":4105},{"EN":4106},"Key Laboratory of Cancer Etiology and Prevention (China Medical University), Liaoning Province Department of Education, Shenyang, China",{"id":4108,"sortIndex":20,"affiliation":4109,"properties":19},"a0a5d506-8821-4d85-83fd-d515b9bee70a",{"id":4110,"createTime":4111,"updateTime":4112,"relativeEntities":4113,"slug":4114,"properties":4115,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"296f832d-1f31-40c5-8d71-106ef8bd5819","2024-01-11T12:47:01.373+00:00","2025-01-28T01:55:54.080+00:00",[],"Department-of-Epidemiology-School-of-Public-Health-China-Medical-University-Shenyang-China",{"title":4116},{"VI":4117},"Department of Epidemiology, School of Public Health, China Medical University, Shenyang, China",{"openalex":4119,"title":4121},{"VOID":4120},"A5033139625",{"EN":4122},"Ruoyi Qu",{"id":4124,"sortIndex":326,"researcher":19,"roles":4125,"affiliations":4126,"properties":4150},"a89266fd-b8a2-494a-b91a-e6d692670067",[],[4127,4133,4139],{"id":4128,"sortIndex":112,"affiliation":4129,"properties":19},"f8a6f96e-7202-46f3-9ca1-d4c58c64191e",{"id":4110,"createTime":4111,"updateTime":4112,"relativeEntities":4130,"slug":4114,"properties":4131,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4132},{"VI":4117},{"id":4134,"sortIndex":225,"affiliation":4135,"properties":19},"15233c74-113f-4e64-a23e-68788d569193",{"id":4100,"createTime":4101,"updateTime":4101,"relativeEntities":4136,"slug":4103,"properties":4137,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4138},{"EN":4106},{"id":4140,"sortIndex":20,"affiliation":4141,"properties":19},"db9bfec0-636c-4df4-87bc-0224bbe0a56d",{"id":4142,"createTime":4143,"updateTime":4144,"relativeEntities":4145,"slug":4146,"properties":4147,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"1190a22a-8881-4ce7-9a36-0b4ab6d46850","2024-01-17T02:40:52.008+00:00","2024-09-17T23:57:01.194+00:00",[],"Department-of-Clinical-Epidemiology-First-Affiliated-Hospital-China-Medical-University-Shenyang-China",{"title":4148},{"VI":4149},"Department of Clinical Epidemiology, First Affiliated Hospital, China Medical University, Shenyang, China",{"openalex":4151,"orcid":4153,"title":4155},{"VOID":4152},"A5018503562",{"VOID":4154},"https:\u002F\u002Forcid.org\u002F0000-0002-5311-3880",{"EN":4156},"Baosen Zhou",{"id":4158,"sortIndex":350,"researcher":19,"roles":4159,"affiliations":4160,"properties":4173},"781695f0-d8e8-4fbc-a1e8-e347ffc2da75",[],[4161,4167],{"id":4162,"sortIndex":20,"affiliation":4163,"properties":19},"03fd1376-5fc3-48aa-8446-ff1fd338cc1f",{"id":4110,"createTime":4111,"updateTime":4112,"relativeEntities":4164,"slug":4114,"properties":4165,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4166},{"VI":4117},{"id":4168,"sortIndex":112,"affiliation":4169,"properties":19},"7551400b-7ea5-430c-b2c0-560740757116",{"id":4100,"createTime":4101,"updateTime":4101,"relativeEntities":4170,"slug":4103,"properties":4171,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4172},{"EN":4106},{"openalex":4174,"orcid":4176,"title":4178},{"VOID":4175},"A5033171575",{"VOID":4177},"https:\u002F\u002Forcid.org\u002F0000-0002-3147-0289",{"EN":4179},"Chang Zheng",{"id":4181,"sortIndex":225,"researcher":19,"roles":4182,"affiliations":4183,"properties":4196},"b30462d2-750c-4be6-9cd6-ef8f8933d8ef",[],[4184,4190],{"id":4185,"sortIndex":20,"affiliation":4186,"properties":19},"aa00e11f-6d2a-4003-b8f2-e59d49dce186",{"id":4110,"createTime":4111,"updateTime":4112,"relativeEntities":4187,"slug":4114,"properties":4188,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4189},{"VI":4117},{"id":4191,"sortIndex":112,"affiliation":4192,"properties":19},"0ea60ec3-26a9-477b-a438-4e43f15e92d3",{"id":4100,"createTime":4101,"updateTime":4101,"relativeEntities":4193,"slug":4103,"properties":4194,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4195},{"EN":4106},{"openalex":4197,"orcid":4199,"title":4201},{"VOID":4198},"A5062458494",{"VOID":4200},"https:\u002F\u002Forcid.org\u002F0000-0002-9981-544X",{"EN":4202},"Xiaowei Quan",{"id":4204,"sortIndex":20,"researcher":19,"roles":4205,"affiliations":4206,"properties":4219},"39c57522-2c1d-47a2-b753-acfe8a65357c",[],[4207,4213],{"id":4208,"sortIndex":112,"affiliation":4209,"properties":19},"49fd9925-6e79-4d99-8fb1-2c5e87341de9",{"id":4100,"createTime":4101,"updateTime":4101,"relativeEntities":4210,"slug":4103,"properties":4211,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4212},{"EN":4106},{"id":4214,"sortIndex":20,"affiliation":4215,"properties":19},"9f06031e-5a5e-407f-9b6d-4b7cc9ae98c2",{"id":4110,"createTime":4111,"updateTime":4112,"relativeEntities":4216,"slug":4114,"properties":4217,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4218},{"VI":4117},{"openalex":4220,"orcid":4222,"title":4224},{"VOID":4221},"A5057284676",{"VOID":4223},"https:\u002F\u002Forcid.org\u002F0000-0001-5870-5634",{"EN":4225},"Min Jiang",{"id":4227,"sortIndex":422,"researcher":19,"roles":4228,"affiliations":4229,"properties":4242},"25290bca-83bf-4a54-9b10-f928c7486533",[],[4230,4236],{"id":4231,"sortIndex":20,"affiliation":4232,"properties":19},"f692f99c-878a-4f10-bb61-0f6b1f1061ee",{"id":4110,"createTime":4111,"updateTime":4112,"relativeEntities":4233,"slug":4114,"properties":4234,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4235},{"VI":4117},{"id":4237,"sortIndex":112,"affiliation":4238,"properties":19},"69188a0e-2f43-456f-ba30-349deb65bdce",{"id":4100,"createTime":4101,"updateTime":4101,"relativeEntities":4239,"slug":4103,"properties":4240,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4241},{"EN":4106},{"openalex":4243,"orcid":4245,"title":4247},{"VOID":4244},"A5001722333",{"VOID":4246},"https:\u002F\u002Forcid.org\u002F0000-0002-5299-0427",{"EN":4248},"Xianglin Yang",{"id":4250,"sortIndex":112,"researcher":19,"roles":4251,"affiliations":4252,"properties":4265},"760fa803-d077-44a9-9b92-2e50a154e5ff",[],[4253,4259],{"id":4254,"sortIndex":20,"affiliation":4255,"properties":19},"7a74546a-4445-4169-96cf-263625a4081b",{"id":4110,"createTime":4111,"updateTime":4112,"relativeEntities":4256,"slug":4114,"properties":4257,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4258},{"VI":4117},{"id":4260,"sortIndex":112,"affiliation":4261,"properties":19},"bb51ce0e-c4a9-4179-a8f9-de227887b861",{"id":4100,"createTime":4101,"updateTime":4101,"relativeEntities":4262,"slug":4103,"properties":4263,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4264},{"EN":4106},{"openalex":4266,"orcid":4268,"title":4270},{"VOID":4267},"A5088941650",{"VOID":4269},"https:\u002F\u002Forcid.org\u002F0000-0001-9043-8580",{"EN":4271},"Xuelian Li",{"id":4273,"sortIndex":249,"researcher":19,"roles":4274,"affiliations":4275,"properties":4288},"5030cd07-d716-4ad0-805f-9417fc4021d5",[],[4276,4282],{"id":4277,"sortIndex":112,"affiliation":4278,"properties":19},"53975792-0350-4ac4-86b7-31b44f7b3d99",{"id":4100,"createTime":4101,"updateTime":4101,"relativeEntities":4279,"slug":4103,"properties":4280,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4281},{"EN":4106},{"id":4283,"sortIndex":20,"affiliation":4284,"properties":19},"d5037466-6e61-4a7f-8548-13733cea706f",{"id":4110,"createTime":4111,"updateTime":4112,"relativeEntities":4285,"slug":4114,"properties":4286,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4287},{"VI":4117},{"openalex":4289,"orcid":4291,"title":4293},{"VOID":4290},"A5100683660",{"VOID":4292},"https:\u002F\u002Forcid.org\u002F0000-0002-4752-8393",{"EN":4294},"Hao Xia",{"url":19,"publisher":4296,"properties":4312},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":4297,"slug":10,"properties":4298,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":4302,"manageAffiliations":4303,"indexDatabases":4304,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":4299,"issn":4300,"title":4301},{"VOID":13},{"VOID":15},{"EN":10},[],[],[4305],{"id":44,"indexDatabase":4306,"url":57,"indexYears":58,"academicFieldIds":4311,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":4307,"label":4308,"description":4309,"key":54,"publicationTags":4310,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":4313,"pages":4314,"issue":4316},{"VOID":3946},{"VOID":4315},"13948-13958",{"VOID":4317},"17",31,{"total":4318,"publishYear":19,"statisticByYear":4320},{"2019":249,"2020":422,"2021":285,"2022":249,"2023":249,"2024":422},"2018-03-02",2018,[4324,4328,4332,4336,4340,4343,4346,4350,4354,4356,4360,4364,4366,4368,4372,4376,4379,4383,4387,4391,4395,4399,4403,4406,4410,4414,4417,4419,4423,4427,4429,4433,4437,4441,4445,4448,4452,4456,4460],{"id":19,"text":4325,"url":19,"identifiers":4326},"Tuschl, 2001, Identification of novel genes coding for small expressed RNAs, Science, 294, 853, 10.1126\u002Fscience.1064921",{"doi":4327},"10.1126\u002Fscience.1064921",{"id":19,"text":4329,"url":19,"identifiers":4330},"Croce, 2011, Non-coding RNAs in cancer initiation and progression and as novel biomarkers, Mol Oncol, 5, 483, 10.1016\u002Fj.molonc.2011.10.003",{"doi":4331},"10.1016\u002Fj.molonc.2011.10.003",{"id":19,"text":4333,"url":19,"identifiers":4334},"Croce, 2006, MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 857, 10.1038\u002Fnrc1997",{"doi":4335},"10.1038\u002Fnrc1997",{"id":19,"text":4337,"url":19,"identifiers":4338},"Luo, 2015, MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1, FEBS J, 282, 579, 10.1111\u002Ffebs.13167",{"doi":4339},"10.1111\u002Ffebs.13167",{"id":19,"text":4341,"url":19,"identifiers":4342},"Wang, 2015, miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON, Hepatol Res, 45, 1312, 10.1111\u002Fhepr.12500",{"doi":4040},{"id":19,"text":4344,"url":19,"identifiers":4345},"Donahue, 2014, Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer, Oncogene, 33, 1181, 10.1038\u002Fonc.2013.42",{"doi":4036},{"id":19,"text":4347,"url":19,"identifiers":4348},"Litman, 2014, Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status, Cell Oncol (Dordr), 37, 215, 10.1007\u002Fs13402-014-0176-6",{"doi":4349},"10.1007\u002Fs13402-014-0176-6",{"id":19,"text":4351,"url":19,"identifiers":4352},"Lin, 2016, Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma, Exp Ther Med, 12, 3411, 10.3892\u002Fetm.2016.3783",{"doi":4353},"10.3892\u002Fetm.2016.3783",{"id":19,"text":4027,"url":19,"identifiers":4355},{"doi":4029},{"id":19,"text":4357,"url":19,"identifiers":4358},"Philip, 2012, MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer, Br J Cancer, 107, 1354, 10.1038\u002Fbjc.2012.383",{"doi":4359},"10.1038\u002Fbjc.2012.383",{"id":19,"text":4361,"url":19,"identifiers":4362},"Myklebost, 2012, Modulation of the osteosarcoma expression phenotype by microRNAs, PLoS One, 7, e48086, 10.1371\u002Fjournal.pone.0048086",{"doi":4363},"10.1371\u002Fjournal.pone.0048086",{"id":19,"text":3614,"url":19,"identifiers":4365},{"doi":3616},{"id":19,"text":4042,"url":19,"identifiers":4367},{"doi":4044},{"id":19,"text":4369,"url":19,"identifiers":4370},"Yousef, 2016, Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma, Eur Urol Focus, 2, 210, 10.1016\u002Fj.euf.2015.11.006",{"doi":4371},"10.1016\u002Fj.euf.2015.11.006",{"id":19,"text":4373,"url":19,"identifiers":4374},"Zhao, 2016, Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study, Oncotarget, 7, 41575, 10.18632\u002Foncotarget.9491",{"doi":4375},"10.18632\u002Foncotarget.9491",{"id":19,"text":4377,"url":19,"identifiers":4378},"Jiang, 2015, The expression and Clinical significance of plasma miR-486 and miR-499 in lung cancer",{},{"id":19,"text":4380,"url":19,"identifiers":4381},"Yang, 2011, Circulating miRNA signature for early diagnosis of lung cancer, EMBO Mol Med, 3, 436, 10.1002\u002Femmm.201100155",{"doi":4382},"10.1002\u002Femmm.201100155",{"id":19,"text":4384,"url":19,"identifiers":4385},"Mutti, 2013, Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer, Biomarkers, 18, 679, 10.3109\u002F1354750X.2013.845610",{"doi":4386},"10.3109\u002F1354750X.2013.845610",{"id":19,"text":4388,"url":19,"identifiers":4389},"Jiang, 2011, Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers, BMC Cancer, 11, 374, 10.1186\u002F1471-2407-11-374",{"doi":4390},"10.1186\u002F1471-2407-11-374",{"id":19,"text":4392,"url":19,"identifiers":4393},"Katz, 2011, Plasma microRNAs as potential biomarkers for non-small-cell lung cancer, Lab Invest, 91, 579, 10.1038\u002Flabinvest.2010.194",{"doi":4394},"10.1038\u002Flabinvest.2010.194",{"id":19,"text":4396,"url":19,"identifiers":4397},"Siwicki, 2017, Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection, Cell Oncol (Dordr), 40, 529, 10.1007\u002Fs13402-017-0334-8",{"doi":4398},"10.1007\u002Fs13402-017-0334-8",{"id":19,"text":4400,"url":19,"identifiers":4401},"Takahashi, 2016, Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma, Sci Rep, 6, 31389, 10.1038\u002Fsrep31389",{"doi":4402},"10.1038\u002Fsrep31389",{"id":19,"text":4404,"url":19,"identifiers":4405},"Ju, 2016, Expression of miR-486 in serum of patients with gastric cancer and its significance, Acta Academiae Medicinae Nanjing, 36, 524",{},{"id":19,"text":4407,"url":19,"identifiers":4408},"Feng, 2016, Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study, J Thorac Dis, 8, 1645, 10.21037\u002Fjtd.2016.06.21",{"doi":4409},"10.21037\u002Fjtd.2016.06.21",{"id":19,"text":4411,"url":19,"identifiers":4412},"Zhao, 2016, Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study, Ann Surg, 263, 1173, 10.1097\u002FSLA.0000000000001345",{"doi":4413},"10.1097\u002FSLA.0000000000001345",{"id":19,"text":4415,"url":19,"identifiers":4416},"Zang, 2016, The expression and clinical significance of plasma miR-486 and miR-499 in patients with lung cancer, Tianjin Yi Yao, 44, 1367",{},{"id":19,"text":3622,"url":19,"identifiers":4418},{"doi":3624},{"id":19,"text":4420,"url":19,"identifiers":4421},"Jin, 2014, A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer, Br J Cancer, 110, 2291, 10.1038\u002Fbjc.2014.119",{"doi":4422},"10.1038\u002Fbjc.2014.119",{"id":19,"text":4424,"url":19,"identifiers":4425},"Wu, 2016, A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles, Mol Med Rep, 13, 4643, 10.3892\u002Fmmr.2016.5114",{"doi":4426},"10.3892\u002Fmmr.2016.5114",{"id":19,"text":3618,"url":19,"identifiers":4428},{"doi":3620},{"id":19,"text":4430,"url":19,"identifiers":4431},"Yuan, 2015, MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer, PLoS One, 10, e0134220, 10.1371\u002Fjournal.pone.0134220",{"doi":4432},"10.1371\u002Fjournal.pone.0134220",{"id":19,"text":4434,"url":19,"identifiers":4435},"Tommasi, 2016, miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome, Tumour Biol, 37, 5503, 10.1007\u002Fs13277-015-4391-1",{"doi":4436},"10.1007\u002Fs13277-015-4391-1",{"id":19,"text":4438,"url":19,"identifiers":4439},"Han, 2016, miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value, Oncotarget, 7, 15840, 10.18632\u002Foncotarget.7417",{"doi":4440},"10.18632\u002Foncotarget.7417",{"id":19,"text":4442,"url":19,"identifiers":4443},"Tian, 2016, miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1, Biomed Pharmacother, 80, 220, 10.1016\u002Fj.biopha.2016.03.020",{"doi":4444},"10.1016\u002Fj.biopha.2016.03.020",{"id":19,"text":4446,"url":19,"identifiers":4447},"Yu, 2016, Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer, Oncotarget, 7, 10594, 10.18632\u002Foncotarget.7236",{"doi":3726},{"id":19,"text":4449,"url":19,"identifiers":4450},"Bossuyt, 2011, QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies, Ann Intern Med, 155, 529, 10.7326\u002F0003-4819-155-8-201110180-00009",{"doi":4451},"10.7326\u002F0003-4819-155-8-201110180-00009",{"id":19,"text":4453,"url":19,"identifiers":4454},"Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol, 25, 603, 10.1007\u002Fs10654-010-9491-z",{"doi":4455},"10.1007\u002Fs10654-010-9491-z",{"id":19,"text":4457,"url":19,"identifiers":4458},"Altman, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136\u002Fbmj.327.7414.557",{"doi":4459},"10.1136\u002Fbmj.327.7414.557",{"id":19,"text":4461,"url":19,"identifiers":4462},"Irwig, 2005, The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed, J Clin Epidemiol, 58, 882, 10.1016\u002Fj.jclinepi.2005.01.016",{"doi":4463},"10.1016\u002Fj.jclinepi.2005.01.016",{"id":4465,"createTime":4466,"updateTime":4466,"relativeEntities":4467,"slug":4468,"properties":4469,"entityType":87,"verifyStatus":88,"verifyTime":4466,"verifyNote":89,"syncStatus":18,"languages":4484,"translateLanguages":19,"viewCount":20,"primaryUrl":4485,"fullTextUrl":19,"authors":4486,"publicationType":442,"publisherRelationship":4632,"citationCount":4654,"citationInfo":4655,"publishDate":1424,"publishYear":1425,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":4657,"isForceReanalyzing":585},"f1e48346-e1fb-4fac-ac53-e16e8698605e","2024-09-05T23:56:28.534+00:00",[],"Exogenously-delivered-heat-shock-protein-70-displaces-its-endogenous-analogue-and-sensitizes-cancer-cells-to-lymphocytes-mediated-cytotoxicity",{"mag":4470,"keywords":4472,"pmc":4473,"openalex":4475,"abstract":4477,"title":4478,"pm":4480,"doi":4482},{"VOID":4471},"1543431526",{},{"VOID":4474},"4102795",{"VOID":4476},"W1543431526",{},{"EN":4479},"Exogenously delivered heat shock protein 70 displaces its endogenous analogue and sensitizes cancer cells to lymphocytes-mediated cytotoxicity",{"VOID":4481},"24797019",{"VOID":4483},"10.18632\u002Foncotarget.1820",[91],"https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.1820",[4487,4509,4526,4543,4560,4577,4594,4615],{"id":4488,"sortIndex":20,"researcher":19,"roles":4489,"affiliations":4490,"properties":4502},"6c9990e4-7762-430e-bd00-3b1eed3f591a",[],[4491],{"id":4492,"sortIndex":20,"affiliation":4493,"properties":19},"393b3339-c029-4cd0-b6ae-f06f34d6035c",{"id":4494,"createTime":4495,"updateTime":4496,"relativeEntities":4497,"slug":4498,"properties":4499,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"18d531da-231e-48ea-a4ae-ab342bab418f","2023-12-07T23:39:37.975+00:00","2024-09-05T23:56:28.545+00:00",[],"Institute-of-Cytology-of-Russian-Academy-of-Sciences-St-Petersburg-Russia",{"title":4500},{"VI":4501},"Institute of Cytology of Russian Academy of Sciences, St. Petersburg, Russia",{"openalex":4503,"orcid":4505,"title":4507},{"VOID":4504},"A5002169373",{"VOID":4506},"https:\u002F\u002Forcid.org\u002F0000-0002-8539-2239",{"EN":4508},"Maxim Shevtsov",{"id":4510,"sortIndex":112,"researcher":19,"roles":4511,"affiliations":4512,"properties":4519},"efad6bb7-05e5-4be3-97e0-04e6a8ae7749",[],[4513],{"id":4514,"sortIndex":20,"affiliation":4515,"properties":19},"139b628e-a0a8-4d30-8109-8733dcfb8ea6",{"id":4494,"createTime":4495,"updateTime":4496,"relativeEntities":4516,"slug":4498,"properties":4517,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4518},{"VI":4501},{"openalex":4520,"orcid":4522,"title":4524},{"VOID":4521},"A5077284666",{"VOID":4523},"https:\u002F\u002Forcid.org\u002F0000-0002-4404-6903",{"EN":4525},"Elena Y. Komarova",{"id":4527,"sortIndex":350,"researcher":19,"roles":4528,"affiliations":4529,"properties":4536},"9335a84f-9bc9-45bc-a3cc-d03939038483",[],[4530],{"id":4531,"sortIndex":20,"affiliation":4532,"properties":19},"8e7f19f1-98ee-469c-9a94-f654653ea074",{"id":4494,"createTime":4495,"updateTime":4496,"relativeEntities":4533,"slug":4498,"properties":4534,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4535},{"VI":4501},{"openalex":4537,"orcid":4539,"title":4541},{"VOID":4538},"A5068500099",{"VOID":4540},"https:\u002F\u002Forcid.org\u002F0000-0002-2549-9149",{"EN":4542},"Nikolay Aksenov",{"id":4544,"sortIndex":249,"researcher":19,"roles":4545,"affiliations":4546,"properties":4553},"92e2aab8-1cda-4396-93c9-04ca75fb0e79",[],[4547],{"id":4548,"sortIndex":20,"affiliation":4549,"properties":19},"d27d4842-4359-4ca1-955a-adae17ea54f2",{"id":4494,"createTime":4495,"updateTime":4496,"relativeEntities":4550,"slug":4498,"properties":4551,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4552},{"VI":4501},{"openalex":4554,"orcid":4556,"title":4558},{"VOID":4555},"A5040837550",{"VOID":4557},"https:\u002F\u002Forcid.org\u002F0000-0002-8476-7449",{"EN":4559},"Sergey V. Abkin",{"id":4561,"sortIndex":326,"researcher":19,"roles":4562,"affiliations":4563,"properties":4570},"2b39e47e-d6bc-4f66-a178-95ad020a61ed",[],[4564],{"id":4565,"sortIndex":20,"affiliation":4566,"properties":19},"ee4f1fe4-40ef-446a-8227-22f67895d320",{"id":4494,"createTime":4495,"updateTime":4496,"relativeEntities":4567,"slug":4498,"properties":4568,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4569},{"VI":4501},{"openalex":4571,"orcid":4573,"title":4575},{"VOID":4572},"A5009729836",{"VOID":4574},"https:\u002F\u002Forcid.org\u002F0000-0002-8775-7713",{"EN":4576},"Irina V. Guzhova",{"id":4578,"sortIndex":225,"researcher":19,"roles":4579,"affiliations":4580,"properties":4587},"bc5b0346-3b87-436e-9512-4fc4f4b89c63",[],[4581],{"id":4582,"sortIndex":20,"affiliation":4583,"properties":19},"eb472767-c3bc-4a60-8fcf-4c6ccd0b806e",{"id":4494,"createTime":4495,"updateTime":4496,"relativeEntities":4584,"slug":4498,"properties":4585,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4586},{"VI":4501},{"openalex":4588,"orcid":4590,"title":4592},{"VOID":4589},"A5055736130",{"VOID":4591},"https:\u002F\u002Forcid.org\u002F0000-0003-3043-1197",{"EN":4593},"Darya A. Meshalkina",{"id":4595,"sortIndex":422,"researcher":19,"roles":4596,"affiliations":4597,"properties":4608},"e8409f8d-7393-44f7-8aa5-834ab9cd7fea",[],[4598],{"id":4599,"sortIndex":20,"affiliation":4600,"properties":19},"593b01e6-1e72-4214-a621-599f46169232",{"id":4601,"createTime":4602,"updateTime":4602,"relativeEntities":4603,"slug":4604,"properties":4605,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"fdc3f7f8-65fb-458f-ab1d-3c8cf3559735","2024-09-05T23:56:28.577+00:00",[],"Laboratory-of-Clinical-Immunology-EMERCOM-of-Russia-St-Petersburg-Russia",{"title":4606},{"EN":4607},"Laboratory of Clinical Immunology, EMERCOM of Russia, St.Petersburg, Russia",{"openalex":4609,"orcid":4611,"title":4613},{"VOID":4610},"A5087006576",{"VOID":4612},"https:\u002F\u002Forcid.org\u002F0000-0002-6907-2817",{"EN":4614},"Bychkova Nv",{"id":4616,"sortIndex":96,"researcher":19,"roles":4617,"affiliations":4618,"properties":4625},"7efe69e2-8efd-41bf-b19b-59487e881618",[],[4619],{"id":4620,"sortIndex":20,"affiliation":4621,"properties":19},"6317356b-7185-4c76-bdd7-954f38a670df",{"id":4494,"createTime":4495,"updateTime":4496,"relativeEntities":4622,"slug":4498,"properties":4623,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4624},{"VI":4501},{"openalex":4626,"orcid":4628,"title":4630},{"VOID":4627},"A5090053515",{"VOID":4629},"https:\u002F\u002Forcid.org\u002F0000-0002-2608-0147",{"EN":4631},"Boris A. Margulis",{"url":19,"publisher":4633,"properties":4649},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":4634,"slug":10,"properties":4635,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":4639,"manageAffiliations":4640,"indexDatabases":4641,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":4636,"issn":4637,"title":4638},{"VOID":13},{"VOID":15},{"EN":10},[],[],[4642],{"id":44,"indexDatabase":4643,"url":57,"indexYears":58,"academicFieldIds":4648,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":4644,"label":4645,"description":4646,"key":54,"publicationTags":4647,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":4650,"pages":4651,"issue":4653},{"VOID":1407},{"VOID":4652},"3101-3114",{"VOID":1411},42,{"total":4654,"publishYear":19,"statisticByYear":4656},{"2014":112,"2015":96,"2016":326,"2017":96,"2018":422,"2019":249,"2020":225,"2021":350,"2022":112,"2023":422,"2024":350},[4658,4662,4666,4670,4674,4678,4682,4686,4690,4693,4697,4701,4705,4709,4713,4717,4721,4725,4729,4733,4737,4741,4745,4749,4753,4757,4761,4765,4769,4773,4777,4781,4785,4789,4793,4797,4801,4805,4808,4812,4815,4819,4823],{"id":19,"text":4659,"url":19,"identifiers":4660},"Ciocca, 2008, Heat shock proteins: stress proteins with Janus-like properties in cancer, Int J Hyperthermia, 24, 31, 10.1080\u002F02656730701858305",{"doi":4661},"10.1080\u002F02656730701858305",{"id":19,"text":4663,"url":19,"identifiers":4664},"Multhoff, 2004, The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells, J Immunol, 172, 972, 10.4049\u002Fjimmunol.172.2.972",{"doi":4665},"10.4049\u002Fjimmunol.172.2.972",{"id":19,"text":4667,"url":19,"identifiers":4668},"Telford, 2002, Translocation of cytoplasmic HSP70 onto the surface of EL-4 cells during apoptosis, Cell Prolif, 35, 193, 10.1046\u002Fj.1365-2184.2002.00239.x",{"doi":4669},"10.1046\u002Fj.1365-2184.2002.00239.x",{"id":19,"text":4671,"url":19,"identifiers":4672},"Sapozhnikov, 2000, Splenic cytotoxic cells recognize surface HSP70 on culture-adapted EL-4 mouse lymphoma cells, Immunol Lett, 74, 133, 10.1016\u002FS0165-2478(00)00256-X",{"doi":4673},"10.1016\u002FS0165-2478(00)00256-X",{"id":19,"text":4675,"url":19,"identifiers":4676},"Houghton, 2000, Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70, Proc Natl Acad Sci USA, 97, 3485, 10.1073\u002Fpnas.97.7.3485",{"doi":4677},"10.1073\u002Fpnas.97.7.3485",{"id":19,"text":4679,"url":19,"identifiers":4680},"Eiz-Vesper, 2009, Heat shock protein 70 (HSP70) induces cytotoxicity of T helper cells, Blood, 113, 3008, 10.1182\u002Fblood-2008-06-162727",{"doi":4681},"10.1182\u002Fblood-2008-06-162727",{"id":19,"text":4683,"url":19,"identifiers":4684},"Srivastava, 2002, Roles of heat-shock proteins in innate and adaptive immunity, Nat Rev Immunol, 2, 185, 10.1038\u002Fnri749",{"doi":4685},"10.1038\u002Fnri749",{"id":19,"text":4687,"url":19,"identifiers":4688},"Calderwood, 2002, Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4, J Biol Chem, 277, 15028, 10.1074\u002Fjbc.M200497200",{"doi":4689},"10.1074\u002Fjbc.M200497200",{"id":19,"text":4691,"url":19,"identifiers":4692},"Medvedeva, 2006, Extracellular heat shock protein 70 mediates heat stress-induced epidermal growth factor receptor transactivation in A431 carcinoma cells, FEBS Lett, 58, 6674",{},{"id":19,"text":4694,"url":19,"identifiers":4695},"Multhoff, 2007, Heat shock proteins in cancer, Ann NY Acad Sci, 1113, 192, 10.1196\u002Fannals.1391.030",{"doi":4696},"10.1196\u002Fannals.1391.030",{"id":19,"text":4698,"url":19,"identifiers":4699},"Margulis, 2001, In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance, Brain Res, 914, 66, 10.1016\u002FS0006-8993(01)02774-3",{"doi":4700},"10.1016\u002FS0006-8993(01)02774-3",{"id":19,"text":4702,"url":19,"identifiers":4703},"Guzhova, 2005, Treatment with extracellular HSP70\u002FHSC70 protein can reduce polyglutamine toxicity and aggregation, J Neurochem, 94, 597, 10.1111\u002Fj.1471-4159.2005.03119.x",{"doi":4704},"10.1111\u002Fj.1471-4159.2005.03119.x",{"id":19,"text":4706,"url":19,"identifiers":4707},"De Maio, 2004, Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability, FASEB J, 18, 1636, 10.1096\u002Ffj.04-2088com",{"doi":4708},"10.1096\u002Ffj.04-2088com",{"id":19,"text":4710,"url":19,"identifiers":4711},"Calderwood, 2011, Investigating receptors for extracellular heat shock proteins, Methods Mol Biol, 787, 289, 10.1007\u002F978-1-61779-295-3_22",{"doi":4712},"10.1007\u002F978-1-61779-295-3_22",{"id":19,"text":4714,"url":19,"identifiers":4715},"Melani, 2004, Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70, Cancer Res, 64, 1502, 10.1158\u002F0008-5472.CAN-03-2936",{"doi":4716},"10.1158\u002F0008-5472.CAN-03-2936",{"id":19,"text":4718,"url":19,"identifiers":4719},"Su, 2014, Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy, Oncotarget, 5, 150, 10.18632\u002Foncotarget.1430",{"doi":4720},"10.18632\u002Foncotarget.1430",{"id":19,"text":4722,"url":19,"identifiers":4723},"Feng, 2006, HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma, Int J Cancer, 118, 2657, 10.1002\u002Fijc.21795",{"doi":4724},"10.1002\u002Fijc.21795",{"id":19,"text":4726,"url":19,"identifiers":4727},"Kobayashi, 2004, Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma, Cancer Immunol Immunother, 53, 26, 10.1007\u002Fs00262-003-0416-5",{"doi":4728},"10.1007\u002Fs00262-003-0416-5",{"id":19,"text":4730,"url":19,"identifiers":4731},"Margulis, 2013, Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool, Cell Stress Chaperones, 18, 391, 10.1007\u002Fs12192-012-0391-x",{"doi":4732},"10.1007\u002Fs12192-012-0391-x",{"id":19,"text":4734,"url":19,"identifiers":4735},"Multhoff, 2011, Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70. 1 antibody, Proc Natl Acad Sci USA, 108, 733, 10.1073\u002Fpnas.1016065108",{"doi":4736},"10.1073\u002Fpnas.1016065108",{"id":19,"text":4738,"url":19,"identifiers":4739},"Murphy, 2013, A modified HSP70 inhibitor shows broad activity as an anticancer agent, Mol Cancer Res, 11, 219, 10.1158\u002F1541-7786.MCR-12-0547-T",{"doi":4740},"10.1158\u002F1541-7786.MCR-12-0547-T",{"id":19,"text":4742,"url":19,"identifiers":4743},"Zuiderweg, 2011, Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones, J Mol Biol, 411, 614, 10.1016\u002Fj.jmb.2011.06.003",{"doi":4744},"10.1016\u002Fj.jmb.2011.06.003",{"id":19,"text":4746,"url":19,"identifiers":4747},"Clague, 1999, Regulation of endosome fusion, Mol Membr Biol, 16, 73, 10.1080\u002F096876899294788",{"doi":4748},"10.1080\u002F096876899294788",{"id":19,"text":4750,"url":19,"identifiers":4751},"Gudkov, 2011, Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib, Oncotarget, 2, 209, 10.18632\u002Foncotarget.246",{"doi":4752},"10.18632\u002Foncotarget.246",{"id":19,"text":4754,"url":19,"identifiers":4755},"Blagosklonny, 2006, Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection, Cell Death Differ, 13, 1434, 10.1038\u002Fsj.cdd.4401812",{"doi":4756},"10.1038\u002Fsj.cdd.4401812",{"id":19,"text":4758,"url":19,"identifiers":4759},"Acharya, 2009, Autologous Hsp70 induces antigen specific Th1 immune responses in a murine T-cell lymphoma, Immunol Invest, 38, 449, 10.1080\u002F08820130902802673",{"doi":4760},"10.1080\u002F08820130902802673",{"id":19,"text":4762,"url":19,"identifiers":4763},"Multhoff, 2005, Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells, Cancer Res, 65, 5238, 10.1158\u002F0008-5472.CAN-04-3804",{"doi":4764},"10.1158\u002F0008-5472.CAN-04-3804",{"id":19,"text":4766,"url":19,"identifiers":4767},"Multhoff, 2009, Activation of natural killer cells by heat shock protein 70. 2002, Int J Hyperthermia, 25, 169, 10.1080\u002F02656730902902001",{"doi":4768},"10.1080\u002F02656730902902001",{"id":19,"text":4770,"url":19,"identifiers":4771},"Margulis, 2013, Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy, Int J Hyperthermia, 29, 399, 10.3109\u002F02656736.2013.807439",{"doi":4772},"10.3109\u002F02656736.2013.807439",{"id":19,"text":4774,"url":19,"identifiers":4775},"Gestwicki, 2009, Pharmacological targeting of the Hsp70 chaperone, Curr Top Med Chem, 9, 1337, 10.2174\u002F156802609789895674",{"doi":4776},"10.2174\u002F156802609789895674",{"id":19,"text":4778,"url":19,"identifiers":4779},"Lippincott-Schwartz, 2009, New roles for endosomes: from vesicular carriers to multi-purpose platforms, Nat Rev Mol Cell Biol, 10, 287, 10.1038\u002Fnrm2652",{"doi":4780},"10.1038\u002Fnrm2652",{"id":19,"text":4782,"url":19,"identifiers":4783},"Bernhagen, 2012, Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF, Eur J Cell Biol, 91, 435, 10.1016\u002Fj.ejcb.2011.08.006",{"doi":4784},"10.1016\u002Fj.ejcb.2011.08.006",{"id":19,"text":4786,"url":19,"identifiers":4787},"Gray, 2007, Extracellular heat shock proteins in cell signaling and immunity, Ann NY Acad Sci, 1113, 28, 10.1196\u002Fannals.1391.019",{"doi":4788},"10.1196\u002Fannals.1391.019",{"id":19,"text":4790,"url":19,"identifiers":4791},"Wieland, 2002, CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes, J Cell Biol, 158, 1277, 10.1083\u002Fjcb.200208083",{"doi":4792},"10.1083\u002Fjcb.200208083",{"id":19,"text":4794,"url":19,"identifiers":4795},"Margulis, 2014, Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma, Neuro-Oncology, 16, 38, 10.1093\u002Fneuonc\u002Fnot141",{"doi":4796},"10.1093\u002Fneuonc\u002Fnot141",{"id":19,"text":4798,"url":19,"identifiers":4799},"Klumperman, 2008, Imaging and imagination: understanding the endo-lysosomal system, Histochem Cell Biol, 129, 253, 10.1007\u002Fs00418-008-0384-0",{"doi":4800},"10.1007\u002Fs00418-008-0384-0",{"id":19,"text":4802,"url":19,"identifiers":4803},"Helenius, 2011, Endosome maturation, EMBO J, 30, 3481, 10.1038\u002Femboj.2011.286",{"doi":4804},"10.1038\u002Femboj.2011.286",{"id":19,"text":4806,"url":19,"identifiers":4807},"Calderwood, 2006, Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes, J Immunol, 17, 7849",{},{"id":19,"text":4809,"url":19,"identifiers":4810},"Min, 2012, Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro, J Biol Chem, 287, 15874, 10.1074\u002Fjbc.M112.340588",{"doi":4811},"10.1074\u002Fjbc.M112.340588",{"id":19,"text":4813,"url":19,"identifiers":4814},"Li, 2008, Activation of NK cells by extracellular heat shock protein 70 through induction of NKG2D ligands on dendritic cells, Cancer Immun, 8, 12",{},{"id":19,"text":4816,"url":19,"identifiers":4817},"Tanaka, 2012, Kaisho T, Udono H. Differential MyD88\u002FIRAK4 requirements for cross-priming and tumor rejection induced by heat shock protein 70-model antigen fusion protein, Cancer Sci, 103, 851, 10.1111\u002Fj.1349-7006.2012.02233.x",{"doi":4818},"10.1111\u002Fj.1349-7006.2012.02233.x",{"id":19,"text":4820,"url":19,"identifiers":4821},"Vígh, 2007, Hyperfluidization-coupled membrane microdomain reorganization is linked to activation of the heat shock response in a murine melanoma cell line, Proc Natl Acad Sci USA, 104, 7945, 10.1073\u002Fpnas.0702557104",{"doi":4822},"10.1073\u002Fpnas.0702557104",{"id":19,"text":4824,"url":19,"identifiers":4825},"Margulis, 2011, Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of Huntington disease, Hum Mol Genet, 20, 3953, 10.1093\u002Fhmg\u002Fddr314",{"doi":4826},"10.1093\u002Fhmg\u002Fddr314",{"id":4828,"createTime":4829,"updateTime":4829,"relativeEntities":4830,"slug":4831,"properties":4832,"entityType":87,"verifyStatus":88,"verifyTime":4829,"verifyNote":89,"syncStatus":18,"languages":4847,"translateLanguages":19,"viewCount":20,"primaryUrl":4848,"fullTextUrl":19,"authors":4849,"publicationType":442,"publisherRelationship":5104,"citationCount":5127,"citationInfo":5128,"publishDate":5133,"publishYear":4322,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":5134,"isForceReanalyzing":585},"a6372d76-11c2-4d72-9d5d-6788d4c02eb5","2024-10-12T23:55:51.751+00:00",[],"Results-and-adverse-events-of-personalized-peptide-receptor-radionuclide-therapy-with-90Yttrium-and-177Lutetium-in-1048-patients-with-neuroendocrine-neoplasms",{"mag":4833,"keywords":4835,"pmc":4836,"openalex":4838,"abstract":4840,"title":4841,"pm":4843,"doi":4845},{"VOID":4834},"2790526699",{},{"VOID":4837},"5908296",{"VOID":4839},"W2790526699",{},{"EN":4842},"Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms",{"VOID":4844},"29682195",{"VOID":4846},"10.18632\u002Foncotarget.24524",[91],"https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.24524",[4850,4881,4902,4919,4938,4960,4977,4998,5019,5036,5051,5068,5089],{"id":4851,"sortIndex":177,"researcher":19,"roles":4852,"affiliations":4853,"properties":4874},"3e3c4112-e2fe-430e-9f5e-a7c8b2ecbfbe",[],[4854,4864],{"id":4855,"sortIndex":112,"affiliation":4856,"properties":19},"7902b710-9e91-47be-a884-2470d354a7ba",{"id":4857,"createTime":4858,"updateTime":4858,"relativeEntities":4859,"slug":4860,"properties":4861,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"3f662607-298c-4bd7-8712-137379025377","2024-10-12T23:55:51.857+00:00",[],"Department-of-Radiology-GROW-School-for-Oncology-and-Developmental-Biology-Maastricht-University-Hospital-Maastricht-The-Netherlands",{"title":4862},{"EN":4863},"Department of Radiology, GROW - School for Oncology and Developmental Biology, Maastricht University Hospital, Maastricht, The Netherlands",{"id":4865,"sortIndex":20,"affiliation":4866,"properties":19},"db714e15-d289-4cff-9379-a04b60cce7c7",{"id":4867,"createTime":4868,"updateTime":4868,"relativeEntities":4869,"slug":4870,"properties":4871,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"cae6a9b0-11f2-4c25-9574-323b11b195b7","2024-10-12T23:55:51.854+00:00",[],"Department-of-Radiation-Oncology-The-D-Lab-GROW-School-for-Oncology-and-Developmental-Biology-Maastricht-University-Maastricht-The-Netherlands",{"title":4872},{"EN":4873},"Department of Radiation Oncology (The D-Lab), GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands",{"openalex":4875,"orcid":4877,"title":4879},{"VOID":4876},"A5058987737",{"VOID":4878},"https:\u002F\u002Forcid.org\u002F0000-0001-7961-0191",{"EN":4880},"Philippe Lambin",{"id":4882,"sortIndex":112,"researcher":19,"roles":4883,"affiliations":4884,"properties":4895},"9bef6d59-cef3-4925-816a-75ba3a390c90",[],[4885],{"id":4886,"sortIndex":20,"affiliation":4887,"properties":19},"72053f53-4645-4e56-ab19-8f0949e20f41",{"id":4888,"createTime":4889,"updateTime":4889,"relativeEntities":4890,"slug":4891,"properties":4892,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"1506d498-5468-4ca1-9da9-aba2501d8429","2024-10-12T23:55:51.777+00:00",[],"THERANOSTICS-Center-for-Molecular-Radiotherapy-Zentralklinik-Bad-Berka-GmbH-Bad-Berka-Germany",{"title":4893},{"EN":4894},"THERANOSTICS Center for Molecular Radiotherapy, Zentralklinik Bad Berka GmbH, Bad Berka, Germany",{"openalex":4896,"orcid":4898,"title":4900},{"VOID":4897},"A5009383052",{"VOID":4899},"https:\u002F\u002Forcid.org\u002F0000-0001-6164-3163",{"EN":4901},"Harshad Kulkarni",{"id":4903,"sortIndex":267,"researcher":19,"roles":4904,"affiliations":4905,"properties":4912},"4df03252-629e-4589-b053-acdf1e65e60c",[],[4906],{"id":4907,"sortIndex":20,"affiliation":4908,"properties":19},"4c94fecf-1afb-4c21-89d9-648ac41c7c5d",{"id":4857,"createTime":4858,"updateTime":4858,"relativeEntities":4909,"slug":4860,"properties":4910,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4911},{"EN":4863},{"openalex":4913,"orcid":4915,"title":4917},{"VOID":4914},"A5045307668",{"VOID":4916},"https:\u002F\u002Forcid.org\u002F0000-0002-7048-7825",{"EN":4918},"Arthur Jochems",{"id":4920,"sortIndex":285,"researcher":19,"roles":4921,"affiliations":4922,"properties":4933},"93c6d5dc-4fc4-4162-8533-c29410bc085e",[],[4923],{"id":4924,"sortIndex":20,"affiliation":4925,"properties":19},"da5702e7-f9bd-402a-8128-c251a7856393",{"id":4926,"createTime":4927,"updateTime":4927,"relativeEntities":4928,"slug":4929,"properties":4930,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"9cb192fd-93c6-4b63-9f51-91042018caf0","2024-10-12T23:55:51.835+00:00",[],"Lohmann-and-Birkner-Berlin-Germany",{"title":4931},{"EN":4932},"Lohmann and Birkner, Berlin, Germany",{"openalex":4934,"title":4936},{"VOID":4935},"A5029591162",{"EN":4937},"Holger Franz",{"id":4939,"sortIndex":422,"researcher":19,"roles":4940,"affiliations":4941,"properties":4953},"7d7a076b-c6b6-488a-a24a-e4e1b87c7391",[],[4942],{"id":4943,"sortIndex":20,"affiliation":4944,"properties":19},"bcee3605-66a5-4818-bc45-bbcb618d25ec",{"id":4945,"createTime":4946,"updateTime":4947,"relativeEntities":4948,"slug":4949,"properties":4950,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"630dd568-ad90-4c24-9223-a52a9941ae1c","2024-02-09T01:56:56.719+00:00","2024-10-12T23:55:51.769+00:00",[],"Department-of-General-and-Visceral-Surgery-Zentralklinik-Bad-Berka-GmbH-Bad-Berka-Germany",{"title":4951},{"VI":4952},"Department of General and Visceral Surgery, Zentralklinik Bad Berka GmbH, Bad Berka, Germany",{"openalex":4954,"orcid":4956,"title":4958},{"VOID":4955},"A5009887617",{"VOID":4957},"https:\u002F\u002Forcid.org\u002F0000-0002-7475-1259",{"EN":4959},"Daniel Kaemmerer",{"id":4961,"sortIndex":225,"researcher":19,"roles":4962,"affiliations":4963,"properties":4970},"82d668f6-0822-4666-9ab2-a733493767a4",[],[4964],{"id":4965,"sortIndex":20,"affiliation":4966,"properties":19},"d9cd2ffd-57a3-40af-9e2b-6be7fe46482a",{"id":4888,"createTime":4889,"updateTime":4889,"relativeEntities":4967,"slug":4891,"properties":4968,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":4969},{"EN":4894},{"openalex":4971,"orcid":4973,"title":4975},{"VOID":4972},"A5039341643",{"VOID":4974},"https:\u002F\u002Forcid.org\u002F0000-0001-6270-9355",{"EN":4976},"Aviral Singh",{"id":4978,"sortIndex":130,"researcher":19,"roles":4979,"affiliations":4980,"properties":4991},"8a912a3e-858b-48ff-a04e-50aa1438bc7e",[],[4981],{"id":4982,"sortIndex":20,"affiliation":4983,"properties":19},"caad9620-cbaa-425a-abca-c7ad6daa12d9",{"id":4984,"createTime":4985,"updateTime":4985,"relativeEntities":4986,"slug":4987,"properties":4988,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"c7f4b37a-c094-48e6-bc11-025b5a178758","2024-10-12T23:55:51.845+00:00",[],"Department-of-Gastroenterology-Endocrinology-Center-for-Neuroendocrine-Tumors-Bad-Berka-ENETS-Center-of-Excellence-Zentralklinik-Bad-Berka-GmbH-Bad-Berka-Germany",{"title":4989},{"EN":4990},"Department of Gastroenterology\u002FEndocrinology, Center for Neuroendocrine Tumors Bad Berka - ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Bad Berka, Germany",{"openalex":4992,"orcid":4994,"title":4996},{"VOID":4993},"A5083493576",{"VOID":4995},"https:\u002F\u002Forcid.org\u002F0000-0002-4872-4337",{"EN":4997},"Dieter Hörsch",{"id":4999,"sortIndex":249,"researcher":19,"roles":5000,"affiliations":5001,"properties":5012},"4364ada8-b2e7-45c7-95af-b12c0c862436",[],[5002],{"id":5003,"sortIndex":20,"affiliation":5004,"properties":19},"6bbb154a-249a-4d0c-8da2-f232c6faba8a",{"id":5005,"createTime":5006,"updateTime":5006,"relativeEntities":5007,"slug":5008,"properties":5009,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"eed3eb92-1f92-43c1-87c6-a5b5de467f7d","2024-10-12T23:55:51.809+00:00",[],"Clinic-for-Nuclear-Medicine-Charit%C3%A9-Berlin-Germany",{"title":5010},{"EN":5011},"Clinic for Nuclear Medicine, Charité, Berlin, Germany",{"openalex":5013,"orcid":5015,"title":5017},{"VOID":5014},"A5062424480",{"VOID":5016},"https:\u002F\u002Forcid.org\u002F0000-0003-2010-4117",{"EN":5018},"Vikas Prasad",{"id":5020,"sortIndex":20,"researcher":19,"roles":5021,"affiliations":5022,"properties":5029},"02e0ef99-694b-495c-858a-8377b101fc74",[],[5023],{"id":5024,"sortIndex":20,"affiliation":5025,"properties":19},"fbfc6d71-f582-4a2d-bb61-a5a0faa1989f",{"id":4888,"createTime":4889,"updateTime":4889,"relativeEntities":5026,"slug":4891,"properties":5027,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5028},{"EN":4894},{"openalex":5030,"orcid":5032,"title":5034},{"VOID":5031},"A5051446048",{"VOID":5033},"https:\u002F\u002Forcid.org\u002F0000-0003-1723-0075",{"EN":5035},"Richard P. Baum",{"id":5037,"sortIndex":96,"researcher":19,"roles":5038,"affiliations":5039,"properties":5046},"7252d3ef-f2e4-45d7-b8b9-701ef1d4cdf2",[],[5040],{"id":5041,"sortIndex":20,"affiliation":5042,"properties":19},"de1f3eca-9fbf-4288-9b7d-0dfa7c1edd76",{"id":4945,"createTime":4946,"updateTime":4947,"relativeEntities":5043,"slug":4949,"properties":5044,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5045},{"VI":4952},{"openalex":5047,"title":5049},{"VOID":5048},"A5079676133",{"EN":5050},"Merten Hommann",{"id":5052,"sortIndex":350,"researcher":19,"roles":5053,"affiliations":5054,"properties":5061},"2582e067-41f8-46d5-bbc6-5de297c756d9",[],[5055],{"id":5056,"sortIndex":20,"affiliation":5057,"properties":19},"157eb445-abf5-4dd3-a9c4-dfe2a6ea8cf1",{"id":4888,"createTime":4889,"updateTime":4889,"relativeEntities":5058,"slug":4891,"properties":5059,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5060},{"EN":4894},{"openalex":5062,"orcid":5064,"title":5066},{"VOID":5063},"A5035821203",{"VOID":5065},"https:\u002F\u002Forcid.org\u002F0009-0001-2672-2496",{"EN":5067},"Dirk Müeller",{"id":5069,"sortIndex":326,"researcher":19,"roles":5070,"affiliations":5071,"properties":5082},"0d13e9d8-95ca-470c-a1bf-3bd1517e9c94",[],[5072],{"id":5073,"sortIndex":20,"affiliation":5074,"properties":19},"bbb28613-1505-445e-b23e-1da6da54afbd",{"id":5075,"createTime":5076,"updateTime":5076,"relativeEntities":5077,"slug":5078,"properties":5079,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"489da02e-4b28-4a91-9dcc-fb46f84ae5b0","2024-10-12T23:55:51.820+00:00",[],"Center-of-Molecular-Imaging-Zentralklinik-Bad-Berka-GmbH-Bad-Berka-Germany",{"title":5080},{"EN":5081},"Center of Molecular Imaging, Zentralklinik Bad Berka GmbH, Bad Berka, Germany",{"openalex":5083,"orcid":5085,"title":5087},{"VOID":5084},"A5090116787",{"VOID":5086},"https:\u002F\u002Forcid.org\u002F0009-0001-1077-0979",{"EN":5088},"F Robiller",{"id":5090,"sortIndex":201,"researcher":19,"roles":5091,"affiliations":5092,"properties":5099},"76b7660a-f3af-41bf-b58e-03cf773eb23a",[],[5093],{"id":5094,"sortIndex":20,"affiliation":5095,"properties":19},"8cedf250-1c7c-4013-94d5-b51a6cd68ee5",{"id":4888,"createTime":4889,"updateTime":4889,"relativeEntities":5096,"slug":4891,"properties":5097,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5098},{"EN":4894},{"openalex":5100,"title":5102},{"VOID":5101},"A5048954546",{"EN":5103},"Karin Niepsch",{"url":19,"publisher":5105,"properties":5121},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":5106,"slug":10,"properties":5107,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":5111,"manageAffiliations":5112,"indexDatabases":5113,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":5108,"issn":5109,"title":5110},{"VOID":13},{"VOID":15},{"EN":10},[],[],[5114],{"id":44,"indexDatabase":5115,"url":57,"indexYears":58,"academicFieldIds":5120,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":5116,"label":5117,"description":5118,"key":54,"publicationTags":5119,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":5122,"pages":5123,"issue":5125},{"VOID":3946},{"VOID":5124},"16932-16950",{"VOID":5126},"24",122,{"total":5127,"publishYear":19,"statisticByYear":5129},{"2017":112,"2018":422,"2019":5130,"2020":2966,"2021":5131,"2022":5132,"2023":267,"2024":130},20,19,27,"2018-03-30",[5135,5139,5143,5147,5151,5155,5159,5163,5167,5171,5174,5178,5182,5186,5190,5194,5198,5201,5205,5209,5213,5216,5220,5224,5228,5232,5236,5240,5244,5248,5252,5256,5260,5264,5267,5271,5274,5277,5281],{"id":19,"text":5136,"url":19,"identifiers":5137},"Delle Fave, 2016, Digestive neuroendocrine neoplasms: A 2016 overview, Dig Liver Dis, 48, 829, 10.1016\u002Fj.dld.2016.04.008",{"doi":5138},"10.1016\u002Fj.dld.2016.04.008",{"id":19,"text":5140,"url":19,"identifiers":5141},"Inzani, 2014, The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction, Endocr Pathol, 25, 186, 10.1007\u002Fs12022-014-9313-z",{"doi":5142},"10.1007\u002Fs12022-014-9313-z",{"id":19,"text":5144,"url":19,"identifiers":5145},"Klöppel, 2017, Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications, Visc Med, 33, 324, 10.1159\u002F000481390",{"doi":5146},"10.1159\u002F000481390",{"id":19,"text":5148,"url":19,"identifiers":5149},"Modlin, 2016, A short history of neuroendocrine tumours and their peptide hormones, Best Pract Res Clin Endocrinol Metab, 30, 3, 10.1016\u002Fj.beem.2015.10.004",{"doi":5150},"10.1016\u002Fj.beem.2015.10.004",{"id":19,"text":5152,"url":19,"identifiers":5153},"Krug, 2016, Neuroendocrine tumours - Medical therapy: Biological, Best Pract Res Clin Endocrinol Metab, 30, 79, 10.1016\u002Fj.beem.2015.09.004",{"doi":5154},"10.1016\u002Fj.beem.2015.09.004",{"id":19,"text":5156,"url":19,"identifiers":5157},"Arnold, 2017, Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival, Neuroendocrinology, 104, 26, 10.1159\u002F000443612",{"doi":5158},"10.1159\u002F000443612",{"id":19,"text":5160,"url":19,"identifiers":5161},"Martinez, 2016, Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study, Endocr Relat Cancer, 23, 191, 10.1530\u002FERC-15-0490",{"doi":5162},"10.1530\u002FERC-15-0490",{"id":19,"text":5164,"url":19,"identifiers":5165},"Delbeke, 2016, Safety and Efficacy of 68Ga-DOTATATE PET\u002FCT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors, J Nucl Med, 57, 708, 10.2967\u002Fjnumed.115.163865",{"doi":5166},"10.2967\u002Fjnumed.115.163865",{"id":19,"text":5168,"url":19,"identifiers":5169},"Krenning, 2016, Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer, Semin Nucl Med, 46, 225, 10.1053\u002Fj.semnuclmed.2015.12.003",{"doi":5170},"10.1053\u002Fj.semnuclmed.2015.12.003",{"id":19,"text":5172,"url":19,"identifiers":5173},"Kwekkeboom, 2016, PRRT of neuroendocrine tumours, Best Pract Res Clin Endocrinol Metab, 30, 103",{},{"id":19,"text":5175,"url":19,"identifiers":5176},"Baum, 2016, Effectiveness and side-effects of PRRT for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up, Eur J Cancer, 58, 41, 10.1016\u002Fj.ejca.2016.01.009",{"doi":5177},"10.1016\u002Fj.ejca.2016.01.009",{"id":19,"text":5179,"url":19,"identifiers":5180},"Baum, 2017, Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors, N Engl J Med, 376, 125, 10.1056\u002FNEJMoa1607427",{"doi":5181},"10.1056\u002FNEJMoa1607427",{"id":19,"text":5183,"url":19,"identifiers":5184},"Hacker, 2010, 68Ga-DOTATATE PET\u002FCT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors, J Nucl Med, 51, 1349, 10.2967\u002Fjnumed.110.075002",{"doi":5185},"10.2967\u002Fjnumed.110.075002",{"id":19,"text":5187,"url":19,"identifiers":5188},"Reichmann, 2012, Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate?, Clin Nucl Med, 37, e141, 10.1097\u002FRLU.0b013e31823926e5",{"doi":5189},"10.1097\u002FRLU.0b013e31823926e5",{"id":19,"text":5191,"url":19,"identifiers":5192},"Baum, 2012, Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET\u002FCT images in patients with metastasized neuroendocrine tumours undergoing PRRT, Eur J Nucl Med Mol Imaging, 39, 501, 10.1007\u002Fs00259-011-2003-x",{"doi":5193},"10.1007\u002Fs00259-011-2003-x",{"id":19,"text":5195,"url":19,"identifiers":5196},"Giesel, 2015, SUV of [68Ga]DOTATOC-PET\u002FCT Predicts Response Probability of PRRT in Neuroendocrine Tumors, Mol Imaging Biol, 17, 313, 10.1007\u002Fs11307-014-0795-3",{"doi":5197},"10.1007\u002Fs11307-014-0795-3",{"id":19,"text":5199,"url":19,"identifiers":5200},"van Echteld, 2017, [(177)Lu-DOTA](0)-D-Phe(1)-Tyr(3)-Octreotide ((177)Lu-DOTATOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II Study, Theranostics, 13, 501",{},{"id":19,"text":5202,"url":19,"identifiers":5203},"Beyer, 2016, Does receptor status impact survival of patients with mid-gut neuroendocrine tumors, J Clin Oncol, 34, 227, 10.1200\u002Fjco.2016.34.4_suppl.227",{"doi":5204},"10.1200\u002Fjco.2016.34.4_suppl.227",{"id":19,"text":5206,"url":19,"identifiers":5207},"Walter, 2012, Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers, J Clin Oncol, 30, 1100, 10.1200\u002FJCO.2011.37.2151",{"doi":5208},"10.1200\u002FJCO.2011.37.2151",{"id":19,"text":5210,"url":19,"identifiers":5211},"Turner, 2015, NeuroEndocrine Tumor Therapy with Lutetium-177-octreotate and Everolimus (NETTLE): A Phase I Study, Cancer Biother Radiopharm, 30, 261, 10.1089\u002Fcbr.2015.1876",{"doi":5212},"10.1089\u002Fcbr.2015.1876",{"id":19,"text":5214,"url":19,"identifiers":5215},"Turner, 2016, Pancreatic Neuroendocrine Tumor Control: Durable Objective Response to Combination 177Lu-Octreotate-Capecitabine-Temozolomide Radiopeptide Chemotherapy, Neuroendocrinology, 103, 32",{},{"id":19,"text":5217,"url":19,"identifiers":5218},"Öberg, 2016, Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study, J Clin Oncol, 34, 3906, 10.1200\u002FJCO.2016.68.0702",{"doi":5219},"10.1200\u002FJCO.2016.68.0702",{"id":19,"text":5221,"url":19,"identifiers":5222},"Turoglu, 2016, Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors, Nucl Med Commun, 37, 9, 10.1097\u002FMNM.0000000000000401",{"doi":5223},"10.1097\u002FMNM.0000000000000401",{"id":19,"text":5225,"url":19,"identifiers":5226},"Walter, 2011, Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers, J Clin Oncol, 29, 2416, 10.1200\u002FJCO.2010.33.7873",{"doi":5227},"10.1200\u002FJCO.2010.33.7873",{"id":19,"text":5229,"url":19,"identifiers":5230},"Turner, 2016, Myelotoxicity of PRRT of Neuroendocrine Tumors: A Decade of Experience, Cancer Biother Radiopharm, 31, 189, 10.1089\u002Fcbr.2016.2035",{"doi":5231},"10.1089\u002Fcbr.2016.2035",{"id":19,"text":5233,"url":19,"identifiers":5234},"Chiti, 2016, Myeloid neoplasms after chemotherapy and PRRT: myth and reality, Endocr Relat Cancer, 23, C1, 10.1530\u002FERC-16-0258",{"doi":5235},"10.1530\u002FERC-16-0258",{"id":19,"text":5237,"url":19,"identifiers":5238},"Ezziddin, 2013, Long-term hematotoxicity after PRRT with 177Lu-octreotate, J Nucl Med, 54, 1857, 10.2967\u002Fjnumed.112.119347",{"doi":5239},"10.2967\u002Fjnumed.112.119347",{"id":19,"text":5241,"url":19,"identifiers":5242},"Kwekkeboom, 2016, Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate, Eur J Nucl Med Mol Imaging, 43, 1802, 10.1007\u002Fs00259-016-3382-9",{"doi":5243},"10.1007\u002Fs00259-016-3382-9",{"id":19,"text":5245,"url":19,"identifiers":5246},"Kwekkeboom, 2013, The joint IAEA, EANM, and SNMMI practical guidance on PRRT (PRRNT) in neuroendocrine tumours, Eur J Nucl Med Mol Imaging, 40, 800, 10.1007\u002Fs00259-012-2330-6",{"doi":5247},"10.1007\u002Fs00259-012-2330-6",{"id":19,"text":5249,"url":19,"identifiers":5250},"Breeman, 2012, Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity, Bioconjug Chem, 23, 1712, 10.1021\u002Fbc300103t",{"doi":5251},"10.1021\u002Fbc300103t",{"id":19,"text":5253,"url":19,"identifiers":5254},"Schultz, 2016, Radiolabeling of DOTA-like conjugated peptides with generator-produced Ga-68 and using NaCl-based cationic elution method, Nat Protoc, 11, 1057, 10.1038\u002Fnprot.2016.060",{"doi":5255},"10.1038\u002Fnprot.2016.060",{"id":19,"text":5257,"url":19,"identifiers":5258},"Baum, 2007, Results of individual patient dosimetry in PRRT with 177Lu DOTA-TATE and 177Lu DOTA-NOC, Cancer Biother Radiopharm, 22, 406, 10.1089\u002Fcbr.2006.325",{"doi":5259},"10.1089\u002Fcbr.2006.325",{"id":19,"text":5261,"url":19,"identifiers":5262},"Baum, 2013, PRRT with (177)Lu labeled somatostatin analogs DOTATATE and DOTATOC: contrasting renal dosimetry in the same patient, Recent Results Cancer Res, 194, 551, 10.1007\u002F978-3-642-27994-2_32",{"doi":5263},"10.1007\u002F978-3-642-27994-2_32",{"id":19,"text":5265,"url":19,"identifiers":5266},"Baum, The Bad Berka dose protocol: comparative results of dosimetry in PRRT using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOC, Recent Results Cancer Res, 2013, 519",{},{"id":19,"text":5268,"url":19,"identifiers":5269},"Carreras, 2012, Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms, Semin Nucl Med, 42, 190, 10.1053\u002Fj.semnuclmed.2012.01.002",{"doi":5270},"10.1053\u002Fj.semnuclmed.2012.01.002",{"id":19,"text":5272,"url":19,"identifiers":5273},"R Core Team. R: A language and environment for statistical computing. R foundation for Statistical Computing, Vienna, Austria. 2012. Available online at http:\u002F\u002Fwww.R-project.org\u002F.",{},{"id":19,"text":5275,"url":19,"identifiers":5276},"Heiberger, 1992, In Statistical Models Eds JM Chambers & TJ Hastie",{},{"id":19,"text":5278,"url":19,"identifiers":5279},"Cox, 1972, Regression models and life tables (with discussion), Journal of the Royal Statistical Society, Series B, 34, 187, 10.1111\u002Fj.2517-6161.1972.tb00899.x",{"doi":5280},"10.1111\u002Fj.2517-6161.1972.tb00899.x",{"id":19,"text":5282,"url":19,"identifiers":5283},"Price, 1999, Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group, Eur J Cancer, 35, 1773, 10.1016\u002FS0959-8049(99)00229-4",{"doi":5284},"10.1016\u002FS0959-8049(99)00229-4",{"id":5286,"createTime":5287,"updateTime":5287,"relativeEntities":5288,"slug":5289,"properties":5290,"entityType":87,"verifyStatus":88,"verifyTime":5287,"verifyNote":89,"syncStatus":18,"languages":5305,"translateLanguages":19,"viewCount":20,"primaryUrl":5306,"fullTextUrl":19,"authors":5307,"publicationType":442,"publisherRelationship":5665,"citationCount":1291,"citationInfo":5688,"publishDate":5690,"publishYear":856,"citationAnalyzeStatus":18,"lastCitationAnalyze":19,"indexDatabases":19,"openAccess":19,"references":5691,"isForceReanalyzing":585},"428cf5e2-88b9-48b4-9f7c-68f9929f00d7","2024-10-12T23:55:46.418+00:00",[],"The-truncated-somatostatin-receptor-sst5TMD4-stimulates-the-angiogenic-process-and-is-associated-to-lymphatic-metastasis-and-disease-free-survival-in-breast-cancer-patients",{"mag":5291,"keywords":5293,"pmc":5294,"openalex":5296,"abstract":5298,"title":5299,"pm":5301,"doi":5303},{"VOID":5292},"2506380075",{},{"VOID":5295},"5312372",{"VOID":5297},"W2506380075",{},{"EN":5300},"The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients",{"VOID":5302},"27507050",{"VOID":5304},"10.18632\u002Foncotarget.11076",[91],"https:\u002F\u002Fwww.oncotarget.com\u002Flookup\u002Fdoi\u002F10.18632\u002Foncotarget.11076",[5308,5363,5380,5415,5450,5485,5506,5551,5566,5587,5608,5643],{"id":5309,"sortIndex":350,"researcher":19,"roles":5310,"affiliations":5311,"properties":5356},"aa64d250-a793-4516-bc5f-cef1faed1a6f",[],[5312,5323,5334,5345],{"id":5313,"sortIndex":112,"affiliation":5314,"properties":19},"e8ac9154-93d8-4d40-b2f2-cf6775d38189",{"id":5315,"createTime":5316,"updateTime":5317,"relativeEntities":5318,"slug":5319,"properties":5320,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"7a91588c-a2c2-4491-b596-c359743b5f33","2024-01-24T22:49:59.191+00:00","2024-10-12T23:55:46.441+00:00",[],"Department-of-Cell-Biology-Physiology-and-Immunology-University-of-Cordoba-Cordoba-Spain",{"title":5321},{"VI":5322},"Department of Cell Biology, Physiology and Immunology, University of Cordoba, Cordoba, Spain",{"id":5324,"sortIndex":20,"affiliation":5325,"properties":19},"48cf42eb-0483-41ca-b1c1-ae9bdac3f358",{"id":5326,"createTime":5327,"updateTime":5328,"relativeEntities":5329,"slug":5330,"properties":5331,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"ad909a61-730c-43a2-8afe-f19dc543db83","2024-01-16T00:21:08.660+00:00","2024-10-12T23:55:46.439+00:00",[],"CIBER-Physiopathology-of-Obesity-and-Nutrition-CIBERobn-Cordoba-Spain",{"title":5332},{"VI":5333},"CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Cordoba, Spain",{"id":5335,"sortIndex":225,"affiliation":5336,"properties":19},"db1ac504-fa56-4469-a401-57dee8cc6d10",{"id":5337,"createTime":5338,"updateTime":5339,"relativeEntities":5340,"slug":5341,"properties":5342,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"a42dd895-875f-4a54-8384-e04b42a2344b","2023-12-27T03:22:20.107+00:00","2024-10-12T23:55:46.443+00:00",[],"Maimonides-Institute-for-Biomedical-Research-of-Cordoba-IMIBIC-Cordoba-Spain",{"title":5343},{"VI":5344},"Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain",{"id":5346,"sortIndex":422,"affiliation":5347,"properties":19},"4cd2561b-3f43-4e05-9c03-239f7592c6c1",{"id":5348,"createTime":5349,"updateTime":5350,"relativeEntities":5351,"slug":5352,"properties":5353,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"8fa5aec9-6aff-4826-893e-91d6fc9ed05a","2024-01-16T00:21:08.702+00:00","2024-10-12T23:55:46.445+00:00",[],"Reina-Sofia-University-Hospital-HURS-Cordoba-Spain",{"title":5354},{"VI":5355},"Reina Sofia University Hospital (HURS), Cordoba, Spain",{"openalex":5357,"orcid":5359,"title":5361},{"VOID":5358},"A5047715168",{"VOID":5360},"https:\u002F\u002Forcid.org\u002F0000-0003-4649-0095",{"EN":5362},"Alejandro Ibáñez‐Costa",{"id":5364,"sortIndex":225,"researcher":19,"roles":5365,"affiliations":5366,"properties":5373},"dcdf2663-bb27-4ae4-90bb-d173bf4f4195",[],[5367],{"id":5368,"sortIndex":20,"affiliation":5369,"properties":19},"25b8216b-51ca-49a1-a9b7-f5c0018ccb89",{"id":5315,"createTime":5316,"updateTime":5317,"relativeEntities":5370,"slug":5319,"properties":5371,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5372},{"VI":5322},{"openalex":5374,"orcid":5376,"title":5378},{"VOID":5375},"A5000225422",{"VOID":5377},"https:\u002F\u002Forcid.org\u002F0000-0001-9652-5765",{"EN":5379},"Mario Durán‐Prado",{"id":5381,"sortIndex":112,"researcher":19,"roles":5382,"affiliations":5383,"properties":5408},"92b0e37d-728c-4508-b5f9-65076637c0f8",[],[5384,5390,5396,5402],{"id":5385,"sortIndex":225,"affiliation":5386,"properties":19},"6b1ad610-7d2c-4084-9571-bfa29ad65011",{"id":5337,"createTime":5338,"updateTime":5339,"relativeEntities":5387,"slug":5341,"properties":5388,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5389},{"VI":5344},{"id":5391,"sortIndex":112,"affiliation":5392,"properties":19},"44170f30-da8d-431d-843d-8a5d82194cef",{"id":5315,"createTime":5316,"updateTime":5317,"relativeEntities":5393,"slug":5319,"properties":5394,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5395},{"VI":5322},{"id":5397,"sortIndex":20,"affiliation":5398,"properties":19},"58a47129-cd39-42d8-8057-cdf5c829ebda",{"id":5326,"createTime":5327,"updateTime":5328,"relativeEntities":5399,"slug":5330,"properties":5400,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5401},{"VI":5333},{"id":5403,"sortIndex":422,"affiliation":5404,"properties":19},"60b4e2fe-4f5b-4a07-9079-1f734db17381",{"id":5348,"createTime":5349,"updateTime":5350,"relativeEntities":5405,"slug":5352,"properties":5406,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5407},{"VI":5355},{"openalex":5409,"orcid":5411,"title":5413},{"VOID":5410},"A5033270528",{"VOID":5412},"https:\u002F\u002Forcid.org\u002F0000-0002-6998-4920",{"EN":5414},"David Rincon Fernandez Pacheco",{"id":5416,"sortIndex":177,"researcher":19,"roles":5417,"affiliations":5418,"properties":5443},"071c7d00-ece0-4a6e-8e49-d59a7c2527bc",[],[5419,5425,5431,5437],{"id":5420,"sortIndex":422,"affiliation":5421,"properties":19},"ab367417-5037-49f5-a61d-e80363581e53",{"id":5348,"createTime":5349,"updateTime":5350,"relativeEntities":5422,"slug":5352,"properties":5423,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5424},{"VI":5355},{"id":5426,"sortIndex":20,"affiliation":5427,"properties":19},"817795c8-361d-4fd9-801d-0e258a3b9269",{"id":5326,"createTime":5327,"updateTime":5328,"relativeEntities":5428,"slug":5330,"properties":5429,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5430},{"VI":5333},{"id":5432,"sortIndex":225,"affiliation":5433,"properties":19},"ed9c80e9-7c14-4a79-9e57-68c43f83be6c",{"id":5337,"createTime":5338,"updateTime":5339,"relativeEntities":5434,"slug":5341,"properties":5435,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5436},{"VI":5344},{"id":5438,"sortIndex":112,"affiliation":5439,"properties":19},"8674c4f4-b4b6-4f8f-9383-2f011223a59c",{"id":5315,"createTime":5316,"updateTime":5317,"relativeEntities":5440,"slug":5319,"properties":5441,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5442},{"VI":5322},{"openalex":5444,"orcid":5446,"title":5448},{"VOID":5445},"A5059027410",{"VOID":5447},"https:\u002F\u002Forcid.org\u002F0000-0002-3145-7287",{"EN":5449},"Justo P. Castaño",{"id":5451,"sortIndex":20,"researcher":19,"roles":5452,"affiliations":5453,"properties":5478},"a0198d8c-ad74-463d-b828-02152c791aa4",[],[5454,5460,5466,5472],{"id":5455,"sortIndex":422,"affiliation":5456,"properties":19},"401e3459-8847-46dd-9d58-73887701ead7",{"id":5348,"createTime":5349,"updateTime":5350,"relativeEntities":5457,"slug":5352,"properties":5458,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5459},{"VI":5355},{"id":5461,"sortIndex":112,"affiliation":5462,"properties":19},"05ebc731-e16a-448f-947f-e5aa0fc6ee08",{"id":5315,"createTime":5316,"updateTime":5317,"relativeEntities":5463,"slug":5319,"properties":5464,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5465},{"VI":5322},{"id":5467,"sortIndex":225,"affiliation":5468,"properties":19},"3d71d830-a25e-4a6a-ab0e-b67ea9fda818",{"id":5337,"createTime":5338,"updateTime":5339,"relativeEntities":5469,"slug":5341,"properties":5470,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5471},{"VI":5344},{"id":5473,"sortIndex":20,"affiliation":5474,"properties":19},"3aaafc79-4b5f-4d1e-bb20-d1954d0d4b26",{"id":5326,"createTime":5327,"updateTime":5328,"relativeEntities":5475,"slug":5330,"properties":5476,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5477},{"VI":5333},{"openalex":5479,"orcid":5481,"title":5483},{"VOID":5480},"A5015262459",{"VOID":5482},"https:\u002F\u002Forcid.org\u002F0000-0002-4578-2179",{"EN":5484},"Manuel D. Gahete",{"id":5486,"sortIndex":285,"researcher":19,"roles":5487,"affiliations":5488,"properties":5499},"93e9f998-986e-457b-b94e-76a5d53efa74",[],[5489],{"id":5490,"sortIndex":20,"affiliation":5491,"properties":19},"2b6a3bb3-b172-4166-bf6c-c0d2ddcf9a79",{"id":5492,"createTime":5493,"updateTime":5493,"relativeEntities":5494,"slug":5495,"properties":5496,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"4d6f7335-d781-4973-bd61-f36cbe34389d","2024-10-12T23:55:46.466+00:00",[],"Department-of-Biochemistry-Universidad-Aut%C3%B3noma-de-Madrid-UAM-Instituto-de-Investigaciones-Biom%C3%A9dicas-Alberto-Sols-CSIC-UAM-IdiPAZ-MD-Anderson-Internacional-Foundation-Madrid-Spain",{"title":5497},{"EN":5498},"Department of Biochemistry, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas “Alberto Sols” (CSIC-UAM), IdiPAZ, MD Anderson Internacional Foundation, Madrid, Spain",{"openalex":5500,"orcid":5502,"title":5504},{"VOID":5501},"A5058485099",{"VOID":5503},"https:\u002F\u002Forcid.org\u002F0000-0002-5030-6687",{"EN":5505},"Gema Moreno–Bueno",{"id":5507,"sortIndex":267,"researcher":19,"roles":5508,"affiliations":5509,"properties":5544},"993a1498-483a-43f0-9498-e02a687ff477",[],[5510,5520,5526,5532,5538],{"id":5511,"sortIndex":20,"affiliation":5512,"properties":19},"cfa2cc3e-1363-4121-bce2-99d2e1b99b91",{"id":5513,"createTime":5514,"updateTime":5514,"relativeEntities":5515,"slug":5516,"properties":5517,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"ffe8062a-4b0d-4c30-b577-028798ac8af6","2024-10-12T23:55:46.534+00:00",[],"Anderson-Internacional-Foundation-Madrid-Spain",{"title":5518},{"EN":5519},"Anderson Internacional Foundation, Madrid, Spain",{"id":5521,"sortIndex":225,"affiliation":5522,"properties":19},"6875cc59-49bb-4792-98ba-cc1fa34d15e9",{"id":5315,"createTime":5316,"updateTime":5317,"relativeEntities":5523,"slug":5319,"properties":5524,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5525},{"VI":5322},{"id":5527,"sortIndex":422,"affiliation":5528,"properties":19},"e25211ba-2f07-4b3f-8da3-92acfa36f242",{"id":5337,"createTime":5338,"updateTime":5339,"relativeEntities":5529,"slug":5341,"properties":5530,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5531},{"VI":5344},{"id":5533,"sortIndex":112,"affiliation":5534,"properties":19},"27ccba63-fab5-4862-9564-cf34b918899d",{"id":5326,"createTime":5327,"updateTime":5328,"relativeEntities":5535,"slug":5330,"properties":5536,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5537},{"VI":5333},{"id":5539,"sortIndex":350,"affiliation":5540,"properties":19},"e2c7429c-a27b-4204-a826-b968b3da5005",{"id":5348,"createTime":5349,"updateTime":5350,"relativeEntities":5541,"slug":5352,"properties":5542,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5543},{"VI":5355},{"openalex":5545,"orcid":5547,"title":5549},{"VOID":5546},"A5006658221",{"VOID":5548},"https:\u002F\u002Forcid.org\u002F0000-0002-7585-1913",{"EN":5550},"Raúl M. Luque",{"id":5552,"sortIndex":422,"researcher":19,"roles":5553,"affiliations":5554,"properties":5561},"ab45bdc9-0209-42c1-9d27-8dfb59a5d743",[],[5555],{"id":5556,"sortIndex":20,"affiliation":5557,"properties":19},"6487687b-b059-414b-a560-fdbc7f7ebd20",{"id":5492,"createTime":5493,"updateTime":5493,"relativeEntities":5558,"slug":5495,"properties":5559,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5560},{"EN":5498},{"openalex":5562,"title":5564},{"VOID":5563},"A5067861199",{"EN":5565},"Marta Hergueta‐Redondo",{"id":5567,"sortIndex":201,"researcher":19,"roles":5568,"affiliations":5569,"properties":5580},"478f06bb-c01f-4f37-a0f7-1099bfaf4048",[],[5570],{"id":5571,"sortIndex":20,"affiliation":5572,"properties":19},"d17192db-8af8-4ddc-8af6-0f71bc7da102",{"id":5573,"createTime":5574,"updateTime":5574,"relativeEntities":5575,"slug":5576,"properties":5577,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"978fdea7-abe0-4e42-aba3-f775dcccac24","2024-10-12T23:55:46.504+00:00",[],"Tumor-Angiogenesis-Group-Catalan-Institute-of-Oncology-IDIBELL-L-Hospitalet-de-Llobregat-Barcelona-Spain",{"title":5578},{"EN":5579},"Tumor Angiogenesis Group, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain",{"openalex":5581,"orcid":5583,"title":5585},{"VOID":5582},"A5051072484",{"VOID":5584},"https:\u002F\u002Forcid.org\u002F0000-0002-4298-3995",{"EN":5586},"Oriol Casanovas",{"id":5588,"sortIndex":249,"researcher":19,"roles":5589,"affiliations":5590,"properties":5601},"c4742928-f4af-432e-ada7-f3bee434e0fb",[],[5591],{"id":5592,"sortIndex":20,"affiliation":5593,"properties":19},"a7b3b616-fe9d-495c-95c7-7b40937e5dfb",{"id":5594,"createTime":5595,"updateTime":5595,"relativeEntities":5596,"slug":5597,"properties":5598,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"32c45789-e946-49b1-8aa5-d8fa5180d073","2024-10-12T23:55:46.430+00:00",[],"Pathology-Deparment-MD-Anderson-Cancer-Center-Madrid-Spain",{"title":5599},{"EN":5600},"Pathology Deparment, MD Anderson Cancer Center, Madrid, Spain",{"openalex":5602,"orcid":5604,"title":5606},{"VOID":5603},"A5064332999",{"VOID":5605},"https:\u002F\u002Forcid.org\u002F0000-0001-6439-3518",{"EN":5607},"Alejandro Rojo‐Sebastián",{"id":5609,"sortIndex":96,"researcher":19,"roles":5610,"affiliations":5611,"properties":5636},"a368bdec-3502-47c3-8216-5ed0d8c9c9f2",[],[5612,5618,5624,5630],{"id":5613,"sortIndex":422,"affiliation":5614,"properties":19},"711f74f9-5d0c-4c0f-9997-f38d43721aeb",{"id":5348,"createTime":5349,"updateTime":5350,"relativeEntities":5615,"slug":5352,"properties":5616,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5617},{"VI":5355},{"id":5619,"sortIndex":112,"affiliation":5620,"properties":19},"9b639a5b-b8f5-400b-b3b1-70f520984d7b",{"id":5315,"createTime":5316,"updateTime":5317,"relativeEntities":5621,"slug":5319,"properties":5622,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5623},{"VI":5322},{"id":5625,"sortIndex":225,"affiliation":5626,"properties":19},"334e1c90-57d8-4208-abff-291decfadcef",{"id":5337,"createTime":5338,"updateTime":5339,"relativeEntities":5627,"slug":5341,"properties":5628,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5629},{"VI":5344},{"id":5631,"sortIndex":20,"affiliation":5632,"properties":19},"edf7c838-1d0e-4ed6-abf0-64662cae2309",{"id":5326,"createTime":5327,"updateTime":5328,"relativeEntities":5633,"slug":5330,"properties":5634,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},[],{"title":5635},{"VI":5333},{"openalex":5637,"orcid":5639,"title":5641},{"VOID":5638},"A5019349454",{"VOID":5640},"https:\u002F\u002Forcid.org\u002F0000-0003-2128-4228",{"EN":5642},"Francisco Gracia‐Navarro",{"id":5644,"sortIndex":326,"researcher":19,"roles":5645,"affiliations":5646,"properties":5658},"965d2418-3891-4b69-bb71-dce1da80d80c",[],[5647],{"id":5648,"sortIndex":20,"affiliation":5649,"properties":19},"ad060ba4-3e56-4040-ab1a-719db3e4b31c",{"id":5650,"createTime":5651,"updateTime":5652,"relativeEntities":5653,"slug":5654,"properties":5655,"entityType":40,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20},"4c68744c-d093-4209-96a3-251ef763ccfd","2024-10-12T23:55:21.068+00:00","2024-10-12T23:55:46.498+00:00",[],"Ipsen-Bioscience-Cambridge-Massachusetts-USA",{"title":5656},{"EN":5657},"Ipsen Bioscience, Cambridge, Massachusetts, USA",{"openalex":5659,"orcid":5661,"title":5663},{"VOID":5660},"A5031937268",{"VOID":5662},"https:\u002F\u002Forcid.org\u002F0000-0001-5168-8739",{"EN":5664},"Michael D. Culler",{"url":19,"publisher":5666,"properties":5682},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":5667,"slug":10,"properties":5668,"entityType":17,"verifyStatus":18,"verifyTime":19,"verifyNote":19,"syncStatus":18,"languages":19,"translateLanguages":19,"viewCount":20,"subjectFields":5672,"manageAffiliations":5673,"indexDatabases":5674,"url":62,"thumbnailPath":19,"statistic":19,"gsStatistic":19,"type":19,"analyzePriority":19},[],{"country":5669,"issn":5670,"title":5671},{"VOID":13},{"VOID":15},{"EN":10},[],[],[5675],{"id":44,"indexDatabase":5676,"url":57,"indexYears":58,"academicFieldIds":5681,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":5677,"label":5678,"description":5679,"key":54,"publicationTags":5680,"standard":19},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":5683,"pages":5684,"issue":5686},{"VOID":462},{"VOID":5685},"60110-60122",{"VOID":5687},"37",{"total":1291,"publishYear":19,"statisticByYear":5689},{"2016":112,"2017":350,"2018":249,"2019":422,"2020":112,"2022":225,"2023":112},"2016-09-13",[5692,5696,5700,5704,5708,5712,5716,5720,5724,5728,5732,5736,5740,5744,5748,5752,5756,5760,5764,5768,5772,5776,5780,5784,5788,5792,5796,5800,5804,5808,5812,5816,5820,5824,5828,5832,5836,5840,5844,5848,5851,5855,5859,5863,5867,5871,5875,5879,5883],{"id":19,"text":5693,"url":19,"identifiers":5694},"Jemal, 2014, Cancer statistics 2014, CA Cancer J Clin, 64, 9, 10.3322\u002Fcaac.21208",{"doi":5695},"10.3322\u002Fcaac.21208",{"id":19,"text":5697,"url":19,"identifiers":5698},"Weinberg, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016\u002FS0092-8674(00)81683-9",{"doi":5699},"10.1016\u002FS0092-8674(00)81683-9",{"id":19,"text":5701,"url":19,"identifiers":5702},"Weinberg, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016\u002Fj.cell.2011.02.013",{"doi":5703},"10.1016\u002Fj.cell.2011.02.013",{"id":19,"text":5705,"url":19,"identifiers":5706},"Ladomery, 2013, Aberrant Alternative Splicing Is Another Hallmark of Cancer, Int J Cell Biol, 2013, 463786, 10.1155\u002F2013\u002F463786",{"doi":5707},"10.1155\u002F2013\u002F463786",{"id":19,"text":5709,"url":19,"identifiers":5710},"Futreal, 2009, The cancer genome, Nature, 458, 719, 10.1038\u002Fnature07943",{"doi":5711},"10.1038\u002Fnature07943",{"id":19,"text":5713,"url":19,"identifiers":5714},"Castano, 2009, Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors, J Clin Endocrinol Metab, 94, 2634, 10.1210\u002Fjc.2008-2564",{"doi":5715},"10.1210\u002Fjc.2008-2564",{"id":19,"text":5717,"url":19,"identifiers":5718},"Zatelli, 2015, The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells, Endocrine, 50, 442, 10.1007\u002Fs12020-015-0594-x",{"doi":5719},"10.1007\u002Fs12020-015-0594-x",{"id":19,"text":5721,"url":19,"identifiers":5722},"Gahete, 2015, Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation invasion and reduced octreotide response) to somatotropinomas, Cancer Lett, 359, 299, 10.1016\u002Fj.canlet.2015.01.037",{"doi":5723},"10.1016\u002Fj.canlet.2015.01.037",{"id":19,"text":5725,"url":19,"identifiers":5726},"Vidal, 2014, The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer, PLoS One, 9, e85527, 10.1371\u002Fjournal.pone.0085527",{"doi":5727},"10.1371\u002Fjournal.pone.0085527",{"id":19,"text":5729,"url":19,"identifiers":5730},"Castano, 2012, The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells, Oncogene, 31, 2049, 10.1038\u002Fonc.2011.389",{"doi":5731},"10.1038\u002Fonc.2011.389",{"id":19,"text":5733,"url":19,"identifiers":5734},"Castano, 2011, Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology, Ann N Y Acad Sci, 1220, 6, 10.1111\u002Fj.1749-6632.2011.05985.x",{"doi":5735},"10.1111\u002Fj.1749-6632.2011.05985.x",{"id":19,"text":5737,"url":19,"identifiers":5738},"Castaño, 2010, A potential inhibitory role for the new truncated variant of somatostatin receptor 5 (sst5TMD4) in pituitary adenomas poorly responsive to somatostatin analogs, J Clin Endocrinol Metab, 95, 2497, 10.1210\u002Fjc.2009-2247",{"doi":5739},"10.1210\u002Fjc.2009-2247",{"id":19,"text":5741,"url":19,"identifiers":5742},"Rich, 2006, Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor, Cancer Res, 66, 7843, 10.1158\u002F0008-5472.CAN-06-1010",{"doi":5743},"10.1158\u002F0008-5472.CAN-06-1010",{"id":19,"text":5745,"url":19,"identifiers":5746},"Zakharenko, 2007, A perivascular niche for brain tumor stem cells, Cancer Cell, 11, 69, 10.1016\u002Fj.ccr.2006.11.020",{"doi":5747},"10.1016\u002Fj.ccr.2006.11.020",{"id":19,"text":5749,"url":19,"identifiers":5750},"Rich, 2008, Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis, J Clin Oncol, 26, 2839, 10.1200\u002FJCO.2007.15.1829",{"doi":5751},"10.1200\u002FJCO.2007.15.1829",{"id":19,"text":5753,"url":19,"identifiers":5754},"Kalluri, 2004, Cancer without disease, Nature, 427, 787, 10.1038\u002F427787a",{"doi":5755},"10.1038\u002F427787a",{"id":19,"text":5757,"url":19,"identifiers":5758},"Benjamin, 2003, Tumorigenesis and the angiogenic switch, Nat Rev Cancer, 3, 401, 10.1038\u002Fnrc1093",{"doi":5759},"10.1038\u002Fnrc1093",{"id":19,"text":5761,"url":19,"identifiers":5762},"Alitalo, 2009, Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system, Nat Rev Mol Cell Biol, 10, 165, 10.1038\u002Fnrm2639",{"doi":5763},"10.1038\u002Fnrm2639",{"id":19,"text":5765,"url":19,"identifiers":5766},"Ferrara, 1993, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature, 362, 841, 10.1038\u002F362841a0",{"doi":5767},"10.1038\u002F362841a0",{"id":19,"text":5769,"url":19,"identifiers":5770},"Benjamin, 2013, Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy, Cancer Res, 73, 1649, 10.1158\u002F0008-5472.CAN-12-4697",{"doi":5771},"10.1158\u002F0008-5472.CAN-12-4697",{"id":19,"text":5773,"url":19,"identifiers":5774},"Del Tacca, 1996, The effects of the somatostatin analog octreotide on angiogenesis in vitro, Metabolism, 45, 49, 10.1016\u002FS0026-0495(96)90080-3",{"doi":5775},"10.1016\u002FS0026-0495(96)90080-3",{"id":19,"text":5777,"url":19,"identifiers":5778},"Bagnoli, 2011, Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin, Naunyn Schmiedebergs Arch Pharmacol, 383, 593, 10.1007\u002Fs00210-011-0625-y",{"doi":5779},"10.1007\u002Fs00210-011-0625-y",{"id":19,"text":5781,"url":19,"identifiers":5782},"Bagnoli, 2007, Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice, Invest Ophthalmol Vis Sci, 48, 3480, 10.1167\u002Fiovs.06-1469",{"doi":5783},"10.1167\u002Fiovs.06-1469",{"id":19,"text":5785,"url":19,"identifiers":5786},"Bagnoli, 2003, Somatostatin inhibits potassium-evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina, Naunyn Schmiedebergs Arch Pharmacol, 367, 188, 10.1007\u002Fs00210-002-0662-7",{"doi":5787},"10.1007\u002Fs00210-002-0662-7",{"id":19,"text":5789,"url":19,"identifiers":5790},"Held-Feindt, 2001, Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells, Int J Cancer, 92, 545, 10.1002\u002Fijc.1223",{"doi":5791},"10.1002\u002Fijc.1223",{"id":19,"text":5793,"url":19,"identifiers":5794},"Cai, 2011, A randomized trial of somatostatin to regulate the VEGFs\u002FVEGFRs in patients with gastric cancer, Hepatogastroenterology, 58, 1425, 10.5754\u002Fhge10749",{"doi":5795},"10.5754\u002Fhge10749",{"id":19,"text":5797,"url":19,"identifiers":5798},"Qin, 2004, Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2, Pancreas, 29, 141, 10.1097\u002F00006676-200408000-00009",{"doi":5799},"10.1097\u002F00006676-200408000-00009",{"id":19,"text":5801,"url":19,"identifiers":5802},"Qin, 2004, Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts, Carcinogenesis, 25, 2075, 10.1093\u002Fcarcin\u002Fbgh216",{"doi":5803},"10.1093\u002Fcarcin\u002Fbgh216",{"id":19,"text":5805,"url":19,"identifiers":5806},"Qin, 2004, Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro, World J Gastroenterol, 10, 393, 10.3748\u002Fwjg.v10.i3.393",{"doi":5807},"10.3748\u002Fwjg.v10.i3.393",{"id":19,"text":5809,"url":19,"identifiers":5810},"Florio, 2008, Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors, Front Biosci, 13, 822, 10.2741\u002F2722",{"doi":5811},"10.2741\u002F2722",{"id":19,"text":5813,"url":19,"identifiers":5814},"Lamberts, 1994, Somatostatin-receptor scintigraphy in primary breast cancer, Lancet, 343, 640, 10.1016\u002FS0140-6736(94)92637-9",{"doi":5815},"10.1016\u002FS0140-6736(94)92637-9",{"id":19,"text":5817,"url":19,"identifiers":5818},"Cataliotti, 2004, Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue, Endocr Relat Cancer, 11, 323, 10.1677\u002Ferc.0.0110323",{"doi":5819},"10.1677\u002Ferc.0.0110323",{"id":19,"text":5821,"url":19,"identifiers":5822},"Kumar, 2008, Biology of somatostatin in breast cancer, Mol Cell Endocrinol, 286, 251, 10.1016\u002Fj.mce.2008.01.006",{"doi":5823},"10.1016\u002Fj.mce.2008.01.006",{"id":19,"text":5825,"url":19,"identifiers":5826},"Martin, 2007, Mechanisms of disease: angiogenesis and the management of breast cancer, Nat Clin Pract Oncol, 4, 536, 10.1038\u002Fncpneuro0859",{"doi":5827},"10.1038\u002Fncpneuro0859",{"id":19,"text":5829,"url":19,"identifiers":5830},"Spiegelman, 2008, HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha, Nature, 451, 1008, 10.1038\u002Fnature06613",{"doi":5831},"10.1038\u002Fnature06613",{"id":19,"text":5833,"url":19,"identifiers":5834},"Massague, 2009, Metastasis: from dissemination to organ-specific colonization, Nat Rev Cancer, 9, 274, 10.1038\u002Fnrc2622",{"doi":5835},"10.1038\u002Fnrc2622",{"id":19,"text":5837,"url":19,"identifiers":5838},"Groom, 1998, Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases, Am J Pathol, 153, 865, 10.1016\u002FS0002-9440(10)65628-3",{"doi":5839},"10.1016\u002FS0002-9440(10)65628-3",{"id":19,"text":5841,"url":19,"identifiers":5842},"Kang, 2007, Beyond tumorigenesis: cancer stem cells in metastasis, Cell Res, 17, 3, 10.1038\u002Fsj.cr.7310118",{"doi":5843},"10.1038\u002Fsj.cr.7310118",{"id":19,"text":5845,"url":19,"identifiers":5846},"Csiszar, 2011, Lysyl oxidase-like 2 (LOXL2) a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas, EMBO Mol Med, 3, 528, 10.1002\u002Femmm.201100156",{"doi":5847},"10.1002\u002Femmm.201100156",{"id":19,"text":5849,"url":19,"identifiers":5850},"Drexler, 2005, Detection of mycoplasma contaminations, Methods Mol Biol, 290, 13",{},{"id":19,"text":5852,"url":19,"identifiers":5853},"Castaño, 2011, A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance, PLoS One, 6, e23302, 10.1371\u002Fjournal.pone.0023302",{"doi":5854},"10.1371\u002Fjournal.pone.0023302",{"id":19,"text":5856,"url":19,"identifiers":5857},"Malagon, 2006, Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas, J Clin Endocrinol Metab, 91, 2225, 10.1210\u002Fjc.2006-0235",{"doi":5858},"10.1210\u002Fjc.2006-0235",{"id":19,"text":5860,"url":19,"identifiers":5861},"Gadelha, 2009, Expression analysis of dopamine receptor subtypes in normal human pituitaries nonfunctioning pituitary adenomas and somatotropinomas and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly, J Clin Endocrinol Metab, 94, 1931, 10.1210\u002Fjc.2008-1826",{"doi":5862},"10.1210\u002Fjc.2008-1826",{"id":19,"text":5864,"url":19,"identifiers":5865},"Gadelha, 2007, Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas, Eur J Endocrinol, 156, 65, 10.1530\u002Feje.1.02313",{"doi":5866},"10.1530\u002Feje.1.02313",{"id":19,"text":5868,"url":19,"identifiers":5869},"Lopez-Miranda, 2014, Dietary fat alters the expression of cortistatin and ghrelin systems in the PBMCs of elderly subjects: putative implications in the postprandial inflammatory response, Mol Nutr Food Res, 58, 1897, 10.1002\u002Fmnfr.201400059",{"doi":5870},"10.1002\u002Fmnfr.201400059",{"id":19,"text":5872,"url":19,"identifiers":5873},"Clarke, 2012, A detailed mammosphere assay protocol for the quantification of breast stem cell activity, J Mammary Gland Biol Neoplasia, 17, 111, 10.1007\u002Fs10911-012-9255-3",{"doi":5874},"10.1007\u002Fs10911-012-9255-3",{"id":19,"text":5876,"url":19,"identifiers":5877},"Eliceiri, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat Methods, 9, 671, 10.1038\u002Fnmeth.2089",{"doi":5878},"10.1038\u002Fnmeth.2089",{"id":19,"text":5880,"url":19,"identifiers":5881},"de Medina, 2010, Reversible Ponceau staining as a loading control alternative to actin in Western blots, Anal Biochem, 401, 318, 10.1016\u002Fj.ab.2010.02.036",{"doi":5882},"10.1016\u002Fj.ab.2010.02.036",{"id":19,"text":5884,"url":19,"identifiers":5885},"Hanahan, 2005, Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors, Cancer Cell, 8, 299, 10.1016\u002Fj.ccr.2005.09.005",{"doi":5886},"10.1016\u002Fj.ccr.2005.09.005"]